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Abstract
p21-activated kinases (PAKs) are downstream targets of many Rho GTPases. They have 
been implicated as regulators of cell migration but little is known of their isoform-specific 
functions. PAK upregulation in some cancers suggests that they could play an important 
role in invasion and metastasis, making them potential therapeutic targets. In this study 
RNA interference (RNAi) was used to investigate the roles of PAK 1, PAK2 and PAK4 in 
DU 145 and PC3 prostate cancer cells in response to hepatocyte growth factor (HGF), 
which stimulates cell migration.
RNAi knockdown of PAK 1, PAK2, or PAK4 did not affect the speed of DU 145 cell wound 
healing in vitro, but knockdown of PAK1 or PAK2 had distinct effects on DU 145 
morphology and scattering. PAK 1-deficient cells remained more spread and maintained 
more junctions than control cells following HGF stimulation. PAK2-deficient cells formed 
disorganised colonies and larger lamellipodia were observed after HGF treatment, which 
were enriched with ERK1/2 and GIT 1/2. Despite the cytoskeletal effects, PAK1 or PAK2 
knockdown did not inhibit DU 145 cell migration through transwells or invasion through 
Matrigel, and phosphorylation of many known PAK 1/2 substrates was unaffected. In PC3 
cells, knockdown of PAK1 or PAK2 but not PAK4 slowed the speed of migration and 
PAK2 impaired the HGF-induced phosphorylation of Op 18 suggesting that decreased 
microtubule stability may lead to the associated phenotype. PAK2 depletion in DU 145 or 
PC3 cells led to increased phosphorylation of PAK 1 at SI99/204, an autophosphorylation 
site which blocks PIX binding, whereas PAK1 knockdown had no effect on the 
phosphorylation of PAK2 at the homologous sites.
These results show that PAK1, PAK2 and PAK4 play distinct roles in cytoskeletal 
regulation, probably through shared and iso form-specific substrates. Op 18 is shown to be a 
likely PAK2 target and a novel regulatory mechanism from PAK2 to PAK1 is identified for 
the first time.
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Chapter 1: Introduction 
1.1: Cancer metastasis
Cancer is a multistep disease caused by gene mutations that lead to uncontrolled cell 
proliferation and formation of a tumour. One o f the factors leading to poor patient 
prognosis is cancer metastasis (Pantel et al., 2008). In this process, signalling pathways 
controlling cellxell junction stability and cell migration are deregulated allowing cells to 
escape the primary tumour, migrate to distal sites and establish secondary tumours 
(reviewed in Sahai, 2007). Understanding these signalling pathways will lead to the 
identification of potential therapeutic targets for the disease. Single cancer cells can migrate 
in vivo by two known mechanisms termed mesenchymal or amoeboid motility (Figure 1.1). 
The mesenchymal model of cell migration has been extensively studied because cells 
moving in vitro on a two dimensional (2D) substrate often migrate in this manner. Cells 
adhere to the substrate and extend protrusions at the leading edge such as large, flat 
lamellipodia or thin filopodia. New adhesion structures form at the front o f the cell and 
enzymes called matrix metalloproteinases (MMPs) are secreted to degrade the extracellular 
matrix (ECM) allowing the cell to move through. At the tail o f the cell, adhesions 
disassemble and contractile force pulls the cell forwards (reviewed in Ridley, 2001). 
Amoeboid migration is less well characterised but it is believed that the majority o f 
metastatic cancer cells migrate in this way. Cells migrating in an amoeboid manner are 
thought to form weaker celkmatrix adhesions than in mesenchymal migration and cells 
squeeze through the ECM rather than secreting enzymes to degrade it. Contractile force 
generates movement by hydrostatic pressure (reviewed in Sahai, 2005). Both modes o f cell 
migration are facilitated by the dynamic remodelling of the cell cytoskeleton and the 
breakdown o f cellxell junctions.
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(a) Receptors sense chemokine gradient 
and trigger actin polymerisation
Actin polymerisation at leading 
edge of cell.
Contractile force generated by 
thick actin cables enables 
translational of movement
Direction of movement
Cells move through matrix by 
using MMPs to degrade ECM
Large integrin-rich focal 
adhesions connect cell 
to ECM Small integrin-rich focal
contacts formed close to 
leading edge
(b)
contractile force in cortical 
actin generates hydrostatic 
pressure and promotes 
remodelling of cell shape
Cells squeeze in between 
gaps in the ECM
Receptors sense chemokine gradient 
and trigger actin polymerisation. This 
may spread through the cell cortex in 
a wave.
Direction of movement
Uniform diffuse integrin 
distribution
Figure 1.1: Mechanisms of ECM invasion by single cancer cells, a) In mesenchymal 
motility cells form strong integrin-based adhesions and migrate by protruding at the front 
and degrading the ECM, while contraction o f actin pulls the tail forward. Chemoreceptors 
at the front of the cell trigger actin polymerisation and facilitate the establishment o f cell 
polarity, b) In amoeboid migration adhesion is weak and actin contraction generates 
hydrostatic pressure to provide a driving force to remodel cell morphology. Receptors at the 
front of the cell sense the chemokine gradient to establish cell polarity. Taken from (Sahai, 
2005)
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1.2: The Cytoskeleton
1.2.1 Actin and myosin
The actin monomer (G-actin) is a protein with a molecular weight o f around 43 kDa. It 
contains a nucleotide binding site which binds ATP in a complex with Mg2+. Nucleotide 
binding serves to stabilise the actin monomer promoting polymerisation of filaments (F- 
actin) while subsequent adenosine triphosphate (ATP) hydrolysis and dissociation o f the 3 '- 
phosphate from F-actin functions as an indicator o f the age of the age of a filament (De La 
Cruz et al., 2000). Actin monomers polymerise in a right handed helix with 'barbed' and 
* pointed’ ends. Both ends o f the filament can accept and release actin monomers but 
filament assembly is favoured at the barbed end which generally points towards the plasma 
membrane.
In order for a new actin filament to polymerise, an initial actin nucleus must be formed 
which can then accept actin monomers. Actin dimers are unstable so this process is 
facilitated by actin nucleators four types of which are known in mammalian non-muscle 
cells: The actin-related protein 2/3 (Arp2/3) complex, comprising Arp2 and Arp3 
monomers together with five actin-related protein complex (ARPC) monomers, binds to an 
existing filament and is thought to mimic a new barbed end promoting a branched network 
of F-actin (reviewed in Goley and Welch, 2006); formins. which are a family of proteins 
that nucleate actin and remain bound to the barbed end of the extending filament (reviewed 
in Kovar. 2006); cordon-bleu, a newly identified actin nucleator that controls neuronal 
morphology ((Ahuja et al., 2007) and reviewed in Winckler and Schafer. 2007); and Spire, 
which was originally identified in Drosophila but is also found in mammals (reviewed in 
Kerkhoff, 2006). In muscle cells a further actin nucleator, Leiomodin has also recently been 
identified (Chereau et al., 2008).
Filament assembly, disassembly, branching and bundling are controlled by many actin 
binding proteins and much research is devoted to uncovering how they bring about the 
multitude of actin-based structures found in cells. Examples of these structures in motile 
cells are lamellipodia in the leading edge which contain a branched network of F-actin and 
filopodia which contain bundled F-actin in a finger-like protrusion (Figure 1.2).
19
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Figure 1.2: Actin-based structures at the leading edge of cells. A) A scanning electron 
micrograph o f a lamellipodium showing the actin network. B) Increased size image of 
bundled actin in a filopodium (Adapted from (Yang et al., 2007)).
The regulation underlying the generation of lamellipodia and filopodia is poorly 
understood. It is thought that Arp2/3 plays an important role in branching and nucleation in 
lamellipodia under the regulation o f its activator WASP-family verprolin homology protein 
(WAVE) (Lai et al., 2008; Sarmiento et al., 2008; and reviewed in Le Clainche and Carlier, 
2008). However, Arp2/3 also plays a role in filopodium formation so the architecture o f 
actin filaments at the leading edge is likely to be governed by a balance in the recruitment 
and activity o f Arp2/3 and other proteins such as actin cross-linkers and barbed end capping 
proteins. For example, the actin cross-linker filamin-A has been shown to be required for 
the formation of dynamic membrane protrusions or membrane ruffles by p21 -activated 
kinase 1 (PAK1) (Vadlamudi et al., 2002) and profilin, an actin binding protein that 
promotes monomer addition to barbed ends, can also play a role in lamellipodia formation 
(Kang et al., 1999; Syriani et al., 2008). This is further controlled by Ena/VASP family 
proteins which are thought to stimulate filament elongation, and protect barbed ends from 
capping proteins that would otherwise block elongation (Barzik et al., 2005; Bear et al.,
2002). However, a study in Dictyostelium suggested that VASP does not compete with 
capping proteins but is instead important in the generation of filopodia via its actin- 
bundling activity (Schirenbeck et al., 2006). Another actin bundling protein, IQGAP serves 
a second function as a scaffold for signalling proteins, binding to actin, Cdc42 and N- 
WASP (reviewed in Brandt and Grosse 2007). IQGAP also stabilises and increases the 
levels of GTP-bound, active Cdc42 (see review Briggs and Sacks 2003).
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In filopodia, formins such as mDia2, which nucleate actin filaments and remain bound to 
the barbed end leading to long, unbranched filaments play a major role in actin 
polymerisation. mDia2 localises to the tips of filopodia and mDia2 knockdown blocks 
filopodium formation. However mDia2 knockdown also impaired the formation of 
lamellipodia suggesting it plays a more universal role in protrusion (Yang et al., 2007). 
Wiscott-Aldrich syndrome protein (WASP) leads to filopodium formation upstream of the 
Arp2/3 complex (reviewed in Carlier et al., 1999) and it is likely that actin cross linkers 
such as HSP90, which was shown to bundle the filaments generated by WASP/Arp2/3, are 
required to produce filopodia rather than lamellipodia (Park et al., 2007).
The dynamic binding and release o f actin monomers is also important in membrane 
protrusion. In order for actin to polymerise at the membrane, the cell requires a pool o f free 
actin monomers. The supply o f monomers is controlled by cofilin which can sever F-actin 
filaments to produce new barbed ends (Maciver, 1998) and increase the off-rate from 
pointed ends to promote F-actin disassembly (Carlier et al., 1997). It has recently been 
shown that cofilin is required for stimulus-induced lamellipodium formation (Kiuchi et al., 
2007) showing its importance in actin dynamics. It also highlights a key point that 
lamellipodium formation and cell migration do not only rely on actin polymerisation and 
filament assembly alone, but the dynamic cycling of actin from the barbed end to the 
pointed end and back into the G-actin pool. In fact, profilin-1 (which promotes G-actin 
addition to barbed ends) is down-regulated in a variety of human cancers and cancer cell 
lines (Gronborg et al., 2006; Janke et al.. 2000; Wu et al., 2006), and knockdown o f the 
basal level of profilin-1 in MDA-MB-231 breast cancer cells leads to increased motility and 
invasion through Matrigel (Zou et al., 2007).
Actin plays another role in cell migration through its role in contractile force generation. 
This is apparent in vitro on a 2D substrate where individual filaments of F-actin can be 
bundled together to form stress fibres, each containing around 10-30 individual actin 
filaments (Cramer et al., 1997). It should be noted however, that stress fibres are rarely 
found in vivo. There are three different types of actin stress fibre found in cells: transverse 
arcs which are not anchored to adhesions (Heath, 1983); dorsal stress fibres which are 
anchored to a focal adhesion at one end and ventral stress fibres anchored to focal 
adhesions at both ends (reviewed in Small et al., 1998). Focal adhesions are the sites o f
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celkmatrix adhesion found in some cell types. Three distinct mechanisms for the formation 
of stress fibres have been described. It is thought that dorsal stress fibres are assembled via 
actin polymerisation driven by formin at focal adhesions while transverse arcs are either 
formed by bundles of myosin and actin being joined in the lamella (Hotulainen and 
Lappalainen, 2006) or by the effect of myosin contraction on actin networks drawing actin 
filaments together (Verkhovsky et al., 1995).
The polarity o f actin filaments in stress fibres appears to be different depending on the 
situation. It has been described that actin filaments can either arrange with uniform polarity 
or with seemingly random orientation (Cramer et al., 1997; Svitkina et al., 1997). It is 
probable that the mechanism by which a stress fibre is generated could dictate the 
orientation of the actin filaments it contains. Actin filaments are bound together by actin 
cross-linking proteins o f which several have been found associated with stress fibres such 
as fascin, espin, filamin and a-actinin (Adams, 1995; Chen et al., 1999; Lazarides and 
Burridge, 1975; Wang et al., 1975). Different actin cross-linkers are thought to cooperate to 
modulate the mechanical properties of the actin cytoskeleton (Tseng et al., 2005). 
Immunostaining of actin bundles revealed that a-actinin and filamin-A are found in bands 
along the length o f stress fibres with bands of myosin between (Langanger et al.. 1984; 
Langanger et al.. 1986).
Myosins are a superfamily of at least 15 classes of molecular motor proteins in mammals 
(reviewed in Sellers, 2000). The non-muscle myosin II class is involved in contraction and 
shortening of stress fibres in non-muscle cells. Much of the research investigating Myosin 
II has been done in relation to smooth muscle contraction but it is thought that the 
mechanism is similar in non-muscle cells. Myosin II is a hexamer composed o f two heavy 
chains, two essential light chains and two regulatory light chains (RLC) (Figure 1.3). 
Multiple myosin II hexamers associate to form bipolar filaments which bind actin at each 
end and hydrolyse ATP to pull the two actin filaments together. Myosin II filament 
assembly, ATPase activity and contraction are regulated by phosphorylation of MHC and 
RLC at multiple sites (reviewed in Tan et al., 1992). Specifically, phosphorylation o f RLC 
at Threonine 18 and Serine 19 is thought to lead to myosin filament assembly and increased 
contractility (Watanabe et al., 2007).
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Figure 1.3: Schematic of non-muscle myosin II. Showing heavy chains (light grey), 
essential light chains (dark grey) and regulatory light chains (black). (Taken from Bresnick 
1999).
Myosin IIA was shown to be required for tail retraction in migrating cells (Even-Ram et al., 
2007). The mechanism for this could be by the action of myosin II on ventral stress fibres 
physically pulling the tail forwards combined with the stimulation of focal adhesion 
disassembly by other pathways.
Actin also plays a major role in polarised cell locomotion (Figure 1.4). In order for a cell to 
migrate persistently it needs to establish an intracellular polarity reflected by features o f the 
actin cytoskeleton and microtubule network. Actin polymerisation is localized towards the 
leading edge of the cell where actin nucleation and branching are stimulated leading to the 
generation of an actin network o f filaments growing towards the membrane (Henson et al., 
1999; Small et al., 1978). Retrograde flow of the actin cytoskeleton is observed (Henson et 
al., 1999) and the nature o f the actin network changes in a gradient from dense, highly 
branched filaments at the front to sparse bundles of aligned filaments at the rear (Svitkina et 
al., 1997). Towards the rear o f the cell, increased contractility driven by myosin either pulls 
the tail forwards or the sides o f the cell inwards. Evidence supports a model where a 
gradient of myosin incorporation into actin bundles could lead to the change in the 
morphology of the actin network and increased contraction at the rear of the cell. (Svitkina 
et al., 1997; Verkhovsky et al., 1995, 1997). This is supported by evidence of a gradient of 
contractility towards the rear of the cell driving cell components forwards (Iwasaki and 
Wang, 2008).
1.2.2 Microtubules
Microtubules (MTs) are cylindrical tubes composed of 13 parallel protofilaments. These 
protofilaments are formed by the polymerisation of heterodimers of a  and p tubulin. Both 
monomers can bind GTP. a-tubulin contains an N-terminal GTP-binding site that is non­
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exchangeable and buried in the dimer while p-tubulin has an exposed GTP-binding site. 
Upon microtubule assembly, the exposed GTP-binding site contacts the newly added dimer 
where catalytic residues on a-tubulin stimulate GTP hydrolysis (reviewed in Nogales and 
Wang, 2006).
Like actin filaments, MTs have distinct ends; the plus-end is usually directed towards the 
periphery o f the cell while the minus end is usually anchored to the microtubule organising 
centre (MTOC) which is the site of MT nucleation. y Tubulin is involved in MT nucleation 
but the mechanism for this is unclear. Evidence in yeast suggests that y Tubulin may also 
play a role in the regulation o f MT plus ends but what this role is remains to be shown 
(Raynaud-Messina and Merdes, 2007; Watanabe et al., 2005). Microtubule assembly and 
disassembly can be controlled by microtubule destabilisation proteins such as 
stathmin/Opl8 , which can either sequester tubulin dimers or promote microtubule 
disassembly at the plus end (Belmont and Mitchison, 1996; Howell et al., 1999; Jourdain et 
al., 1997; Larsson et al., 1999). O p l8 is inhibited by phosphorylation on one or more of 
four serine residues (S eri6 , Ser25, Ser38, Ser63). Multiple kinases have been identified that 
can phosphorylate these sites (reviewed in Cassimeris 2002).
One of the functions o f MTs is to serve as an intracellular track along which motor proteins 
of the dynein and kinesin families can move. Dynein and kinesin carry vesicles along MTs 
in a directional manner; dyneins move towards the minus end while most kinesins move 
towards the plus end (reviewed in Caviston and Holzbaur, 2006). The microtubule network 
polarises in motile cells (Figure 1.4). In many cell types the centrosome is reorientated 
towards the direction o f migration and microtubules become orientated towards the leading 
edge (Etienne-Manneville and Hall, 2001; Euteneuer and Schliwa, 1992; Gomes et al., 
2005; Gotlieb et al., 1981; Gregory et al., 1988; Gundersen and Bulinski, 1988; Kupfer et 
al., 1982).
Most o f these studies were carried out using in vitro wound healing but it is thought that 
microtubule polarity also occurs in migration o f single cells (reviewed in Wittmann and 
Waterman-Storer, 2001). Microtubule growth in migrating cells is promoted at the leading 
edge to prevent plus ends moving backwards with retrograde flow o f actin filaments 
(Wadsworth, 1999; Waterman-Storer and Salmon, 1997). The roles of microtubules in cell
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polarity are probably mediated through their facilitation o f intracellular transport by motor 
proteins such as kinesin and dynein. Membrane and associated proteins including recycled 
receptors are transported to the leading edge during migration and transmigration and this is 
thought to depend on the the microtubule network (Bergmann et al., 1983; Hopkins et al., 
1994; Mamdouh et al., 2008). A possible pathway for the stabilisation of microtubules in 
cell migration is through p21-activated kinase 1 (PAK1) which phosphorylates Op 18 at 
S eri6 inhibiting it (Wittmann et al., 2004). PAK1 will be described in detail later.
It has also been suggested that microtubules have a direct effect on membrane ruffling 
independent o f their transport activity via the activation of Racl (Waterman-Storer et al., 
1999). However, it is possible that this effect is due to the delivery of Racl GEFs or 
IQGAP to the leading edge via microtubule plus ends (reviewed in Siegrist and Doe, 2007). 
A further role for microtubules in focal adhesion disassembly has been identified and it is 
believed that this requires molecular transport by kinesin (Bershadsky et al., 1996; 
Kaverina et al., 1999; Kaverina et al., 1998; Krylyshkina et al., 2002).
As well as their role in migration, MTs are also responsible for the segregation o f 
chromosomes during mitosis (reviewed in O'Connell and Khodjakov, 2007).
1.2.3 Intermediate filaments
Intermediate filaments are formed from polymers of protein subunits and extend throughout 
the cell tethering to organelles, other cytoskeletal components, the nucleus and the 
extracellular matrix via linker proteins (reviewed in Goldman et al., 2008). Many 
intermediate filament proteins are cell-type specific and their major roles are believed to be 
structural integrity and mechanotransduction (see review Herrmann et al., 2007). 
Intermediate filaments also play roles in cell migration and invasion. Initial investigation o f 
the presence o f intermediate filament proteins in tumours indicated that vimentin (normally 
expressed in mesenchymal cells) was sometimes coexpressed with keratin (an epithelial 
intermediate filament) in metastatic tumours (Miettinen and Rapola, 1989; Ramaekers et 
al., 1983; Zarbo et al., 1990). Further studies using vimentin-positive melanoma cell lines 
showed that expression o f keratin correlates with invasive potential, and disruption o f 
keratin in the highly metastatic C8161 cells decreased invasive and metastatic potential 
(Hendrix et al., 1992). Further work showed that expression o f keratin 8 or 18 in the poorly
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invasive, vimentin-positive A375P melanoma cell line increased their invasion and 
migration ability (Chu et al., 1996).
Other data show that vimentin may also play an individual role; vimentin null fibroblasts 
have defects in migration, chemotaxis and contraction (Eckes et al., 1998). It was later 
found that vimentin overexpression correlates with invasiveness of prostate cancer cells 
(Wei et al., 2008) and knockdown of vimentin impaired migration and collagen invasion o f 
SW480 colon cancer and MDA-MB-231 breast cancer cell lines (Mclnroy and Maatta, 
2007). The effect o f vimentin on cell migration and invasion could be mediated through 
modulation of cell adhesion as vimentin depletion by RNAi leads to cells with smaller focal 
contacts and decreased adhesion (Tsuruta and Jones, 2003). Vimentin associates with focal 
adhesions through integrin binding (Kreis et al., 2005) and is believed to play a role in cell 
migration via integrin recycling in a process which requires vimentin phosphorylation by 
PKCe (Ivaska et al., 2005). Vimentin phosphorylation at multiple sites by p21-activated 
kinase (PAK), at different sites to those phosphorylated by PKCe, is also thought to control 
filament organization (Goto et al., 2002; Li et al., 2006).
1.3 Cell:substrate adhesion
As previously mentioned, adhesion is weak in amoeboid migration where cell surface 
adhesion molecules are diffuse but in mesenchymal migration cell:substrate interaction is 
stronger and occurs at defined regions in the cell membrane termed focal contacts or focal 
adhesions (Abercrombie and Dunn, 1975). The main proteins responsible for extracellular 
matrix (ECM) adhesion at focal complexes are the integrins. These are heterodimers 
containing a  and P subunits, each o f which has a large extracellular domain, a single 
transmembrane domain and a small intracellular domain. In vertebrates there are 18 known 
a  and 8 known p subunits which form multiple combinations (reviewed in Luo et al., 2007). 
Inactive integrins exist in a closed conformation and can be activated in an extracellular 
manner by binding their ligand (outside-in) or signalling inside the cell can lead to 
activation (inside-out) (reviewed in Hynes, 2002). Integrins cluster at sites o f adhesion and 
recruit many structural and cell-signalling molecules which are responsible for kinase 
signalling following integrin binding and physical association with the cytoskeleton. The 
association with actin filaments is important in cell migration as this provides a means for 
the cell to exert force on the substrate to pull itself forwards. Several proteins are believed
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to play a role in the connection between integrins and the cytoskeleton. One o f these is talin 
and is believed to be required for the integrin:actin connection (Cram et al., 2003; Lee et 
al., 2004; Tanentzapf et al., 2006). Vinculin and a-actinin also play a role, probably in 
complex with talin (reviewed in Ziegler et al., 2008). Pathways regulating focal adhesion 
stability are not fully understood but signalling through focal adhesion kinase (FAK) has 
been shown to induce focal adhesion disassembly and FAK knockout mice have fibroblasts 
with larger and more numerous focal adhesions (Ilic et al., 1995; Webb et al., 2004).
Strength of adhesion to the substrate is polarised in motile cells to allow detachment from 
the substrate at the rear and formation of new adhesions at the front (reviewed in Broussard 
et al., 2008). It is clear that a spatial balance is required between pathways driving focal 
adhesion assembly and disassembly in the cell as it has been suggested that increased 
contractility can lead to focal adhesion assembly (Chrzanowska-Wodnicka and Burridge, 
1996).
1.4: Phopholipid asymmetry in cell polarity and migration
The phosphorylation state o f membrane lipids is likely to be important in some cell types to 
establish cell polarity and stimulate protrusion (Figure 1.5). Initial studies in Dictyostelium  
discoidium showed that pleckstrin homology (PH) domain-containing proteins localized 
towards the source o f chemoattractant (Meili et al., 1999; Parent et al., 1998). Some PH 
domains bind to phosphatidylinositol-3,4,5-trisphosphate (PIP3) and PI(3 ,4 )P2, both 
products of phosphatidylinositide-3-kinases (PI3Ks). (For a review o f the discovery o f 
PI3K and PIP3 see Stephens et al., 1993). PIP3 can be dephosphorylated to PI(4 ,5 )P2 by 
phosphatase and tensin homologue (PTEN). It was found that PI3K and PTEN are 
reciprocally regulated in response to a chemotactic gradient with PI3K localizing towards 
the chemoattractant and PTEN localizing away from it (Funamoto et al., 2002; Iijima and 
Devreotes, 2002). Asymmetric phospholipid distribution in a chemotactic gradient is not 
limited to Dictyostelium; it was shown that PIP3-binding PH domains show a similar 
localization in neutrophils and fibroblasts (Haugh et al., 2000; Wang et al., 2002b). 
However, the importance o f phospholipid distribution in cells is unclear. PI3Ky-dependent 
PIP3 accumulation is not required for gradient sensing in neutrophils (Ferguson et al., 2007) 
so it is likely that other signalling mechanisms such as Rho GTPases and effector 
localization can still lead to cell polarization in the absence o f PIP3 (reviewed in Ward,
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2004). Likewise, in Dictyostelium genetic deletion experiments showed that PI3K deficient 
cells could still migrate towards a cAMP gradient but this was blocked by the combined 
deletion o f PI3K and a phospholipase A2 homologue suggesting that the pathways act in 
parallel (Chen et al., 2007b).
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Figure 1.4: Polarity of the cytoskeleton in mesenchymal migration. As described in the 
text, actin polymerisation occurs at the leading edge and bundles as it moves towards the 
back of the cell forming stress fibres. New focal adhesions form and turnover at the front o f 
the cell, some o f which develop into larger mature focal adhesions at either end of the stress 
fibres. The MTOC is localized in front of the nucleus and microtubules orient towards the 
leading edge to facilitate protrusion, and towards focal adhesions in the rear to facilitate tail 
detachment. The presence of active PI3K in the leading edge is thought to increase local 
PIP3 concentration in some cell types.
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1.5: Cell:cell junctions 
1.5.1: Adherens Junctions
Adherens junctions are formed by two classes o f adhesion molecule, nectins and cadherins. 
Nectins are a family o f four proteins o f which all. except the secreted protein nectin-ly, 
have an N-terminal extracellular region containing three IgG-related domains and an 
intracellular region which interacts with afadin (AF-6 ) (reviewed in Takai and Nakanishi,
2003). Afadin is an actin binding protein which gives nectins a direct link to the 
cytoskeleton (Mandai et al., 1997; Takahashi et al., 1999). Nectins mediate cellicell 
adhesion by forming a c/v-dimer on one cell followed by a trans-dimer with nectins in a 
neighbouring cell in a calcium-independent manner (Aoki et al., 1997; Lopez et al., 1998; 
Reymond et al., 2001; Satoh-Horikawa et al., 2000). Nectins are believed to be required for 
the assembly o f both adherens junctions and tight junctions (Sato et al., 2006; Yamada et 
al., 2006). In adherens junctions, it has been suggested that nectins form the initial adhesion 
site and recruit E-cadherin together with associated catenins in a manner that requires the 
presence o f the actin cytoskeleton (Honda et al., 2003; Okamoto et al.. 2005; Yamada et al.,
2004).
Cadherins are a family o f transmembrane adhesion molecules originally identified to be 
involved in calcium-dependent cell adhesion (Yoshida and Takeichi, 1982). Expression 
studies in cells which normally express little endogenous cadherins showed that cells 
aggregated with other cells expressing the same type o f cadherin. They therefore play a role 
in the selectivity o f  celLcell adhesion (Nose et al., 1988). The adhesive function o f 
cadherins requires the binding o f catenins to the cadherin cytoplasmic domain, beta-catenin 
and pl20-catenin (p i20) bind directly while alpha-catenin binds via beta-catenin (Ozawa et 
al.. 1989; Ozawa et al., 1990). alpha-catenin was originally thought to link cadherin to the 
actin cytoskeleton (Rimm et al., 1995) but it now appears that alpha-catenin binding to 
beta-catenin or actin is mutually exclusive (Drees et al.. 2005; Yamada et al., 2005). alpha- 
catenin may instead regulate the actin cytoskeleton at adherens junctions, either by binding 
directly to actin and blocking Arp2/3 complex-mediated nucleation or by controlling the 
localization o f the formin Fmnl (Drees et al., 2005; Kobielak et al., 2004; Verma et al.,
2004). beta-catenin and p i 20 regulate cadherin adhesion and localization in pathways 
controlled by phosphorylation. Tyrosine phosphorylation o f beta-catenin disrupts its 
binding to E-cadherin while tyrosine phosphorylation o f p i20 leads to loss o f E-cadherin
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from the cell surface (Rosato et al., 1998; Roura et al.. 1999). There is evidence that there is 
a constant cycle o f endocytosis o f unbound cadherin in complex with beta-catenin which is 
then recycled to the plasma membrane (Le et al., 1999). p i 20 knockdown leads to targeting 
o f cadherin for degradation (Davis et al., 2003; Xiao et al., 2003), It is therefore possible 
that p i 20  binding to cadherin could decrease cadherin turnover increasing adhesion.
1.5.2: Tight junctions
fight junctions are required for epithelial barrier function but are also involved in cell 
signalling to regulate junction assembly and gene expression (reviewed in Matter and 
Baida, 2003). Tight junctions are formed by four types o f  transmembrane protein; claudins; 
occludin; tricellulin and junctional adhesion molecules (JAMs) (Furuse et al., 1998; Furuse 
et al., 1993; M artin-Padura et al.. 1998; M cCarthy et al., 1996). The claudin family o f 
proteins consist o f four transmembrane regions, two extracellular loops and a C-terminal 
intracellular domain. They are important in determining the barrier function o f tight 
junctions (Furuse et al.. 1998 and reviewed in Krause et al.. 2008). Occludin, the first 
identified component o f tight junctions, has similar features to claudins but has a second 
intracellular domain at the N-terminus (Furuse et al., 1993). It is thought that Occludin 
plays a role in signal transduction from tight junctions (reviewed in Chiba et al.. 2008). 
Tricellulin is a four transmembrane protein found in tricellular junctions o f epithelial sheets 
(Ikenouchi et al., 2005). It appears to be particularly important in the ear as tricellulin 
mutation can lead to deafness (Riazuddin et al.. 2006). JAMs are a family o f  IgG-like 
adhesion molecules. As well as tight junction adhesion, JAMs are thought to be involved in 
many other processes including leukocyte transendothelial migration and angiogenesis 
(reviewed in Mandell and Parkos, 2005). Many o f these tight junction proteins bind to 
multiple cytoplasmic scaffolds. An important group o f scaffold proteins associated with 
tight junctions are the zona occludens (ZO) proteins ZO-1, ZO-2 and ZO-3 (Itoh et al., 
1999). O f these, ZO-1 was the first identified (Stevenson et al., 1986) and has multiple 
binding partners including claudins, JAM-1, actin and a-catenin (Itoh et al., 1999; Itoh et 
al., 1997). This allows ZO-1 to provide a possible link between tight junctions and the actin 
cytoskeleton. It has been suggested that binding between ZO-1 and a-catenin at adherens 
junctions could play a role in the formation o f tight junctions: characterisation o f E- 
cadherin knockout mice showed that epidermal barrier function was impaired, as was the 
localization o f ZO-1. claudin-1 and claudin-4 to junctions. However, occludin localization
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was not affected showing that incomplete tight junctions still formed (Tunggal et al., 2005). 
The role o f E-cadherin in tight junction formation is therefore still unclear.
1.6: The Rho GTPases
Cytoskeletal dynamics during cell migration are controlled by Rho GTPases. This family o f 
small GTPases is part o f the Ras superfamily o f GTP binding proteins which also includes 
the Rab, A rf and Ran families. There are twenty identified members of the Rho GTPase 
family which can be placed in 8 subgroups (Figure 1.5).
Ran family
Arf family
M IR02 RhoBTB3
MIR01
Rab family
RhoBTB2/DBC-2
RhoBTBI
RhoH/TTF
Ras family
RhoU/Wrch
RhoV/Chp
Rnd1/Rho6
RhoJ/TCL
Rnd2/RhoN
RhoQ/TC10
Cdc42 Rnd3/RhoERho family
Rac2 Rac3 \ 
Rac1 RhoG
RhoB
RhoA
RhoC
RhoF/Rif RhoD
Figure 1.5: Phylogenetic tree of m am m alian Ras superfam ily GTPases. (Taken from 
(Vega and Ridley, 2008))
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1.6.1: Rho GTPase regulation
Most Rho GTPases bind GTP and GDP with a high affinity and therefore usually exist in a 
nucleotide-bound state in vivo (Li and Zhang, 2004). Many of the Rho GTPases cycle from 
an active, GTP-bound state to an inactive, GDP-bound state. This is catalysed by two 
classes o f regulators; GTPase activating proteins (GAPs) that stimulate hydrolysis o f bound 
GTP to GDP; and guanine nucleotide exchange factors (GEFs) which catalyse exchange of 
GDP for GTP (Figure 1.5). GTP-bound to Rho GTPases are able to bind effectors and 
stimulate downstream signalling. Some o f the Rho GTPases including Rnd proteins and 
RhoH have no detectable GTPase activity and it is thought that they are therefore 
constitutively active (Foster et al., 1996; Li et al., 2002; Nobes et al., 1998). Wrch-1 
(RhoU) is also constitutively active because o f its high GDP/GTP exchange rate (Shutes et 
al., 2004).
GTP GDP
GEF
Rho-GDP
Rho-GDP
GAP
GDI
Figure 1.6: M echanism of Rho GTPase regulation. Active Rho GTPases are GTP-bound 
and many have intrinsic GTPase activity which is stimulated by GAPs. GDP-bound Rho 
can be sequestered and inhibited by GDIs while GEFs stimulate exchange o f GDP with 
GTP.
Further regulation occurs by localization. Many Rho GTPases are post-translationally 
modified by prenylation at a CAAX motif in their C-terminus, which enhances their 
association with the plasma membrane. This is regulated by guanine nucleotide dissociation 
inhibitors (GDIs) which block membrane localization by masking the prenyl group. Not all 
Rho GTPases are regulated in this way for example RhoBTBl and RhoBTB2 lack the 
CAAX motif for prenylation (Gosser et al., 1997; Longenecker et al., 1999) (Figure 1.6). It 
has been described that RhoGDIs can interact with the GTP-bound for of Racl and RhoA
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blocking GTPase activity. The association with GTP-bound protein is 10-fold lower than 
with GDP-bound Racl/R hoA  and the relevance in vivo is unknown (Sasaki et al., 1993). 
Regulation by GDIs is not universal among the Rho GTPases and some, such as TC10 
(RhoJ) probably do not bind to GDIs (reviewed in (DerMardirossian and Bokoch, 2005)).
GEF and GAP regulation is o f clear importance to the correct functioning o f Rho GTPases 
and deregulation o f some GAPs have been implicated in disease. Each family contains over 
60 proteins with differing GTPase specificity. This allows each Rho GTPase to be switched 
on or o ff selectively according to the stimulus or cell state. GAPs, GEFs and GDIs can be 
regulated by protein-protein interaction; phosphorylation; lipid interaction; cell localisation 
and proteolytic degradation (reviewed in (Bernards and Settleman, 2004)).
RhoGTPases can also be regulated by phosphorylation or by transcriptional regulation. 
RhoE is phosphorv lated by ROCK1 at Seri 1 and this correlates with its functional activity 
to disrupt stress fibres (Riento et al., 2005). RhoA is negatively regulated by 
phosphorylation at Seri 88  by cAMP-dependent protein kinase A (Ellerbroek et al., 2003; 
Lang et al., 1996; Rolli-Derkinderen et al.. 2005). RhoB is a negative regulator o f 
proliferation which is transcriptionally regulated. Its expression is induced by many factors 
such as growth factor stimulation and UVB irradiation (Canguilhem et al.. 2005; Chen et 
al.. 2007a; de Cremoux et al., 1994; Jahner and Hunter, 1991)
1.6.2: Roles o f Rho GTPases in cell migration
Early characterisation o f three o f  the Rho GTPases showed that they have distinct effects 
on the actin cytoskeleton. M icroinjection o f cells with active RhoA led to formation o f 
actin stress fibres (Ridley and Hall, 1992); Racl led to the formation o f membrane ruffles 
and lamellipodia (Ridley et al., 1992); while Cdc42 stimulated formation o f filopodia 
(Nobes and Hall, 1995). This implied that Rho GTPases could be key regulators o f cell 
migration and further research has shown this to be the case. There is also evidence that 
many Rho GTPases are upregulated at the mRNA or protein level in human cancers and it 
is thought that they play a part in tum our progression (see review (Lozano et al., 2003)). 
Rho GTPases take part in each feature o f  cell migration; cell polarisation and directional 
sensing; junctional breakdown; protrusion o f lamellipodia; formation o f new adhesions; cell
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body contraction and adhesion breakdown in the tail. Some o f the major downstream 
targets o f  RhoA, Racl and Cdc42 associated with cell migration are shown (Table 1.1).
Rho GTPase Target Cellular effects References/Reviews
RhoA
ROCK Contractility regulation and 
stress-fibre formation.
(Pellegrin and 
Mellor, 2007)
mDia Actin nucleation and filament 
assembly
(Goode and Eck, 
2007)
Racl/Cdc42
PAKs Actin polymerisation, 
microtubule stability, 
contractility
(Bokoch, 2003)
mDia Actin polymerisation (Goode and Eck, 
2007)
IRSp53 Filopodia and lamellipodia 
formation
(Abou-Kheir et al., 
2008; Lim et al., 
2008)
IQGAP Actin cross linking and assembly (Brandt and Grosse. 
2007)
Sra-l(W A V E) Lamellipodia formation and actin 
polymerisation
(Takenawa and 
Suetsugu, 2007)
WASP Filopodia formation and actin 
polymerisation
(Takenawa and 
Suetsugu, 2007)
Table 1.1: M ajor targets o f RhoA, Racl and Cdc42 involved in cell migration.
i) Cell junction breakdown
RhoA. Racl and Cdc42 are important for the formation o f cadherin-based cell junctions 
(reviewed in Braga, 2000). Interestingly RhoA, Racl and Rac3 have also been shown to 
play roles in epithelial junction breakdown suggesting that up-regulation o f their expression 
or activity could be relevant to the first stages o f cancer metastasis (Sahai and Marshall, 
2002; Akhtar and Hotchin, 2001; Braga et al., 2000; Lozano et al., 2008). Investigation o f 
the dual role o f RhoA suggested that RhoA is required for adherens junction stability 
through m D ial whereas RhoA-associated kinase (ROCK) activation downstream of RhoA
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leads to junctional breakdown (Sahai and M arshall, 2002). The latter effect was confirmed 
with siRNA which showed that a RhoA/ROCK II pathway is required for epithelial 
junctional breakdown stimulated by removal o f  Ca2+ (Samarin et al., 2007). In the case o f 
Rac, active Racl and Rac3 were shown to induce disassembly o f cell junctions and R acl- 
mediated junctional breakdown requires the presence o f PAK1 (Akhtar and Hotchin, 2001; 
Braga et al., 2000; Lozano et al., 2008; Sahai and Marshall, 2002). Little is known about 
whether Cdc42 can facilitate junctional breakdown but as it activates PAK1, it might be 
expected that consitutively active Cdc42 would have a similar effect to R ac l.
ii) Cell polarity
Expression o f dom inant negative Cdc42 in neutrophils leads to cells that have multiple 
leading edges (Srinivasan et al., 2003). This blocks directional chemotaxis even though the 
cells can still migrate (A llen et al., 1998; Srinivasan et al., 2003). Cdc42 is also required for 
orientation o f  the Golgi apparatus and polarity o f the leading edge in fibroblast scratch 
wound healing assays (Nobes and Hall, 1999). A model has been proposed where activated 
Gpy binds PAK1 associated with the Cdc42-GEF a-PIX. This would lead to localized 
Cdc42 activation, which in turn would activate PAK leading to cytoskeletal rearrangement 
and generation o f a leading edge (Li et al., 2003). It is likely that there is positive feedback 
in this model as overexpressed PAK1 which became phosphorylated at S199/S204 (a site 
which inhibits PIX binding), localised to membrane ruffles, and this was blocked by 
overexpression o f the W ASP-CRIB to inhibit Cdc42 (Cau and Hall, 2005). Fluorescence 
lifetime imaging m icroscopy (FLIM) has provided further evidence for the spatial 
relationship between PAK1 and Cdc42 as they were shown to interact at the plasma 
membrane, particularly in membrane protrusions (Parsons et al., 2005). Although these 
findings implicate a controlling role for Cdc42 in cell polarity, it is likely that other 
pathways are also required. Fibroblasts from Cdc42-null mice migrate slightly slower than 
wild type cells but reintroduction o f  dominant-negative Cdc42 strongly inhibits this 
suggesting that the mutant also inhibits other pathways controlling cell polarity and 
migration (Czuchra et al., 2005).
Rho GTPases may facilitate the localisation o f  PTEN in some cells as neutrophils isolated 
from a-PIX-deficient mice or wild type neutrophils treated with the ROCK inhibitor Y- 
27632 are unable to polarise PTEN localisation (Li et al., 2005). However, PTEN
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localisation in mammalian cell migration is controversial as it is not observed in all cells. 
Racl is believed to play a role in cell polarity through interaction with the Par complex. 
One function o f this complex is in the regulation o f tight junction assembly and apical-basal 
polarity through the activation o f R acl/C dc42, but it is also believed to play a role in cell 
polarity in migration (reviewed in (M acara, 2004)). Racl could also establish cell polarity 
due to its intracellular localisation. Racl is localised to membrane ruffles and in a gradient 
towards the leading edge o f growth factor-stimulated cells (Kraynov et al., 2000). Polarised 
Racl activity could lead to localised membrane protrusion and actin polymerisation 
through the mechanisms described below .
iii) Actin polym erisation and membrane protrusion
Studies using dominant negative Racl or Racl-null mice have shown that Racl regulates 
membrane ruffling and lamellipodium formation in a variety o f cell systems (Giehl et al., 
2008; Nobes and Hall, 1999; Wells et al., 2004; Wheeler et al., 2006). It is thought that this 
can be facilitated through binding o f the adapter protein IRSp53 to Racl to mediate 
interaction between R acl and WAVE2 (Abou-Kheir et al., 2008; Miki et al., 2000). Racl 
activates WAVE2 which binds Arp2/3 and leads to increased actin filament branching 
(Suetsugu et al., 1999; Suetsugu et al., 2001). WAVE2 is part o f a complex with A bil, 
N apl and Sra-1 (Innocenti et al., 2004; Kunda et al.. 2003; Steffen et al.. 2004). Formins 
are required for correct lamellipodium formation in some systems and it has previously 
been shown that formin-related protein (FRL) associates with Racl and is thought to 
participate in R acl-induced actin polymerisation (Yang et al.. 2007; Yayoshi-Yamamoto et 
al., 2000). PAKs also play a role in Racl-induced lamellipodia formation by 
phosphor) lating LIMK1/2 leading to cofilin inhibition and actin polymerisation which will 
be discussed in more detail later (Edwards et al., 1999).
Although RhoA is well characterized for its roles in stress fibre formation and tail 
retraction, it may also play a role in membrane ruffles and lamellipodia in some situations. 
Dominant negative (DN) RhoA but not DN Racl was shown to inhibit a6p4-integrin- 
dependent membrane ruffling and lamella formation in adenocarcinoma cells (O'Connor et 
al., 2000). In agreement with this, RhoA localised to membrane ruffles in spreading 
endothelial cells (M enager et al., 1999) and active RhoA localised to protrusions as well as 
the rear o f HeLa cells (Kurokawa and Matsuda, 2005). The presence o f active RhoA in the
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same location as active Racl and Cdc42 could be explained by overlapping GEFs, for 
example Vav2 activates RhoA, Racl and Cdc42 (Abe et al., 2000). The role o f RhoA at the 
leading edge is unclear as it has also been suggested that RhoA restricts the formation o f 
multiple lamellipodia (W orthylake and Burridge, 2003) and recent work in MTLn3 cells 
showed that ROCK inhibition leads to increased Racl activity and spreading in response to 
EGF which is rescued by Racl knockdown. This suggests that ROCK activity downstream 
o f  RhoA could negatively regulate Racl (El-Sibai et al., 2008). However it is possible that 
RhoA could increase lamellipodium formation through LIMK. ROCK has been shown to 
phosphorylate LIMK which would lead to cofilin inhibition and increased actin 
polymerisation (Sumi et al., 2001). Another possibility is that RhoA induces actin 
polymerisation through activation o f the formin mDia. RhoA is believed to relieve 
autoinhibition o f m D ial (Lammers et al., 2005) while mDia and not ROCK was found to 
be stably associated with membrane ruffles (Kurokawa and Matsuda, 2005).
An expression screen o f  active Rho GTPases showed that RhoG, Rac2, Rac3. and Cdc42 
can all induce lamellipodium formation whereas Wrch-1 (RhoU) induced formation o f 
filopodia (Aspenstrom et al.. 2004). RhoG probably induces lamellipodium formation 
through the activation o f  Racl (Katoh et al.. 2006; Katoh and Negishi. 2003) and Cdc42 
was originally characterized as inducing the formation o f filopodia (Nobes and Hall, 1995) 
so it is likely that the effect o f each Rho GTPase depends on the cell system, level o f 
expression and the balance o f other signalling pathways regulating actin dynamics. For 
example, as Racl and Cdc42 both interact with IRSp53, Cdc42 overexpression could lead 
to lamellipodia formation via crosstalk to the Racl pathway. Cdc42-mediated filopodium 
formation is believed to occur through its activation o f WASP upstream o f Arp2/3 (Section 
1.2.1 and reviewed in Carlier et al.. 1999). IQGAP, an actin binding adapter protein, is 
probably also involved in Cdc42-mediated WASP activation. IQGAP stimulates 
W ASP/Arp2/3 based actin assembly and it has been suggested that stabilisation o f GTP- 
bound Cdc42 could be involved (Le Clainche et al., 2007) and reviewed in (Brandt and 
Grosse, 2007). IQGAP could also be involved in actin polymerisation induced by Dial 
although it does not activate the actin-nucleation ability o f Dial (Brandt et al., 2007).
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iv) Adhesion turnover
Rho GTPases have been implicated in the control o f new adhesions. Racl was shown to 
recruit aVp3 integrin to lamellipodia suggesting it plays a role in adhesion formation 
(Kiosses et al., 2001). A Racl effector implicated in focal adhesion dynamics is PAK1 and 
this will be discussed in more detail later.
v) Contractility’
RhoA is believed to play a controlling role in myosin contractility. Inhibition o f RhoA in 
macrophages led to an elongated morphology consistent with defective tail-retraction and 
active RhoA leads to the formation o f stress-fibres (Allen et al., 1997; Ridley and Hall, 
1992). RhoA is thought to exert control on contractility through its effector ROCK which 
can phosphorv late R-MLC at Seri 9 (Amano et al., 1996). ROCK also phosphorylates the 
myosin-binding subunit o f  myosin phosphatase inhibiting it (Kawano et al., 1999). In this 
way RhoA/ROCK serves a dual role in the increase o f myosin II incorporation into actin 
bundles and contractility. Recently a new member o f the myosin phosphatase complex has 
been identified. Myosin phosphatase-Rho interacting protein, which is thought to recruit 
RhoA and is required for ROCK phosphorylation o f myosin phosphatase (Riddick et al., 
2008). Cdc42 can also regulate contractility through myotonic dystrophy kinase-related 
Cdc42-binding kinase (M RCK) in cooperation with ROCK to phosphorylate R-MLC 
(W ilkinson et al., 2005).
1.7: p21-activated kinases
p21-activated kinases (PAKs) are a family o f serine/threonine kinases with an N-terminal 
regulatory region and a C-terminal kinase domain. Yeast PAK homologues (Ste20) were 
first characterized in 1992 where they were found to play a role in pheromone signalling 
(Leberer et al., 1992). Orthologues were subsequently identified in slime moulds, worms, 
tlies and mammals (Figure 1.7) (reviewed in (Hofmann et al., 2004))
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Figure 1.7: PAK orthologues. Phylogenetic tree o f PAK orthologues showing isoforms 
from Caenorhabditis elegans (Ce); Drosophila melanogaster (Dm); Dictyostelium 
discoideum  (Dd); Saccharomyces cerevisiae (Sc); Homo sapiens (Hs) and 
Schizosaccharomyces pombe (Sp). Colours represent groups o f PAKs; Slime mould PAKs 
(yellow); yeast PAKs containing a PH domain (purple) and without a PH domain (orange) 
and two groups o f PAKs from higher eukaryotes; group I (green) and group II (blue). 
Modified from (Hofmann et al., 2004).
Six PAKs have been identified in mammals, which are further classified into two groups 
with PAK1 - PAK3 in group I and PAK4 - PAK6 in group II. The group I PAKs share 
around 88% homology in the regulatory region and around 93% homology in the kinase 
domain. For group II PAKs the homology is around 60% in the regulatory region and 75% 
in the kinase domain (Figure 1.8 ).
All mammalian PAKs have a p21-binding domain (PBD) in the N-terminal region which 
contains a Cdc42/Rac interactive binding (CRIB) motif. The regulatory region also has
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multiple proline-rich regions which bind SH3 domain-containing adapter proteins. Group I 
PAKs have several defining features that are absent from group II PAKs; an acidic region 
with an as yet unknown function; two proline-rich regions N-terminal to the CRIB; a non- 
classical SH3-binding site for the adapter PIX and an autoinhibitory domain (AID) that 
overlaps the PBD, which is key to group I PAK regulation (Figure 1.8) (reviewed in (Arias- 
Romero and Chemoff, 2008))
Group I Pak1
Pak2
(88%)
Kinase
(93%)
Pak3 HHHEHWCQ}1
(90%)
Group II Pak4
kinase
(95%)
kinase
Pak5 kinase
(54%)
Pak6 0— 0
(60%)
kinase
(54%)
PBD:p21 binding domain (■  ^ _ mm _ ■  .
] Prolme nch region i n  PIX binding site ■  Acidic region
AJD autoinhbitorydoman ■ ■ ■  ■
Figure 1.8: Schematic showing the conserved features of mammalian PAKs. Major 
features o f group I and group II PAKs are shown including % homology between the N- 
terminal regulatory regions and between the kinase domains within each group compared to 
PAK1 for group I and PAK4 for group II. Taken from (Arias-Romero and Chemoff, 2008).
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1.7.1: PAK regulation
1.7.1.1: Regulation o f Group 1 PAKs
The presence o f an autoinhibitory domain in group I PAKs means that their activation is 
distinct from that o f the group II PAKs.
i) Regulation by small GTPases
Activation o f PAK1 by Racl and Cdc42 has been extensively studied and is believed to 
provide a model for group I PAK activation by small GTPases. PAK1 exists as an 
autoinhibited homodimer in solution and in vivo with the AID o f  one PAK1 molecule 
bound to the kinase domain o f  another (Lei et al., 2000; Parrini et al., 2002). Small GTPase 
binding to the CRIB m otif within the PBD releases the autoinhibition and leads to 
dissociation o f  the dim er together with structural changes that shift the kinase domain into 
an active state (Buchwald et al., 2001; Knaus et al.. 1998; Leeuw et al., 1998; Lei et al.. 
2000; Tu and Wigler, 1999; Zhao et al., 1998). PAK1 then autophosphorylates at Thr423 or 
is possibly phosphorylated by an exogenous kinase such as PDK1 to achieve full kinase 
activity (Benner et al., 1995; King et al., 2000; Yu et al., 1998; Zenke et al., 1999) (Figure 
1.10). There are also other phosphorylation sites that modulate activity which will be 
discussed in more detail later (Chong et al., 2001a; Gatti et al., 1999). Once PAK has 
become active through autophosphorylation, the small GTPase can dissociate and activate 
further molecules o f PAK (M anser et al., 1994).
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Figure 1.9: Mechanism of PAK activation. As described in the text, binding o f a GTP- 
bound small GTPase to the PBD of a group I PAK relieves autoinhibition leading to 
autophosphorylation at T423 and full kinase activity. Subsequent phosphorylation at S21 by 
Akt blocks binding o f the adapter Nek; autophosphorylation at S I44/179 increases activity 
and at S I99/204 blocks PIX binding and phosphorylation o f T212 by ERK2 facilitates 
downstream ERK signalling.
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PAK activation by Racl and Cdc42 have been well studied but other Rho GTPases have 
been shown to bind and activate group I and group II PAK isoforms (Table 1.2).
PAK isoform Main suggested roles Binding Rho GTPases References
PAK1 Breakdown o f adherens 
junctions; formation o f 
lamellipodia; focal 
adhesion turnover; cell 
migration; regulation of 
actin organisation; 
spine morphogenesis; 
actin contractility .
Racl; Rac2; Rac3; 
Cdc42; TCL (RhoJ); 
TC10 (RhoQ); Clip 
(RhoV); Wrchl 
(RhoU)
(Abo et al., 1998; 
Aronheim et al., 1998; 
Boda et al., 2008; 
Knaus et al., 1998; 
Lozano et al., 2008; 
Manser et al., 1994; 
Mira et al., 2000; 
Neudauer et al., 1998; 
Sells et al., 1999; Tao 
et al., 2001; Vignal et 
al., 2000; Weisz 
Hubsman et al., 2007)
PAK2 Focal adhesion 
turnover; regulation o f 
actin organization; 
regulation o f apoptosis.
Racl; Cdc42 (Coniglio et al., 2008; 
Gatti et al., 1999; 
Goeckler et al., 2000; 
Rudel and Bokoch, 
1997; Zhang et al., 
1998)
PAK3 Neuronal development; 
spine morphogenesis.
Racl; Cdc42 (Bagrodia et al., 
1995a; Bagrodia et al., 
1995b; Boda et al., 
2008)
PAK4 Cell migration; anti- 
apoptotic effects;
regulation o f actin 
organisation.
Racl; Cdc42 (Abo et al., 1998; 
Ahmed et al., 2008; 
Gnesutta et al., 2001; 
Lu et al. 2003)
PAK5 Neurite outgrowth; 
Raf-1 signalling at 
mitochondria.
Cdc42; RhoD; RhoH (Ching et al., 2003; 
Dan et al., 2002; Wu 
and Frost, 2006; Wu et 
al., 2008)
PAK6 Inhibition o f androgen 
receptor signaling.
Currently unknown Schrantz et al., 2004;
Table 1.2: Rho GTPases shown to bind m am m alian PAK isoforms. Rho GTPases also 
shown to activate kinase activity of the relevant PAK are shown in green.
ii) G TPase-independent regulation
PAK activation by GTPase-independent mechanisms has been observed. PAK2 is cleaved 
by caspase 3 yielding an active kinase domain fragment which is thought to regulate 
morphological changes during apoptosis in Jurkat cells (Rudel and Bokoch, 1997). PAK1
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has been shown to be activated by filamin-A binding to the CRIB domain in a similar way 
to GTPase binding (Vadlamudi et al., 2002).
SH3-containing adaptor proteins can further regulate the intracellular localisation o f PAK. 
Both Grb2 and Nek recruit PAK to activated receptor tyrosine kinases such as the 
epidermal growth factor receptor (Galisteo et al., 1996; Puto et al., 2003). Binding o f a-PIX 
or p-PIX to PAK in complex with GIT recruits it to focal adhesions and this will be 
discussed in more detail later (ten Klooster et al., 2006).
iii)Regulation by phosphorylation.
Group I PAKs are further regulated by phosphorylation at multiple sites (Figure 1.9). 
Phosphorylation o f PAK1 at T423 in the kinase domain by autophosphorylation or PDK1 
in the presence o f  sphingosine is required for full PAK activation (King et al., 2000; Zenke 
et al., 1999). PAK2 and PAK3 contain an homologous site (T402 and T421 respectively), 
phosphorylation o f  which is also required for full kinase activity (Chong et al., 2001a; 
Walter et al., 1998; Zenke et al., 1999).
Autophosphorylation o f another conserved site, SI 44/S 149 in PAK1 or SI 39 in PAK3, also 
affects kinase activity (Chong et al., 2001a). PAK2 contains this site at S141 but it may be 
constitutively phosphorylated (Zhan et al., 2003)
Other phosphorylation sites affect binding o f adapters and the persistence o f PAK 
activation. For example, Akt phosphorylation o f PAK at serine 21 by Akt blocks Nek 
binding (Zhou et al., 2003) and phosphorylation at serine 199 and 204, both 
autophosphorylation sites, blocks PIXa binding (Mott et al., 2005). Phosphorylation at 
S I99/204 has previously been used as an experimental indicator o f PAK1 activation but 
phosphorylation by another kinase cannot be ruled out. PAK1 is also phosphorylated by 
ERK2 at threonine 212 which is believed to facilitate downstream mitogen activated 
protein kinase (MAPK) signalling (Sundberg-Smith et al., 2005).
1.7.1.2: Regulation of Group 11 PAKs
The mechanisms o f group II PAK activation are not well known and few Rho GTPase 
binding partners have been identified (Table 1.2). It was shown that Cdc42 binding to
45
Chapter I Introduction
PAK4 does not increase kinase activity and it was suggested that group II PAKs do not 
contain an AID (Abo et al., 1998). However, it has now been proposed that PAK5 is 
activated by Cdc42 and may possess an N-terminal AID but this finding remains 
controversial (Ching et al., 2003). PAK4 and PAK6 lacking the N-terminal region are more 
active than the full length isoforms suggesting that the N-terminal region negatively 
regulates their kinase activity (Abo et al., 1998; Yang et al., 2001). Group II PAKs contain 
an autophosphorylation site homologous to the PAK1 T423 site but it is a serine rather than 
a threonine. In PAK4, mutation o f this site (S474) to methionine blocks kinase activity 
(Abo et al., 1998) and mutation o f S474 to glutamine increases PAK4 activity towards a 
peptide encompassing the S474 region suggesting that phosphorylation might increase 
activity although it is not known if this occurs in vivo (Callow et al., 2002).
Although the mechanisms o f activation are unclear, the pathways leading to Group II PAK 
activation are beginning to be revealed. PAK4 binds Cdc42, and is activated following 
HGF stimulation via PI3K in a Cdc42-independent manner in MDCK cells (Wells et al., 
2002). PAK4 also binds keratinocyte growth factor (KGF) receptor and is thought to 
mediate anti-apoptotic effects o f KGF (Lu et al., 2003). Like the group I PAKs, group II 
PAKs are also regulated by localization as they contain adapter binding sites. Activated 
PAK4 is targeted to the cell periphery (Wells et al., 2002) and PAK5 is localized to 
mitochondria in a manner blocked by truncation o f the CRIB domain. It was also suggested 
that the binding o f Cdc42 targets PAK5 to a different subcellular localization than RhoD 
binding (Wu and Frost, 2006). PAK6 binds to androgen receptor (AR) and translocates to 
the nucleus with AR in androgen-stimulated cells (Yang et al., 2001). PAK6 has also been 
shown to be activated by MAP kinase kinase 6 and p38 MAP kinase (Kaur et al., 2005). 
Through these different pathways, it seems likely that group II PAKs have distinct 
functions from each other.
1.7.2: PAK expression
PAK isoforms are differentially expressed in normal tissues and can be upregulated in some 
cancers. PAK1 was found to be amplified, overexpressed or stabilised in breast, ovarian, 
colon, bladder and brain cancers as well as neurofibromatosis and T-cell lymphoma. PAK4 
has been found amplified and overexpressed in pancreatic cancer and many cancer cell 
lines (Callow et al., 2001 and reviewed in Kumar et al., 2006).
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Knockout mice have been generated for five o f the PAKs: PAK1 knockout mice have 
immune defects, PAK2 and PAK4 knockouts are embryonic lethal, PAK3 knockout mice 
have neuronal defects and PAK5 knockout mice have no detectable phenotype (Table 1.3). 
For this reason it was suggested that PAK5 is redundant but recent evidence shows that 
PAK5 probably does have a role in cells: It is the only PAK shown to bind to RhoD and 
RhoH (Wu and Frost, 2006). In the case o f PAK3, loss o f function in humans is found in X- 
linked mental retardation syndrome (Peippo et al., 2007).
PAK isoform Mouse knockout phenotype References
PAK1 Immune defects (ten Klooster et al., 2006)
PAK2 Embryonic lethal and defective 
MAPK signalling
(Arias-Romero and Chemoff, 2008)
PAK3 Learning and memory deficiency, 
and abnormal synaptic plasticity
(Meng et al., 2005)
PAK4 Embryonic lethal due to heart and 
nervous system defects
(Qu et al., 2003)
PAK5 No detectable phenotype (Li and Minden, 2003)
Table 1.3: Phenotypes o f PAK knockout mice.
1.7.3: Roles of PAK in cell migration
PAKs mediate a link between many Rho GTPases and cytoskeletal rearrangement, and take 
part in each o f the stages o f cell migration.
i) Breakdown o f cell junctions
It was described that N-cadherin-regulated adhesion inhibits Racl and Cdc42 suggesting 
that it would also locally inhibit PAK activation (Charrasse et al., 2002). But in a different 
study, E-cadherin ligation was shown to recruit and stimulate Racl implying that R acl- 
mediated signalling could be involved in junctional stability (Kovacs et al., 2002). Until 
recently the role o f PAK1 in cell junctional breakdown had not been described, but it is 
now believed that PAK1 can mediate the breakdown o f adherens junctions downstream of 
Racl (Lozano et al., 2008). Another possible role for PAK1 in junctional breakdown is
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through the transcriptional repression o f E-cadherin and occludin via phosphorylation o f 
Snail, but this could also alter the expression o f many other proteins making it difficult to 
draw specific conclusions (Yang et al., 2005). It is unknown whether PAKs influence the 
breakdown or formation o f tight junctions. A possible link could be by PAK1 or PAK4- 
mediated phosphorylation o f GEF-H1, a Rho GEF that regulates junctional permeability, 
but this link has not been investigated (Benais-Pont et al., 2003; Callow et al., 2005; Zenke 
et al., 2004).
ii) Cell polarity and focal adhesion turnover
PAK1 is recruited to the leading edge o f motile neutrophils and fibroblasts, and dominant 
negative PAK1 blocked chemotaxis towards the chemokine CXCL1 in RBL-2H3 mast cells 
suggesting that it plays a part in polarised cell signalling and persistence o f the leading edge 
(Dharmawardhane et al., 1999; Dharmawardhane et al., 1997; Wang et al., 2002a). As 
previously mentioned, it was found that activation o f Cdc42 in an a-PIX/PAKl-dependent 
manner is required for directional migration o f leukocytes including actin polymerisation 
and the exclusion o f PTEN from the leading edge (Li et al., 2003). PAK1 or PAK2 are 
thought to form a complex with G protein-coupled receptor kinase-interacting protein 
(GIT 1/2) through mutual interaction with a  or p-PIX. This complex localizes to focal 
adhesions by the binding o f GIT to FAK or paxillin (Bagrodia et al., 1999; Manser et al., 
1998; Nayal et al., 2006; Zhang et al., 2008; Zhao et al., 2000) (Figure 1.11). In this way, 
GIT/PIX/PAK would be recruited to the sites o f nascent adhesion formation in the leading 
edge or ruffles o f motile cells.
Localization o f the complex can be influenced by each o f PAK, GIT or PIX (Manabe et al., 
2002; Stofega et al., 2004; Webb et al., 2006; Za et al., 2006). Complex binding is believed 
to be further regulated by phosphorylation. It was described that phosphorylation o f paxillin 
at Ser273 increases binding o f GIT1 but recent in vitro data disputes this so it remains to be 
confirmed (Nayal et al., 2006; Zhang et al., 2008). GIT1 phosphorylation was also 
investigated. GIT1 contains two serine residues in the paxillin binding site at amino acid 
709 and 710. It was suggested that phosphorylation o f Ser709 in GIT1 would increase 
binding to paxillin, as mutation o f Ser709 to alanine impaired protrusion and paxillin 
binding (Webb et al., 2006). However, mutation to glutamic acid to mimic phosphorylation 
had little effect. Furthermore, in the same study it was suggested that Ser709 in GIT1 might
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be a PAK1 substrate. A peptide surrounding Ser709 was phosphorylated by active but not 
kinase dead PAK1 and S709A substitution decreased phosphorylation by active PAK1. 
However, the S709A peptide was still phosphorylated around 10-fold more by active PAK1 
than kinase dead PAK1. Taken together, it seems more likely that Ser710 is a PAK1 
substrate and regulates binding o f GIT1 to paxillin.
GIT/PIX/PAK coupling to focal adhesions is thought to stimulate focal adhesion turnover 
together with kinase signalling to phosphorylate ERK (Stockton et al., 2007; Yin et al., 
2005; Zhao et al., 2000). However, there is some conflicting evidence as to whether both 
GIT1 and GIT2 are involved. GIT2 knockdown led to smaller focal adhesions and 
increased spreading in HeLa cells (Frank et al., 2006). It seems that GIT2 may be 
differentially regulated to GIT1 as knockout o f some focal adhesion proteins including 
FAK and paxillin blocked focal adhesion localization o f GIT2 but not GIT1 in MEFs 
(Brown et al., 2005). The roles for PAK in focal adhesion turnover are still unclear as PAK 
has been implicated in both formation and disassembly o f focal adhesions (Kiosses et al., 
1999). Evidence also suggests that PAK1 could be required for FAK phosphorylation in 
certain situations and it was recently suggested that knockdown o f PAK2 leads to an 
increase in the size o f focal adhesions, hence decreased turnover (Coniglio et al., 2008; 
Jung et al., 2004). PAK3 might directly bind and phosphorylate paxillin although this is 
controversial and has not been subsequently investigated (Hashimoto et al., 2001).
The ability o f the GIT/PIX/PAK complex to regulate focal adhesion turnover and 
protrusion is likely to be mediated through Racl/Cdc42 and PAK kinase activity, alpha 
and beta-PIX are Racl/C dc42 GEFs and P-PIX has been shown to be important for the 
localization o f Racl to membrane ruffles and associated Racl activity. This was blocked by 
PAK, presumably by competing for the Racl binding site in P-PIX (ten Klooster et al., 
2006). A model was proposed where GIT/PIX/PAK localization to focal adhesions and 
subsequent PAK activation would lead to PAK phosphorylation at S I99/204 and 
dissociation from P-PIX. This would allow p-PIX to bind Racl and mediate its activation 
(Figure 1.11). Rac 1-mediated activation o f PAK would serve as a positive feedback loop in 
this model leading to further PAK autophosphorylation. Phosphorylation o f GIT1 and 
paxillin by PAK could also be a source o f positive feedback by increasing the recruitment 
o f GIT1 to paxillin. Active Racl could lead to membrane protrusion via WAVE (Chapter 1,
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Section 1.6.2) or via PAK as described in section iii below. PAK1 was also shown to be 
activated by GIT1 independently of Cdc42 or Racl binding to PAK1 but this could occur 
through another Rho GTPase (Loo et al., 2004).
^  Actin 
PolymerizationPaxillii P a x i l l i i Paxillii
Integrin Integrin Integrin
Figure 1.10: Model for the control of R acl, Cdc42 and PAK1 activation by GIT/PIX.
GIT/p-PIX/PAKl targeting to paxillin and localised Cdc42 activity at the leading edge of 
cells leads to PAK1 activation and phosphorylation at S I99/204 releasing it from p-PIX as 
well as phosphorylation at other sites. Release of PAK1 frees P-PIX to bind and activate 
Racl and downstream signalling leads to actin polymerisation. Phosphorylation o f GIT1 
and paxillin by PAK1 would increase the recruitment o f GITl/p-PIX in a positive feedback 
mechanism. Adapted from (ten Klooster et al., 2006).
iii) Actin polym erisation
PAK-dependent induction o f actin polymerisation is thought to be mediated through LIM- 
kinase 1 (LIMK1). PAK1, PAK2 and PAK4 have all been shown to activate LIMK1 (Dan 
et al., 2001; Edwards et al., 1999; Misra et al., 2005). LIMK1 phosphorylates and 
inactivates actin filament severing and depolymerisation by cofilin leading to an increase in 
actin filaments (Arber et al., 1998). PAK1, PAK2 and PAK4 have also been described to 
phosphorylate LIMK2 although data has not yet been published (Bokoch, 2003). Another 
protein implicated in PAK-dependent actin dynamics is Filamin-A, an actin cross-linking 
protein which links actin filaments in a flexible manner with no defined angle (reviewed in 
(Popowicz et al., 2006)). It has been described that filamin-A is required for ruffle 
formation by overexpressed PAK1 and it was shown that filamin-A binds to PAK1 at the 
CRIB domain and stimulates PAK1 activity, probably in a similar way to Rho GTPase 
binding. In turn, PAK1 phosphorylates Filamin-A at Ser2152 (Vadlamudi et al., 2002). As
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yet no more is known o f the significance o f this study and it would be interesting to know 
the role endogenous filamin-A plays in PAK-mediated actin polymerisation.
Whether PAK regulates the Arp2/3 complex is poorly understood but recent work has 
provided some insight from investigation o f the formation o f podosomes. These are 
adhesion structures containing integrins and an Arp2/3-crosslinked network o f actin 
filaments perpendicular to the plasma membrane allowing membrane protrusion. They are 
found in myeloid and Src-transformed cells (reviewed in (Block et al., 2008) and (Spinardi 
and Marchisio, 2006)). It was described that caldesmon, an actin binding protein, inhibits 
podosome formation by competing with Arp2/3 to bind actin. Phosphorylation o f 
caldesmon by PAK 1/2 enhances this inhibition (Morita et al., 2007). Interestingly this 
suggests a negative regulatory role for PAK in Arp2/3 branching and barbed end formation 
which is surprising considering the role o f Arp2/3 in lamellipodium formation. 
Nonetheless, studies using alanine and glutamic acid mutations o f the PAK phosphorylation 
site in caldesmon suggest that phosphorylation o f caldesmon by PAK could play a role in 
the actin dynamics o f lamellipodia and stress fibres although both mutations impaired cell 
migration (Eppinga et al., 2006). Further work is clearly required to determine the role o f 
caldesmon phosphorylation by PAK in cell migration.
iv) Cell contractility
PAK1 and PAK2 have been shown to be able to phosphorylate R-MLC at Seri 9 which 
leads to increased contraction (Chew et al., 1998; Ramos et al., 1997; Rudrabhatla et al., 
2003; Zeng et al., 2000). Conversely, PAK1 and PAK2 can also inhibit myosin contraction 
by phosphorylating and inhibiting MLCK which normally phosphorylates R-MLC at both 
T h r l8 and S e ri9 (Goeckeler et al., 2000; Ikebe and Hartshome, 1985; Ikebe et al., 1986; 
Sanders et al., 1999). The relevance o f the dual role o f PAK 1/2 is unclear but it seems 
likely that the functional outcome in terms o f contractility would depend on the cellular 
localization and relative local concentrations o f PAK 1/2, myosin and MLCK. As 
previously described, in some cell types there appears to be a gradient o f myosin II 
incorporation onto actin bundles in migrating cells from a low concentration o f myosin at 
the leading edge to a high concentration in the tail (Svitkina et al., 1997; Verkhovsky et al., 
1995, 1997). The dual role o f PAK 1/2 could facilitate this. Active PAK 1/2 localised to the 
leading edge would phosphorylate R-MLC at Seri 9 initiating the incorporation o f myosin
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into actin bundles. At the same time, MLCK would be inhibited by PAK blocking 
diphosphorylation o f R-MLC. Retrograde flow moving the actin network towards the rear 
o f the cell would carry phospho-Serl9 myosin with it and MLCK would become 
diphosphorylated and active. Expression studies in rat embryo fibroblasts (REF-52), bovine 
pulmonary artery endothelial cells and HeLa cells showed that the 130 kDa isoform o f 
MLCK is localized throughout the cell with localized regions o f higher concentration in 
ruffles or in the perinuclear region o f REF-52 and HeLa cells (Blue et al., 2002; 
Poperechnaya et al., 2000). In a migrating cell PAK 1/2 activity in the leading edge could 
lead to a gradient o f active MLCK towards the rear o f the cell which would phosphorylate 
R-MLC at both T h rl8 and S e ri9 further incorporating myosin into actin bundles and 
stimulating contraction to drive the cell forwards. The distribution o f phospho-S19 R-MLC 
and diphosphorylated R-MLC in motile fibroblasts and COS7 cells seem to support this 
model as S19 R-MLC was enriched at the leading edge and diphosphorylated R-MLC 
localised at stress fibres (Komatsu and Ikebe, 2004; Matsumura et al., 1998). However 
there was some enrichment o f S19 R-MLC in the tail o f fibroblasts, perhaps due to 
dephosphorylation as stress fibres disassemble.
PAK1 and PAK4 have been described to play a role in contractility by phosphorylating the 
RhoGEF GEF-H1 at Ser885 and it was suggested that this might inhibit its RhoA GEF 
activity and increase activity on Racl although further evidence is required (Callow et al., 
2005; Zenke et al., 2004). It has been shown that GEF-H1 is active towards RhoA, RhoB, 
RhoC and Racl but not Cdc42 in vitro but it is not known whether this specificity is the 
same in vivo (Ren et al., 1998). Inhibition o f GEF-H1 could lead to a decrease in GTP 
bound RhoA which would decrease contractility through Rho A/ROCK.
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F ig u re l .i l :  Control of the cytoskeleton by PAKs. As described in the text PAK isoforms 
can increase microtubule stability through inhibition of O p l8 ; increase actin polymerisation 
through LIMK and Filamin-A dependent pathways; and either suppress or stimulate myosin 
contractility through R-MLC or RhoA.
1.7.4: Roles of PAKs in M APK signalling
The original identification o f Ste20 as a kinase in the yeast pheromone pathway suggested 
that PAKs could regulate MAPK signalling in mammalian cells (Leberer et al., 1992). A 
role for PAK1 in the Rafl/MEK/ERK pathway was described when PAK1 was found to 
phosphorylate Rafl at Ser338, an activating phosphorylation, and MEK1 at Ser298 which 
is believed to prime MEK1 for phosphorylation by Rafl. (Beeser et al., 2005; Chong et al., 
2001b; Coles and Shaw, 2002; Eblen et al., 2002; Slack-Davis et al., 2003). PAK4 has also 
been shown to activate the ERK pathway (Cammarano et al., 2005) and initial 
characterization of PAK5 showed that it can activate the c-Jun N-terminal kinase (JNK) 
pathway (Dan et al., 2002). Subsequently PAK1 and PAK2 were also implicated in the 
activation o f the p38 MAPK pathway downstream of CXCL12 (Rousseau et al., 2006).
As well as transcriptional regulation, it has been suggested that p38a could be involved in 
cell motility as pharmacological inhibition o f p38 MAP kinases impaired P-PIX-induced 
membrane ruffling (Lee et al., 2001), and p38 MAP kinase-deficient mouse embryonic 
fibroblasts have impaired migration (Rousseau et al., 2006).
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1.8: Problem s associated with dom inant negative m utants
Most studies o f PAK regulation and signalling have been carried out using expression of 
dominant negative and active mutants. There are several forms o f dominant negative 
PAK1; a point mutation in the kinase domain making the molecule kinase dead is used but 
it is still able to bind Racl/Cdc42, substrates and SH3-containing adapter proteins (Figure 
1.13). This is sometimes combined with point mutations in the PBD to block Racl/Cdc42 
binding. Alternatively, the truncated PBD can be expressed but this sequesters small 
GTPases. Constitutively active mutants o f PAKs have similar drawbacks as they can 
sequester substrate, GTPases and adapter proteins depending on the mutations present to 
prevent this (Figure 1.13). Experimentally it has been shown that both dominant negative 
and constitutively active PAK inhibit migration o f HMEC-1 highlighting the possibility of 
unwanted effects due to binding properties (Kiosses et al., 1999).
Pakl
czm m
L83L86
m m
E423
Kinase Rac/Cdc42- 
activity binding
WT
E423 + + + +
R299
L83,L86 +++
Figure 1.12: Schem atic show ing wild ty pe, constitutively active and dom inant negative 
form s of PA K l. Point mutations are shown together with relative activity o f the construct 
and Racl/Cdc42 binding status. (Taken from (Sells et al., 1999))
Dominant negative and constitutively active Rho GTPases have a similar problem because 
they sequester active Rho GEFs, GAPs and effectors thereby inhibiting signalling by other 
Rho GTPases which share the same regulatory proteins.
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1.9: RNA interference (RNAi)
RNAi provides an alternative to the use o f dominant negative mutants and also allows the 
study o f proteins and signalling pathways where a dominant negative is not available. Its 
use has increased rapidly because it is simple to perform and can be used to screen families 
o f genes for function in specific assays. RNAi makes use o f a previously unknown gene 
regulation pathway in cells where the presence o f double stranded RNA (dsRNA) in the 
cytoplasm leads to the down-regulation o f mRNA containing an identical sequence. The 
effect o f double stranded RNA was first discovered in plants (reviewed in (Vaucheret, 
2006)) and it has subsequently been shown to have the same effect in a variety o f species 
including Caenorhabditis Elegans, Drosophila melanogaster, Mus musculus and Homo 
sapiens (Caplen et al., 2001; Fire et al., 1998; Kennerdell and Carthew, 1998). It is thought 
that RNAi is both an endogenous mechanism for gene regulation and an intracellular 
defence against viruses that have a dsRNA genome. In gene regulation, an RNA is 
expressed that forms a short hairpin structure and is subsequently processed in the nucleus 
into a precursor-microRNA (pre-miRNA) by Drosha and DGCR8 . This pre-miRNA can 
then be exported to the cytoplasm via Exportin 5 or mediate a number o f effects in the 
nucleus including transcriptional gene silencing and degradation o f nuclear mRNA. Pre- 
miRNA that is exported to the cytoplasm is cleaved by Dicer into a mature double-stranded 
miRNA which binds to Argonaute in the miRNA-containing ribonucleoprotein complex 
(miRNP) and leads to degradation o f complementary miRNA (reviewed in Martin and 
Caplen, 2007) (Figure 1.14).
Experimentally, transient gene knockdown can be accomplished by transfecting a short 
dsRNA oligomer usually consisting o f 19 matched nucleotides with additional 3' 
dinucleotide overhangs. Once in the cytoplasm, Argonaute 2 (Ago2) recognizes the 3' 
overhang and incorporates the siRNA into the RNA-induced silencing complex (RISC), 
which then degrades complementary mRNA (Figure 1.14). The methods used for the 
transfection o f cells with siRNA are the same as those used to transfect DNA i.e. 
electroporation and lipid-based transfection. Stable knockdown or inducible knockdown 
can also be achieved using plasmid-based expression o f a short-hairpin RNA (shRNA) 
which is processed in the same way as endogenous miRNA.
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Figure 1.13: The miRNA/siRNA pathway: See text for details. (Taken from (Martin and 
Caplen, 2007))
1.10: Problems with RNAi
Although RNAi was originally believed to be highly specific, it became clear that the 
introduction of siRNA into cells causes degradation of multiple mRNAs in addition to the 
target (Jackson et al., 2003). Studies into the mechanism of miRNA showed that 
knockdown can be mediated through complementarity between the ‘seed region’ of the 
miRNA and the 3’ untranslated region o f an mRNA (Lim et al., 2005; Lewis et al., 2003). It 
was subsequently shown that the seed region o f an siRNA can mediate off-target 
knockdown in the same way in a concentration-dependent manner (Birmingham et al.,
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2006; Jackson et al., 2006a). This prompted research into a chemical modification that 
could make siRNA more specific. It was found that 2’-0-m ethyl ribosyl substitution o f the 
base at position 2 towards the 5 ’ end o f the antisense strand rescued much o f the off-target 
knockdown and siRNAs with this modification were made commercially available (Jackson 
et al., 2006). It has also been reported that miRNA can repress translation of protein in a 
manner independent o f mRNA cleavage suggesting that siRNA can do the same (Doench 
and Sharp, 2004). As this is also dependent on the 5' region o f the miRNA it seems likely 
that chemical modification o f an siRNA would rescue off-target translational repression.
shRNA and siRNA can also regulate gene expression by triggering an immune response. 
Firstly, dsRNA triggers the interferon response in a concentration-dependent manner 
through toll-like receptor 3 (TLR3) (Bridge et al., 2003; Kariko et al., 2004; Persengiev et 
al., 2004; Reynolds et al., 2006). Secondly, sequence-dependent gene regulation occurs in 
immune cells by dsRNA acting through TLR7 or TLR8 (Homung et al., 2005; Judge et al.,
2005). A recent study highlights these effects, trials using siRNA against vascular 
endothelial growth factor-A (VEGFA) or its receptor-1 (VEGFR1) in mice showed that 
they blocked laser-injury-induced choroidal neovascularisation (CNV) prompting clinical 
trials in humans as treatment for blinding CNV (Reich et al., 2003; Shen et al., 2006). 
However, it has now been shown that the effect is not sequence-dependent but occurs as a 
result o f the effect o f  siRNA on TLR3 (Kleinman et al., 2008)
dsRNA can have further non-specific effects by inhibiting the endogenous miRNA pathway 
through the saturation o f  dsRNA binding proteins. It is thought that this is mainly a 
problem with overexpression o f an shRNA as it appears to involve saturation o f Exp5, the 
protein responsible for the nuclear export o f pre-miRNA which is not involed in the siRNA 
pathway (Grimm et al., 2006; Yi et al., 2005). However, saturating effects o f high siRNA 
concentrations cannot be ruled out.
The concentration-dependent nature o f many off-target effects highlights the need to use as 
low an effective concentration o f  siRNA as possible in experiments. It is also important to 
replicate an experimental result with at least two different siRNA sequences targeting the 
same mRNA to control for sequence-dependent off-target effects. A scrambled non­
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targeting siRNA or shRNA should be used as a control for sequence-independent effects 
and chemical inhibition of the target should be used where available to corroborate results.
1.11: Hepatocyte growth factor signalling
Hepatocyte growth factor (HGF) is a protein in the plasminogen-related growth factor 
family. The HGF receptor c-Met is a receptor tyrosine kinase which is expressed as a 150 
kDa precursor and then glycosylated and cleaved into a 50 kDa extracellular a  chain linked 
by disulphide bonds to a 140 kDa p chain with a single transmembrane domain (reviewed 
in Ma et al., 2003 and Birchmeier et al., 2003) (Figure 1.15). Binding of HGF to c-Met 
leads to tyrosine kinase activation and trans-phosphorylation o f Tyrl234 and Tyrl235 in 
the kinase domain. Further autophosphorylation at Tyrl349 and Tyr 1356 creates a docking 
site for adaptor proteins.
PM
Figure 1.14: Schematic diagram  of c-Met. As described, c-Met consists of an 
extracellular a-chain linked to a p-chain with an intracellular tyrosine kinase domain (K).
Signalling downstream o f HGF is highly diverse, HGF binding to c-Met leads to the 
activation o f PI-3-K and Ras, the downstream pathways of which cause a variety o f cell 
responses including altered transcriptional regulation, cell scattering and chemotaxis, 
increased proliferation and invasion (Ahmed et al., 2008; Behrens et al., 1991; Ramos-Nino 
et al., 2008; Rosen et al., 1993; Tulasne et al., 2002). A well defined readout of HGF 
stimulation in c-Met-expressing cells is the phosphorylation and activation of MAP kinases
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such as ERK1 and ERK2. Signalling to these pathways is not thought to be limited to c- 
MET at the plasma membrane. HGF stimulates the endocytosis and degradation o f c-Met 
and c-Met signalling to ERK1 and ERK2 continues after endocytosis (Hammond et al., 
2001; Kermorgant et al., 2003; Kermorgant et al., 2004). HGF-induced cell migration is 
likely to be mediated by Rho GTPases such as Cdc42 and Racl (Bosse et al., 2002), but as 
yet the contribution o f each individual Rho GTPase to HGF-induced membrane ruffling 
and cell migration has not been defined. HGF has been shown to activate PAK1 and PAK4 
in MDCK cells suggesting that PAKs could mediate cell migration downstream of HGF 
(Royal et al., 2000; Wells et al., 2002). Further investigation implicated a PAK4/LIMK1 
pathway in cancer cell migration which could be o f relevance to cancer metastasis (Ahmed 
et al., 2008).
Upregulated c-M et/HGF signalling caused by overexpression o f c-Met or a mutant form of 
c-Met has been observed in many cancers and this is thought to correlate with poor 
prognosis (reviewed in Gao and Vande Woude, 2005). The roles HGF plays in cancer 
progression are consequentially the subject o f intense study and c-Met is an important 
target for a range o f anti-cancer drugs (reviewed in Knudsen and Vande Woude, 2008).
The use o f HGF experimentally in vitro provides a model system for the investigation o f 
cell signalling in migration and invasion. MDCK cells and DU 145 cancer cells scatter in 
response to HGF stimulation leading to a loss o f E-cadherin from junctions combined with 
increased motility and invasion (Miura et al., 2001; Stoker and Perryman, 1985). The 
identification o f individual proteins required for this process could reveal potential targets 
for new anti-cancer drugs.
1.12 Aims
PAKs have been implicated in many signalling pathways associated with increased cell 
migration and they have been shown to be upregulated in many cancers. This implies that 
PAKs could be potential therapeutic targets for anti-metastatic drugs, although whether 
PAKs are required for cancer metastasis is unknown.
Many previous studies characterizing the functions o f PAKs have used overexpression of 
dominant-negative and constitutively active mutants which have a major drawback because
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they can sequester adapter proteins, substrates and Rho GTPases depending on the 
mutations present. Rapid advances in the availability and use o f RNAi provides an 
alternative means to study the function o f individual PAK isoforms in cancer cell migration 
without sequestering proteins from interconnected signalling pathways.
Much previous work on PAK function was also carried out in non-human cells or cells 
originating from non-cancerous tissue and it is possible that the roles and importance of 
PAKs could be different in cancer cells. It has recently been shown that the DU 145 cancer 
cell line scatters in response to HGF providing a model system to investigate cell migration 
and scattering in cancer cells.
The aim o f this project is therefore to investigate the roles o f PAK isoforms in cancer cells 
using siRNA and to define isoform-specific roles in cell migration and scattering stimulated 
by HGF.
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C hanter 2: M aterials and methods 
2.1: M aterials
2.1.1Tissue culture m aterials
Tissue culture reagents *
Reagent M anufacturer Catalog num ber
Dulbecco's modified eagle medium (DMEM) 
(Glucose (4500 mg/L) + L-glutamine (580 
mg/L) + Pyruvate (110 mg/L)
Gibco
(Invitrogen)
41966-029
Foetal Calf Serum (FCS) Biosera S 1810
Penicillin/streptomycin (100X) Gibco
(Invitrogen)
Phosphate buffered saline (PBS) Gibco
(Invitrogen)
14190
Phosphate buffered saline (PBS) +Mg2+ +Ca2+ Gibco
(Invitrogen)
14040
Roswell Park Memorial Institute (RPMI) 1640 
(+ 300 mg/L L-Glutamine + 25 mM HEPES)
Gibco
(Invitrogen)
52400-025
Roswell Park Memorial Institute (RPMI) 1640 
(+ 300 mg/L L-Glutamine)
Gibco
(Invitrogen)
21875-034
Trypsin/EDTA Gibco
(Invitrogen)
25300
Table 2.1: Reagents used for tissue culture
2.1.2: Protein biochemistry m aterials
Protein biochemistry solutions
Buffer/solution Composition
Cell lysis buffer 10 mM Tris-Cl pH 7.6
5 mM EDTA
150 mM NaCl
30 mM Na Pyrophosphate
0.5% Triton X -100
Complete mini EDTA-free protease
inhibitor.
PhosSTOP phosphatase inhibitor
1 OX SDS-PAGE running buffer 248 mM Tris-Cl 
1.92 M Glycine 
10% SDS (w/v)
4X SDS sample buffer 0.25 M Tris-Cl pH6.8 
8% SDS (w/v)
40 % Glycerol (w/v)
2.82 M p-mercaptoethanol 
0.2% Bromophenol blue (w/v)
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SDS-PAGE 7.5% gel 375 mM Tris-Cl pH 8.8 
7.5% Acrylamide (w/v) 
0.1% SDS (w/v)
0.1% APS (w/v) 
0.005% TEMED (w/v)
SDS-PAGE stack gel 126 mM Tris-Cl pH 6.8 
10% Acrylamide (w/v) 
0.1% SDS (w/v)
0.1% APS (w/v)
0.01% TEMED (w/v)
10X SDS-PAGE transfer buffer 248 mM Tris-Cl,
1.92 M Glycine
(20% Methanol added upon dilution to IX)
Tris-buffered saline + 0.1% tween (TBS-T) 50 mM NaCl,
25 mM Tris-Cl pH 7.6 
0.1% Tween (w/v)
Immunoprecipitation wash buffer 10 mM Tris-Cl 
5 mM EDTA 
150 mM NaCl 
30 mM Na Pyrophosphate 
0.5% Triton X-100 (w/v)
Table 2.2: Composition of solutions used for protein biochemistry.
Protein Biochemistry reag<mts
Reagent Manufacturer Catalogue number
Complete, mini 
EDTA-free protease 
inhibitor cocktail
Roche Applied Science 04 693 159 001
PhosSTOP 
phosphatase inhibitor 
cocktail
Roche Applied Science 04 906 837 001
Precision Plus protein 
all blue standards
BIO-RAD 161-0373EDU
Enhanced
chemiluminescence 
(ECL) reagents
Amersham biosciences RPN2106V2
PageRuler prestained 
protein ladder
Fermentas #SM0671
Dried, skimmed milk Marvel N/A
Bovine Serum 
Albumin (BSA)
Sigma A7906-100G
MOPS running buffer Invitrogen NP0001
Immobilon-P PVDF 
membrane
Millipore IPVH00010
Immobilon-FL PVDF 
membrane
Millipore IPFL00010
Table 2.3: Reagents used for protein biochemistry.
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Protein biochemistry equipm ent
Equipm ent M anufacturer
NuPAGE 4-12% polyacrylamide gels Invitrogen
Nu PAGE X-Cell II eletrophoresis system Invitrogen
Mini-Protean electrophoresis and western blotting system Bio-Rad
Table 2.4: Equipm ent used for protein biochemistry.
’rim arv antibodies used on western blots
Antigen Species Dilution M anufacturer Catalogue
num ber
P-actin Mouse 1/4000 Sigma-Aldrich A-5441
p-Akt (S473) Rabbit 1/1000 Cell Signaling Technology #4058
Cdc42 Rabbit 1/1000 Cell Signaling Technology F-2168
p-cofilin (S3) Rabbit 1/1000 Cell Signaling Technology #3311
E-cadherin Rabbit 1/1000 Transduction Labs 610181
ERK1/2 Rabbit 1/1000 Santa Cruz Biotechnology sc-94
p-ERKl/2
(T202/Y204)
Rabbit 1/1000 Cell Signaling Technology #9101L
p-FAK (Y576/577) Rabbit 1/1000 Cell Signaling Technology #3281
LIMK1 Rabbit 1/1000 Cell Signaling Technology #3842
p-LIM Kl/2 (T508) Rabbit 1/1000 Cell Signaling Technology #3841
p-MEK (S298) Rabbit 1/1000 Abeam ab5613-50
p-R-MLC (T 18/S 19) Rabbit 1/1000 Cell Signaling Technology #3674
p-Opl8 (S I6) Rabbit 1/1000 Santa Cruz Biotechnology sc-12948-R
p-p38 (T180/Y182) Rabbit 1/1000 Cell Signaling Technology #9211
PAK1 Rabbit 1/1000 Cell Signaling Technology #2602
PAK2 Rabbit 1/1000 Cell Signaling Technology #2608
PAK3 Rabbit 1/1000 Cell Signaling Technology #2609
PAK4 Goat 1/1000 Santa Cruz Biotechnology sc-18622
PAK4 Rabbit 1/1000 Cell Signaling Technology #3442
p-PAK 1/2/3 (T423) Rabbit 1/1000 Cell Signaling Technology #2601
p-PAK 1/2/3 (T423) Rabbit 1/1000 Abeam ab-2477-100
p-PAK 1/2 (S I99/204) Rabbit 1/1000 Cell Signaling Technology #2605
p-PAK 1/2/3 (S 141) Rabbit 1/1000 Biosource 44-940
p-Raf (S338) Rabbit 1/1000 Cell Signaling Technology #9427
Racl Mouse 1/1000 Upstate 05-389
Secondary antibodies used on western blots
Antibody Species Concent
ration
M anufacturer Catalogue
num ber
Horseradish 
peroxidase-conj ugated 
anti-mouse IgG
Sheep 1/15000 Amersham Biosciences NA-931
Horseradish 
peroxidase-conj ugated 
anti-rabbit IgG
Donkey 1/2000 Amersham Biosciences NA-934
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IR DYE 800-linked 
anti-mouse IgG
Donkey 1/2000 Rockland 610-732-124
Alexa 680-linked anti­
rabbit IgG
Goat 1/2000 Molecular Probes A21076
Alexa 680-linked anti­
goat IgG
Donkey 1/2000 Molecular Probes A21084
Table 2.5: Prim ary and secondary antibodies used for probing western blots.
2.1.3: Cell biology m aterials
Cell biology reagents
Reagent Manufacturer Catalogue number
Human recombinant 
Hepatocyte Growth 
Factor (HGF)
R and D systems 294-HG-005
Fluorescent mounting 
medium
Dakocytomation S3023
20 pi aerosol-resistant 
tips for scratch assays
Rainin RT-20F
Matrigel-coated 
transwells (8 pm pore 
size)
BD Biosciences 354480
Uncoated transwells 
(8 pm pore size)
Falcon (BD Biosciences) 355097
Lipofectamine 2000 Invitrogen 11668-019
Optimem GlutaMAX Gibco (Invitrogen) 51985-026
A/G-linked agarose 
beads
Santa Cruz Biotecnology sc-2003
13 mm coverslips VWR 631-0150
Sterile filtered 
mineral oil
Sigma M5310-1L
Table 2.6: Reagents used in cell biology experiments.
short interfering RNA oligomers
Oligomer Supplier Serial
num ber
Sense (top) and antisense (bottom) 
sequences
siC ontrolQ Qiagen 1022076 UUCUCCGAACGUGUCACGUdTdT
ACGUGACACGUUCGGAGAAdTdT
siC ontrolD Dharmacon D-001810-01 ON-TARGET/?/ws modified, sequence not
available
Cdc42_02 Dharmacon D-005057-02 GAUUACGACCGCUGAGUUAUU 
5 ' -PUAACUCAGCGGUCGUAAUCUU
Cdc42_03 Dharmacon D-005057-03 GALJGACCCCUCUACUAUUGUU 
5 ' - PCAAUAGUAGAGGGGUCAUCUU
PAK la Dharmacon D-003521-01 GAAGAAAUAUACACGGUUUUU 
5 ' -PAAACCGUGUAUAUUUCUUCUU
PAK lb Dharmacon D-003521-03 CAUCAAAUAUCACUAAGUCUU
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5 ' -PGACUUAGUGAUAUUUGAUGUU
PA K lc Dharmacon D-003521-05 CAACAAAGAACAAUCACUAUU 
5 ' -PUAGUGAUUGUUCUUUGUUGUU
PAK Id Dharmacon D-003521-07 AGAAAUACCAGCACUAUGAUU 
5 ' -PUCAUAGUGCUGGUAUUUCUUU
PA K le AstraZeneca N/A; from 
collaborators
CACACAAUUCAUGUCGGUUdTdT
AACCGACAUGAAUUGUGUGdTdT
PAK2a Dharmacon D-003597-05 AGAAGGAACUGAUCAUUAAUU 
5 ' -PUUAAUGAUCAGUUCCUUCUUU
PAK2b Dharmacon D-003597-06 CUACAGACCUCCAAUAUCAUU 
5 ' -PUGAUAUUGGAGGUCUGUAGUU
PAK2c Dharmacon D-003597-07 GAAACUGGCCAAACCGUUAUU 
5 ' -PUAACGGUUUGGCCAGUUUCUU
PAK2d Dharmacon D-003597-09 ACAGUGGGCUCGAUUACUAUU 
5 ' -PUAGUAAUCGAGCCCACUGUUU
PAK4a Dharmacon D-003615-03 GGAUAAUGGUGAUUGAGAUUU 
5 ' -PAUCUCAAUCACCAUUAUCCUU
PAK4b Dharmacon D-003615-05 GGGUGAAGCUGUCAGACUUUU 
5 ' -PAAGUCUGACAGCUUCACCCUU
PAK4c Dharmacon D-003615-06 AGAAUGUGGUGGAGAUGUAUU 
5 ' -PUACAUCUCCACCACAUUCUUU
PAK4d Dharmacon D-003615-07 CCAUGAAGAUGAUUCGGGAUU 
5 ' -PUCCCGAAUCAUCUUCAUGGUU
Racl 05 Dharmacon D-003560-05 AGACGGAGCUGUAGGUAAAUU 
5 ' -PUUUACCUACAGCUCCGUCUUU
Racl 07 Dharmacon D-003560-07 UAAGGAGAUUGGUGCUGUAUU 
5 ' -PUACAGCACCAAUCUCCUUAUU
Rac2_01 Dharmacon D-007741-01 GAGAUGGGGCCGUGGGCAAUU 
5 ' -PUUGCCCACGGCCCCAUCUCUU
Rac2_02 Dharmacon D-007741-02 CAGCCAAUGUGAUGGUGGAUU 
5 ' -PUCCACCAUCACAUUGGCUGUU
Rac2_03 Dharmacon D-007741-03 CCAAUGUGAUGGUGGACAGUU 
5 ' -PCUGUCCACCAUCACAUUGGUU
Rac2_04 Dharmacon D-007741-04 ACAAGGACACCAUCGAGAAUU 
5 ' -PUUCUCGAUGGUGUCCUUGUUU
Rac3_01 Dharmacon D-008836-01 GGAGAUUGGCUCUGUGAAAUU 
5 ' -PUUUCACAGAGCCAAUCUCCUU
Rac3_02 Dharmacon D-008836-01 ACGUGAUGGUGGACGGGAAUU 
5 ' -PUUCCCGUCCACCAUCACGUUU
Rac3_04 Dharmacon D-008836-01 CGAGAAUGUUCGUGCCAAGUU 
5 ' - PCUUGGCACGAACAUUCUCGUU
Rac3_05 Dharmacon D-008836-01 AAACUGACGUCUUUCUGAUUU 
5 ' - PAUCAGAAAGACGUCAGUUUUU
R h o A l 1 Dharmacon J-003860-11 On-Target+ G AC C AAAG AU G G AG U G AG AU U 
5 ' -PUCUCACUCCAUCUUUGGUCUU
RhoJ_05 Dharmacon J-010367-05 ON-TARGET/?/ws modified, sequence not
available
RhoJ 06 Dharmacon J-010367-06 ON-TARGET/?/w5 modified, sequence not
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available
RhoJ_07 Dharmacon J-010367-07 ON-TARGETp/ws modified, sequence not
available
RhoJ_08 Dharmacon J-010367-08 ON-TARGETp/ws modified, sequence not
available
RhoQ_05 Dharmacon J-009943-05 ON-TARGETp/ws modified, sequence not
available
RhoQ_06 Dharmacon J-009943-06 ON-TARGETp/ws modified, sequence not
available
RhoQ_07 Dharmacon J-009943-07 ON-TARGETp/ws modified, sequence not
available
RhoQ_08 Dharmacon J-009943-08 ON-TARGETp/ws modified, sequence not
available
R hoU O l Dharmacon D-009882-01 GUACUGCUGUUUCGUAUGAUU 
5 ' - PUCAUACGAAACAGCAGUACUU
RhoU_02 Dharmacon D-009882-02 GAACGUCAGUGAGAAAUGGUU 
5 ' -PCCAUUUCUCACUGACGUUCUU
RhoU_03 Dharmacon D-009882-03 CAGAGAAGAU GU CAAAG U C U U 
5 ' - PGACUUUGACAUCUUCUCUGUU
RhoU_04 Dharmacon D-009882-04 AAGCAGGAC U C CAGAU AAAU U 
5 ' -PUUUAUCUGGAGUCCUGCUUUU
Rho V O  1 Dharmacon D-006374-01 GAG G GAC GAU G U CAAC G UAU U 
5 ' -PUACGUUGACAUCGUCCCUCUU
RhoV_02 Dharmacon D-006374-02 GAAGAAACUGAAUGCCAAAUU 
5 ' -PUUUGGCAUUCAGUUUCUUCUU
RhoV_03 Dharmacon D-006374-03 GUAUUUGACUCGGCUAUUCUU 
5 ' - PGAAUAGCCGAGUCAAAUACUU
RhoV_04 Dharmacon D-006374-04 GC U CAGC C U U GAC G CAGAAU U 
5 ' - PUUCUGCGUCAAGGCUGAGCUU
Table 2.7: siRNA oligomers used for protein knockdown.
Prim ary antibodies and fluorescent probes used for immunofluorescence
Antigen Species Concentration M anufacturer Catalogue
num ber
F-actin (Phalloidin)- 
(Alexa 546-linked)
N/A 1/200 Invitrogen A22283
Tubulin-(FITC-linked) Mouse 1/200 Sigma
E-Cadherin Rabbit 1/100 Transduction Labs 610181
p95PKL (GIT1/2) Mouse 1/100 Transduction Labs 611388
ERK1/2 Rabbit 1/100 Santa Cruz 
Biotechnology
sc-94
Hoechst 33342 N/A 1/2000 Invitrogen H3570
Secondary antibodies used for immunofluorescence
Antigen Species C oncentration M anufacturer Catalogue
num ber
Alexa 647-linked anti­
rabbit IgG
Goat 1/200 Invitrogen A21245
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Alexa 488-linked anti­ Goat 1/200 Invitrogen A l1001
mouse IgG
Table 2.8: Antibodies used for immunofluorescence.
Cell biology software
Software Source
Photoshop CS3 software Adobe
Metamorph software Molecular Devices
I mage J National Institutes of Health
LSM510 software Zeiss
Definiens imaging software Definiens
Table 2.9: Software used for image capture, processing and analysis.
Cell biology microscopes/instruments
Software Source
LSM510 confocal microscope Carl Zeiss
Aiovert 135 microscope Carl Zeiss
Eclipse TE 100-E microscope Nikon
ArrayScan imaging system Cellomics
Table 2.10: Microscopes and instruments used for image capture.
Growth Media
Cell lines Medium
DU 145, PC3
Growth
medum
RPMI + 10% FCS, L-glutamine (300 mg/L), penicillin (100 IU/ml) and 
streptomycin (100 pg/ml), + 25 mM HEPES for experiments or HEPES 
free for general cell culture.
DU145, PC3
Starvation
medium
RPMI + 0.1% FCS, L-glutamine (300 mg/L), penicillin (100 IU/ml) and 
streptomycin (100 fig/ml), + 25 mM HEPES for experiments or HEPES 
free for general cell culture.
MCF7, HT29
Growth
medum
DMEM + 10% FCS, Glucose (4500 mg/L), L-glutamine (580 mg/L), 
penicillin (100 IU/ml) and streptomycin (100 pg/ml).
MCF7, HT29
Starvation
medium
DMEM + 0.1% FCS, Glucose (4500 mg/L), L-glutamine (580 mg/L), 
penicillin (100 IU/ml) and streptomycin (100 pg/ml).
Table 2.11: Composition of grow th media used for tissue culture and experiments
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2.2: Methods 
2.2.1: Tissue culture
2.2.1.1: Passaging cell lines
For passaging, cells were washed twice in phosphate buffered saline (PBS) and incubated 
with 1 ml trypsin/EDTA at 37°C until all cells had detached. Cells were then suspended in 
10 ml growth medium and 2ml o f this was added to a new flask already containing a further 
10 ml growth medium.
All experiments except for Figures 3.1 -  3.4, 4.1 and 4.19 were carried out in medium 
supplemented with 25 mg/L HEPES
2.2.2: Protein Biochemistry
2.2.2.1: HGF stimulation for cell lysis
Cells were seeded in 24-well plates at the following densities and allowed to adhere for 18 
h: DU145, 4 x l0 5/well; PC3, 2 x l0 5/well; MCF7, 4 x l0 5/well; HT29, 8 x l0 5/well. If cells 
were to be transfected, antibiotic-free medium was used. Cells were then either transfected 
with siRNA according to the protocol (2.2.3.1) or untreated and maintained in growth 
medium. After a further 48 h, medium was removed and replaced with 1 ml fresh growth 
medium containing 10 ng/ml HGF. Cells were lysed at the desired time points.
2.2.2.2: Cell lysis
Cells were grown and treated as required. Medium was removed from the cells and they 
were washed once with PBS +Mg2+ +Ca2+. Cells were then placed on ice and an 
appropriate volume o f TritonX-100 lysis buffer was added (in 24-well plates, 100 pi lysis 
buffer was used per well). Following incubation on ice for 5 min, cells were scraped from 
the substrate using a wide-bore pipette tip, transferred to a microfuge tube and incubated on 
ice for 10 min Lysates were then centrifuged at 4°C and 16.2 G (Thermo Scientific Fresco 
17 centrofuge) for 10 min and the supernatant was transferred to a fresh microfuge tube. 
For figures 3.2, 3.3 and 3.4, protein concentration was assayed using the BioRad protein 
assay protocol shown below. 4X sample buffer was added to each supernatant, heated to 
100°C for 5 min and stored at -20°C.
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2.2.2.3: BioRad protein concentration assay
5 pi o f cell lysate (or fresh lysis buffer as a blank) was added to a plastic cuvette containing 
795 pi ddH20 and 200 pi BioRad protein assay reagent. Solutions were mixed by inversion 
several times and absorbance was measured at 595 nm using a BioRad spectrophotometer.
2.2.2.4: Immunoprecipitation
DU 145 cells were seeded in 6 cm dishes at a density o f 5 x l0 5 cells/dish. After 32 h, 
medium was removed and replaced with fresh growth medium or starvation medium 
containing 0.1% FCS. After a further 16 h, cells were sequentially stimulated with fresh 
starvation medium containing 10 ng/ml HGF over a time course o f 2 h. Cells were then 
lysed in 1 ml Triton X-100 lysis buffer according to the protocol above except that sample 
buffer was not added. Lysates were pre-cleared by rotation with 5 pi protein A/G-linked 
agarose beads for 30 min at 4°C followed by centrifugation at 6000 G for 5 min. The 
supemantant was transferred to a fresh tube and immunoprecipitation was performed; for 
each lysate, 20 pi protein A/G-linked agarose beads were combined with 2.5 pi PAK4 
antibody (Cell Signaling Technology). A further two tubes containing 20 pi protein A/G- 
linked agarose beads and 2.5 pi Myc antibody were prepared as a control for non-specific 
binding. 0.5 ml ice-cold PBS was added to each tube and rotated at 4°C for 2 h. Beads were 
centrifuged at 6000 G. for 5 min, supernatant was removed and beads were washed twice in 
lysis buffer. 10 pi o f 10% BSA was added to each sample o f beads and 500 pi pre-cleared 
lysate was transferred to each. (Myc-linked beads received 500 pi lysate from starved, 
unstimulated and starved cells stimulated with HGF for 60 min) Lysates/beads were rotated 
at 4°C for 2 h then centrifuged for 5 min at 6000 G. Supernatant was removed and beads 
were washed 4 times in wash buffer. Finally, supernatant was removed, 15 pi 2X sample 
buffer was added to each tube and heated to 100°C for 5 min Samples were stored at -20°C 
prior to western blotting.
2.2.2.S: NuPAGE (SDS-PAGE using pre-cast gels)
An X-Cell II gel tank was assembled using a pre-cast SDS-PAGE gel o f the appropriate 
concentration and composition (usually 4-12% polyacrylamide, 1.5 mm thickness). Lysates 
in sample buffer were added to the wells and Bio-Rad precision plus all-blue standard was
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used as molecular weight markers. Where protein concentration was measured, an equal 
amount o f protein was loaded into each lane. For other lysates, an equal volume o f sample 
was loaded. Electrophoresis was carried out at 120 volts for approximately 1.5 h and the 
resulting gel was used for western blotting (2.2.2.7).
2.2.2.6: SDS-PAGE using non-precast gels
When pre-cast gels were not used, proteins were separated by electrophoresis through a 
7.5%, 1.5 mm polyacrylamide gel using a Mini-Protean electrophoresis system. The gel 
mixture was prepared, poured into the scaffold and overlaid with water-saturated butanol. 
After 30 min, the butanol was washed off, a 15-well or 10-well comb was inserted and the 
stacking gel mixture was prepared and pipetted on top o f the gel. Once set, the gel was 
placed in a Mini-Protean gel-tank which was filled with IX  SDS-PAGE running buffer. 
Lysates in sample buffer were added to the wells and PageRuler prestained protein ladder 
was used as molecular weight markers. Where protein concentration was measured, an 
equal amount o f protein was loaded into each lane. For other lysates, an equal volume o f 
sample was loaded. Electrophoresis was carried out at 100 volts for approximately 1.5 h. 
The resulting gel was used for western blotting (2.22.1).
2.2.2.7: Western blotting
Following SDS-PAGE, proteins were transferred onto polyvinylidene fluoride (PVDF) 
membrane (Immobilon-FL, or Immobilon-P) by wet transfer using the Mini Protean 
transfer system (Bio-Rad). Sponges and Whatmann paper were pre-soaked in IX transfer 
buffer, and PVDF was pre-soaked in methanol. The polyacrylamide gel was overlaid with 
PVDF and sandwiched between two pieces o f blotting paper and two sponges in a Mini 
Protean transfer cassette. The cassette was inserted into a transfer tank containing IX 
transfer buffer at 4°C and electrophoresed at 80 V for 90 min. The resulting membrane with 
bound proteins was blocked for 1 h in TBS-T containing 5% BSA. Blocking buffer was 
then replaced with TBS-T containing 5% BSA or 5% milk and the appropriate primary 
antibody and incubated overnight at 4°C (or for 1 h at room temperature for p-actin). The 
membrane was then washed four times in TBS-T for 5 min and incubated with HRP-linked 
or IR dye-linked secondary antibody at a concentration o f 1:4000 in TBS-T + 1% Milk for 
1 h. The membrane was washed in TBS-T briefly twice, and then again four times for 5 
min and developed by addition o f ECL reagent and exposure to X-ray film (for HRP-linked
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secondary antibodies) or imaged using the LI-COR Odyssey IR imaging system (For IR 
dye-linked secondary antibodies).
2.2.2.8: Quantification of western blots
Films were scanned and resulting images were analysed using ImageJ software. First the 
image was inverted to give a positive grey value for light pixels and a selection box was 
placed over the first band. The average grey value was recorded and the selection box was 
moved to the next band so the selection area remained the same for each. A grey value for 
the background was measured and subtracted from the band measurements. If a final 
normalized grey value was less than 0 (less than background) it was counted as 0.
2.2.3: Cell Biology
2.2.3.1: Transfection o f cells with siRNA using Lipofectamine 2000
In experiments where cells were transfected, antibiotic-free media were used throughout the 
protocols. Cells were seeded, allowed to adhere for at least 7 h and then given fresh growth 
medium (500ul in 24-well plates, 2.5 ml in 2 cm dishes or SlideFlasks) before siRNA 
treatment. Lipofectamine 2000 (Invitrogen) was diluted in Optimem (Invitrogen) in a ratio 
o f 1:50 and incubated at room temperature for 5 min (Buffer B). siRNA was diluted to a 
concentration o f 40 pmoles/ml in Optimem Glutamax and an equal volume o f Buffer B was 
added. This mixture was incubated at room temperature for 20 min and then added to the 
cells (100 pi (2 pmoles siRNA) in 24-well plates or 500 pi (10 pmoles siRNA) in 2 cm 
dishes and SlideFlasks. Medium was removed after between 5 and 24 h and replaced with 
1 ml fresh antibiotic-free medium.
2.2.3.2: Scattering and random migration assays
Cells were seeded at the following densities and allowed to adhere for 18 h: DU 145, 
l^xlO'^ cells/well in a 24-well plate (or 6x10? cells/2 cm dish for Figure 4.1); PC3, 8x l04 
cells/well in a 24-well plate (or 4 x l0 5 cells/2 cm dish for Figure 4.1); MCF7, 6 x l0 5 cells/2 
cm dish; HT29 cells lx lO 6 cells/ 2 cm dish.
For Figure 4.1, cells were maintained in growing conditions for a total o f 48 h prior to 
starvation in medium containing 0.1% FCS for 6 h. Cells were then stimulated with 10 
ng/ml HGF and movies were made for 16 h using an Axiovert 135 microscope.
71
Chapter 2 Materials and methods
For Figure 4.2 cells were maintained in growing conditions for a total o f 48 h then either 
starved in medium containing 0.1% FCS or kept in growing conditions for 6 h. Medium 
was then changed and cells were either kept unstimulated in 0.1% FCS or stimulated with 
10 ng/ml or 20 ng/ml HGF. Mineral oil was placed on top o f the medium to maintain pH 
and movies were made for 24 h.
For all other scattering or random migration assays, cells were either transfected with 
siRNA using Lipofectamine 2000 or untreated and maintained in growth medium as 
required. 54 h after transfection, medium was removed and replaced with fresh growth 
medium or growth medium supplemented with 10 ng/ml HGF. Mineral oil was placed on 
top o f the medium to maintain pH and time lapse movies were made over a period o f up to 
24 h using a Nikon TE2000-E microscope with a Plan Fluor 10X objective. Image series 
were captured using Metamorph software.
2.2.3.3: Analysis of cell rounding
Appropriate frames from movies o f DU 145 cell scattering were analysed (Figure 2.1 A). 
Image brightness and contrast were adjusted using Adobe Photoshop CS3 software; 
brightness -50, contrast +100 with ‘use legacy’ ticked. This gave an image where rounded 
cells had a saturated white circle encompassing a black spot at the nucleus (Figure 2 .IB, 
red arrow). The Paint Bucket tool was used to fill the black background with white leaving 
any discontiguous spots, i.e. nuclei o f rounded cells, black (Figure 2.1C). The brightnes and 
contrast used defined the stringency of counting to ensure that no flat cells were counted as 
round cells. Metamorph software was used to automatically count the number o f black 
objects in each image. Size exclusions were set to include spots corresponding to whole 
cells but not smaller background objects.
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Figure 2.1: Processing of images using Adobe Photoshop CS3 for cell rounding 
measurements. As described, frames from movies (A) were extracted from image 
sequences and brightness/contrast was altered to make an image with saturated phase-bright 
objects in white (B). The background was filled with white but any discontiguous black 
objects i.e. the nuclei o f rounded cells remained black (C). Black objects of appropriate size 
were counted using Metamorph.
2.2.3.4: Analysis of Iamellipodium length
After DU 145 cell scattering assays for 24 h, the final frame from movies was analysed. 
Cells not in contact with more than one other cell which had at least one Iamellipodium 
were selected for measurement so that round cells with no lamellipodia, or cells still within 
groups did not influence the data. Lamellipodium length was measured using ImageJ 
software by drawing a line along the leading edge of each lamellipodium and making a 
measurement in pixels.
2.2.3.5: DU145 cell scratch assays using the Cellomics A rrayScan instrum ent
DU 145 cells were seeded at a density of 8000 cells/well in black-sided 96-well plates. After 
24 h, medium was removed and replaced with 83 pi fresh medium before siRNA treatment. 
Cells were transfected with siRNA using Lipofectamine 2000 or left untransfected. (Note 
that siRNA was not washed off after 4 h). 48 h after transfection medium was removed 
from each well, cells were washed once and medium was replaced with either fresh growth 
medium or starvation medium containing 0.1% FCS. After a further 7 h a 200 pi pipette tip 
was used to scratch the monolayer in the centre of each well, medium was then removed 
and replaced with fresh medium or medium containing 10 ng/ml HGF. Cells were then 
incubated for 16 h prior to fixation in 3.7% formaldehyde and staining for F-actin 
(Phalloidin) and nuclei (Hoechst).
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The centre o f each well was imaged automatically using the Cellomics ArrayScan system 
and the Definiens program was used with an algorithm written by collaborators at 
AstraZeneca to measure the area o f each scratch based on the phalloidin stain. Data from 
wells where the scratch was off-centre and not imaged completely were not included in 
subsequent data analysis.
2.2.3.6: Dl! 145 cell scratch assays using time-lapse microscopy
DU 145 cells were seeded at 7.5x105 cells/well in a 24-well plate and allowed to adhere and 
grow for 16 h. Cells were transfected with siRNA or left untreated in growth medium. 48 h 
after transfection, medium was removed from each well and replaced with starvation 
medium containing 0.1% FCS. After a further 8 h, when cells had formed a confluent 
monolayer, a 20 pi pipette tip was used to scratch a line o f cells from the centre o f the well. 
Medium was then removed and replaced with fresh starvation medium or starvation 
medium supplemented with 10 ng/ml HGF and time-lapse movies were made o f scratches 
healing over a period o f 16 h.
Frames from movies o f DU 145 cell scratch assays were taken and Adobe Photoshop CS 
was used to colour the cells black and the scratch white. Metamorph software was used to 
measure the area covered by white pixels in the resulting images.
2.2.3.7: DU145 M atrigel invasion assays
DU 145 cells were seeded in 6-well plates at a density o f 1.5xl0? cells/well and allowed to 
adhere for 18 h. Cells were transfected with siRNA using Lipofectamine 2000 and kept 
growing for a further 48 h. Matrigel-coated transwells were rehydrated for 2 h in growth 
medium at 37°C. Transfected cells were washed twice in PBS, trysinized and counted. 
lx lO 6 cells were seeded into the upper chamber o f the Matrigel-coated transwells in 
antibiotic-free growth medium. Growth medium containing 40 ng/ml HGF was placed in 
the bottom chamber as a chemoattractant. 2 x l0 5 cells were seeded in uncoated transwells as 
a migration control with the same chemoattractant concentration. Cells were allowed to 
invade or migrate for 24 h then remaining cells and matrix were removed from the upper 
chamber, and cells on the bottom o f the transwells were fixed in methanol containing 0.1% 
crystal violet. 5 separate bright-field images were captured o f each transwell with 
Metamorph software using a Nikon TE2000-E microscope with a Plan FluorlOX objective.
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The levels o f each image were auto-adjusted to remove background using Adobe 
Photoshop CS3 autolevels with clipping set to; shadows 9%; highlights 0.1%. Images were 
then thresholded so that the area o f stained cells could be measured automatically using 
Metamorph software.
2.2.3.8: Acid washing coverslips
13 mm glass coverslips were washed in concentrated nitric acid for 5 min followed by 10 
washes with copious amounts o f tap water, 5 washes with distilled water and 2 washes with 
100% methanol. Coverlips were than baked at 180 °C for 4 h.
2.2.3.9: Immunofluorescent staining
Cells were seeded on acid-washed coverslips in 24-well plates at densities o f 1.2xl05 
cells/well (DU 145) or 8 x l0 4 cells/well (PC3). Cells were allowed to adhere for 18 h prior to 
transfection with siRNA using Lipofectamine 2000. 48 h after transfection, medium was 
removed and replaced with either fresh growth medium or growth medium containing 10 
ng/ml HGF. After a further 24 h, cells were fixed in 4% paraformaldehyde (PFA) for 20 
min at room temperature or in methanol at -20 °C for 5 min. Fixed cells were washed three 
times in PBS and then PFA-fixed cells were permeabilized in 0.1% Triton X-100 for 5 min 
prior to washing three times again in PBS. All coverslips were then transferred to 5% BSA 
in PBS.
Primary antibodies were diluted in 5% BSA in PBS and 20 pi spots were pipetted onto 
parafilm in a 10 cm dish containing water-soaked paper towel to humidify the dish. 
Coverslips were inverted onto the antibody spots and incubated at 4 °C for 18-22 h.
Secondary antibodies, or phalloidin solutions were prepared in the same way as primary 
antibodies and coverslips were washed four times in PBS prior to being inverted onto the 
secondary antibody spots and incubated for 1 -3 h at room temperature.
Coverslips were then washed 5 times and mounted onto glass slides using fluorescence 
mounting medium. Slides were stored in the dark at room temperature for 3-5 h for 
mounting medium to set and the stored at 4 °C until images were taken.
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2.2.3.10: Confocal microscopy
A Zeiss LSM510 confocal laser-scanning microscope with an EC Plan-Neofluar 40X/1.3 
oil DIC M27 objective and LSM510 software were used to capture images o f fluorescently 
stained cells with the pinhole set for an approximate optical slice thickness o f 1 pm. Images 
captured were 1056x1056 pixels with a pixel scanning time of 2.18 ps. Microscope and
filter settings used are shown:
Fluorophore wavelengths, lasers and filters used
Fluorophore Laser Excitation (nm) Emission (nm) Filter (nm)
FITC/Alexa 488 Argon 488/494 520/517 Band Pass 505- 
530
Alexa 546 Helium/Neon 556 573 Band Pass 560- 
615 IR
Alexa 647 Helium/Neon 650 668 Meta detector 
636-754
Table 2.12: Lasers and filters used for confocal microscopy.
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Chapter 3: PAK expression and regulation in cancer cell migration 
3.1: Introduction
PAKs are not uniformly expressed in all tissues and PAK expression can be upregulated in 
cancer cells (reviewed in Arias-romero et al., 2008 and Kumar et al., 2006). For example, 
PAK4 mRNA expression is upregulated in multiple breast cancer cell lines (Callow et al., 
2002). As PAKs play multiple roles in cell migration, their upregulation in cancer is 
suggestive o f a role in cancer metastasis.
In vitro the cellular processes involved in cancer metastasis including junctional 
breakdown, cell migration and matrix invasion, can be studied using hepatocyte growth 
factor (HGF) as a stimulus (Wells et al., 2005 and our unpublished data). HGF has been 
shown to activate PAK1 and PAK4 in MDCK cells (Royal et al., 2000; Wells et al., 2002). 
If the same is true in cancer cells it would further implicate a role for PAKs in cancer 
metastasis.
PAKs are regulated by phosphorylation at multiple sites which affect persistence and level 
o f activation, or binding o f adaptor proteins (Chong et al., 2001). In PAK1, phosphorylation 
o f Thr423 in the kinase domain is required for full kinase activity (Zenke et al., 1999). The 
other group I PAK isoforms contain a highly homologous site (T402 in PAK2 and T421 in 
PAK3). Group II PAKs contain a homologous site at S474, S602 or S560 in PAK4, PAK5 
and PAK6 respectively. Group I PAKs also contain autophosphorylation sites at S I99 and 
S204 in PAK1 or S I92 and S I97 in PAK2 (Manser et al., 1997). Phosphorylation o f these 
sites follows PAK activation and modulates binding o f the adapter protein (3-PIX (Mott et 
al., 2005). It is also possible that these sites are phosphorylated by another kinase or PAK 
isoform but this has not been described.
Previous studies o f PAK isoforms using overexpression o f dominant negative and active 
mutants suggest that PAKs are controlling elements o f cell migration and MAP kinase 
signalling (Kiosses et al., 1999; Qu et al., 2001; Royal et al., 2000; Zhang et al., 1995). 
However, dominant negative and constitutively active mutants are still able to bind 
substrate and adapter proteins, thereby sequestering those proteins and blocking multiple 
signalling pathways. This is highlighted by the finding that dominant negative and 
constitutively active PAK mutants both inhibit migration o f HMEC-1 cells due to the
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presence o f the N-terminal SH3 binding region in both mutants (Kiosses et al., 1999). 
Overexpression also makes it difficult to study individual PAK isoforms due to the 
possibility o f shared binding partners, whereby overexpression o f one PAK isoform would 
also inhibit signalling through another. RNA interference (RNAi) provides an alternative to 
expression o f dominant negative mutants by selectively knocking down expression o f a 
target protein. This technique has recently been used to investigate the functions o f PAK 
isoforms, highlighting roles in the breakdown o f cell junctions and matrix invasion (Lozano 
et al., 2008; Pavey et al., 2006). The specificity o f RNAi makes it an ideal tool to 
investigate isoform-specific functions o f PAKs.
The aims o f this chapter are to investigate how the expression and phosphorylation o f 
PAK1, PAK2 and PAK4 are regulated in cancer cells and to establish a protocol for the 
knockdown o f PAK expression using RNAi.
Results
3.2: PAK expression in cancer cell lines
PAK expression can be altered in cancer compared to normal tissue and upregulation is 
thought to correlate with progression o f the disease. DU 145 (prostate), PC3 (prostate), 
MCF7 (breast) and HT29 (colon) cancer cell lines were chosen for study due to their 
different morphology and invasion characteristics (Figure 3.1). DU145 cells grow in groups 
and scatter in response to HGF (Miura 2001). They are less invasive than the other prostate 
cancer cell line, PC3 cells, which grow as single cells (Colella et al., 2004). MCF7 cells are 
weakly invasive and junctional breakdown can be stimulated by overexpression o f the cell 
adhesion molecule LI (Milde-Langosch, 2008; Schtutman, 2006). HT29 cells also grow in 
groups and respond to HGF stimulation by spreading (Nabeshima 1998).
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DU145 PC3
MCF7 HT29
Figure 3.1: M orphology of DU145, PC3, M CF7 and HT29 cells. Cells were seeded and 
allowed to grow for 48 hours before phase contrast images were captured using a Nikon 
microscope.
Expression of PAK 1, PAK2 and PAK4 was determined by western blotting (Figure 3.2). 
Each o f the cell lines tested expressed PAK1. PAK2 and PAK4 although expression of 
PAK1 was lower in PC3 and MCF7 cells. PAK4 expression was lowest in DU 145 and PC3 
cells. An antibody against PAK3 was also tested but gave no signal at the correct molecular 
weight (data not shown). PAK5 and PAK6 were not tested; PAK5 is though to be 
functionally redundant as the PAK5 knockout mouse has no detectable phenotype 
compared to control mice. PAK6 has been shown to inhibit androgen receptor signalling 
(Schrantz et al., 2004) but a role in cell migration has not yet been described.
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Figure 3.2: C ancer cell lines express PAK1, PAK2 and PAK4. Western blots were 
performed on cell lysates from DU 145, PC3, MCF7 and HT29 cells and probed with 
antibodies against PAK1, PAK2, PAK4 and p-actin.
3.3: DU145, PC3, M CF7 and HT29 cells respond to HGF
HGF is a growth factor responsible for stimulating cancer cell scattering, increased 
migration and invasion. PAK1 and PAK4 have been shown to be activated downstream of 
HGF in MDCK cells (Royal et al., 2000; Wells et al., 2002) but this has not yet been shown 
in cancer cells. DU 145, PC3, MCF7 and HT29 cells express the HGF receptor c-Met
t
(Hiscox and Jiang, 1999; Wells et al., 2005; Wielenga et al., 2000) so provide potential 
models for studying HGF-induced PAK activation. HGF induces a robust phosphorylation 
o f ERK1/2 so this was used as a readout o f HGF signalling. ERK1/2 phosphorylation was 
observed in DU145, PC3, MCF7 and HT29 cells following stimulation with 10 ng/ml HGF 
(Figure 3.3).
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Figure 3.3: HGF induces ERK phosphorylation in the cancer cell lines tested. DU 145, 
PC3, MCF7 or HT29 cells were seeded and allowed to grow for 48 hours. Cells were then 
either kept in growth medium (G) or serum starved in 0.1% FCS for 16 hours (St) then 
stimulated with 10 ng/ml HGF for the times shown. Lysates were prepared, western blots 
were performed and probed with antibodies against phospho-ERKl/2, ERKl/2 or p-actin.
3.4: PAK1 and PAK2 are phosphorylated in response to HGF
Full activation o f group 1 PAKs requires phosphorylation o f a site equivalent to T423 in 
PAK1, termed the activation loop (Chapter 1, Section 1.7.1.1) Phosphorylation of this site 
can be used as a readout o f PAK activity. To determine whether HGF stimulates an 
increase in the activity o f PAK1 or PAK2, western blots were probed with an antibody 
described to recognise PAK1, PAK2 and PAK3 phosphorylated at T423, T402 and T421 
respectively (Cell Signaling Technology (CST)) (Figure 3.4). From this point on 
phosphorylation at this site will be referred to with the PAK1 numbering. The peptide used 
to generate the antibody is identical to the region in the activation loop o f PAK1, PAK2 and 
PAK3. Results were not conclusive because multiple non-specific bands were observed 
which are expected to correspond to phosphorylation of Ste20-related kinases as well as 
other proteins (discussed in detail later). The non-specific bands were observed at a range 
o f molecular weights as shown on the full western blot (Figure 3.4, DU145). However, a 
band close to the predicted molecular weight o f PAK1 increased in intensity with HGF
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stimulation in each cell line. A band at the molecular weight of PAK2 was also present in 
DU 145 cells but its intensity did not change following HGF stimulation (Figure 3.4).
[— PT423 (CST)------- ] [-— total PAK1/2— ]
m G St 5 10 30 60 m G St 5 10 30 60 min. HGF
170
r • i  • M  r i  
^  I ■ * ! 1 t  * 1 ?
130
*
%
DU145 100 -
70 ______ m PAK 1
■ ------------ . TZ -PAK2
55 • ---------------------------- •
40 %
-  _ ___ Apt in
100 m G St 5 10 30 60
<■■■» W  MW rVLUll
m G St 5 10 30 60 min. HGFI •
PC3 70
55 |I
w' ~  m  -PAK1
100 m G St 5 10 30 60 m — q j G St 5 10 30 60 min. HGF
MCF7 70 1 1 ____________ .  ^ »  mm mm m m -PAK1
55 » •  - *
G S t 5 10 30 60
—■ " A c tin  
G St 5 10 30 60 min. HGF
-PAKl
HT29 •
Figure 3.4: Detection of PAK phosphorylation using the pT423 antibody (CST).
DU 145, PC3, MCF7 or HT29 cells were seeded and allowed to grow for 48 hours. Cells 
were then either maintained in growth medium (G) or serum starved in 0.1% FCS overnight 
(St) then stimulated with 10 ng/ml HGF for the times shown. Lysates were prepared, 
western blots were performed and probed with antibodies against pT423 (Cell Signaling), 
PAK1, PAK2, actin or ERKl/2. m = marker (kDa), data are from one experiment for 
DU 145 and HT29 cells, and are representative o f two experiments for PC3 and MCF7 cells. 
For HT29, the same lysates were used as for Figure 3.3.
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The result with the CST pT423 antibody was reproduced twice in PC3 and MCF7 cells but 
it can only be considered as a preliminary result as when a new batch o f antibody was used, 
the band at 65 kDa was not detected and therefore it was not possible to back up the result 
by testing the antibody on lysate from PAK 1-depleted or PAK2-depleted cells. For this 
reason a different antibody raised using the same phosphopeptide was tested (Abeam) 
(Figure 3.5). As with the CST pT423 antibody, multiple non-specific bands were observed 
and no band was detected at the predicted molecular weight o f PAK1. However, in a 
preliminary experiment, several bands were detected close to the predicted molecular 
weight o f PAK2 (62 kDa) in each cell line and the intensity o f these bands increased with 
HGF stimulation. The intensity o f one band (marked with an asterisk) was decreased by 
PAK2 knockdown (Figure 3.11) showing that this could correspond to phosphorylated 
PAK2. The antibody also detected a protein migrating at a slightly lower molecular weight 
than PAK2 which was unaffected by knockdown o f PAK 1 or PAK2 (Figure 3.10 and 3.11) 
so it is likely that this band was non-specific. The total level o f PAK1 and PAK2 in each 
case was unaffected. Due to the number o f non-specific bands detected in western blots, the 
results from both pT423 antibodies were inconclusive. Different techniques could be used 
in future assays to assess PAK phosphorylation. Firstly, PAK1 or PAK2 could be 
immunoprecipitated from lysates prior to SDS-PAGE and subsequent western blots could 
be probed with the pT423 antibody. Secondly, HGF stimulation o f cells could be carried 
out in the presence o f radioactive phosphate, PAK1 or PAK2 could than be 
immunoprecipitated from lysates and phosphorylation could be assessed by autoradiograph.
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Figure 3.5: Effect of HGF on bands detected by an alternative phospho-T423 antibody 
(Abeam). Cancer cell lines were stimulated with 10 ng/ml (DU 145, PC3, MCF7) or 40 
ng/ml (HT29) HGF and lysates were prepared from 0 - 6 0  minutes after stimulation. 
Western blots were performed and probed with antibodies against A) pT423 (Abeam) and 
PAK2 or B) PAK1 and p-actin. m = molecular weight markers (kDa). Asterisks denote the 
band which was decreased by PAK2 knockdown (Figure 3.11). Data is from one 
experiment.
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PAK1 and PAK2 have autophosphorylation sites at S I99/204 or S I92/197, phosphorylation 
of which blocks binding of the Racl/Cdc42 GEF pPIX (Mott et al., 2005). If these are 
autophosphorylation sites only, they could be used as an alternative indicator o f PAK 
activation. However, it cannot be ruled out that another kinase could phosphorylate 
S I99/204. Phosphorylation of these sites downstream of HGF stimulation was observed by 
probing western blots with an antibody that recognises PAK1 and PAK2 phosphorylated at 
S I99/204 or S I92/197 respectively (Figure 3.6). From this point PAK1 numbering will be 
used to indicate phosphorylation of both PAK1 and PAK2. In each cell line, two bands 
were observed at the molecular weights o f PAK1 and PAK2, the intensity o f which 
corresponded to the expression profile o f PAK1 and PAK2. Phosphorylation of PAK1 and 
PAK2 at S I99/204 increased rapidly following HGF stimulation in each cell line with 
maximal phosphorylation at five minutes or before.
DU145 PC3
0 5 10 30 60 min. HGF
pS 199/204
P-actin
M CF7 HT29
0 5 10 30 60 0 5 10 30 60 min. HGF
pS 199/204
p-actin
Figure 3.6: HGF induces phosphorylation of PAK1 and PAK2 at S I99/204. Western 
blots were performed using the lysates prepared for Figure 3.7 and probed with antibodies 
against PAK1 and PAK2 phosphorylated at S I99/204 and actin as a loading control.
It has been suggested that group II PAKs also contain an activating autophosphorylation 
site in the activation loop (Callow 2002) although it is serine rather than threonine; S474 in 
PAK4; S602 in PAK5 or S560 in PAK6. DU 145, PC3, MCF7 and HT29 cells express 
PAK4 (Figure 3.1) and it has been previously shown that PAK4 is activated downstream of 
HGF in MDCK cells (Wells et al., 2002). To investigate whether PAK4 or another Group II 
PAK is phosphorylated at S474 following HGF stimulation of cancer cell lines, an antibody
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described to be specific for phosphorylated PAK4, PAK5 and PAK6 was used in PC3 cells 
but multiple non-specific bands, and no significant change in band intensity following HGF 
stimulation, meant it was not possible to determine whether PAK4, PAK5 or PAK6 became 
phosphorylated (result not shown). In order to overcome this and observe the 
phosphorylation state o f PAK4, PAK4 was immunoprecipitated from lysates o f cells treated 
with HGF for 0-60 minutes prior to western blotting (Figure 3.7). The antibody against 
phosphorylated PAK4, PAK5 and PAK6 did not detect a change in the level o f 
phosphorylated PAK4 following HGF stimulation. However, this may not be indicative o f 
PAK4 activation. It has been shown that S474 is an autophosphorylation site in vitro and 
PAK4 with an S474E mutation is more active than wild type PAK4, but not as active as the 
PAK4 kinase domain alone suggesting that phosphorylation at S474 is not necessary for 
kinase activity. There is also a possible phosphorylation site at T478 which blocks binding 
of an anti-pS474 antibody (Callow 2002). The relevance of both o f these sites in vivo is 
unknown so the pS474 antibody may not detect an increase following HGF stimulation but 
PAK4 could still be activated. To check that the phospho-PAK4 antibody detected 
phosphorylated and not unphosphorylated PAK4, lysate could be treated with phosphatase 
prior to western blotting as a control.
[------------------- ip PAK4------------------- ][—IP Myc~]
m G St 5 10 30 60 120 St 60 min. HGF
75 kDa
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pPAK4/5/6
PAK4
Figure 3.7: An antibody against phosphorylated PAK4 did not detect a change 
downstream  of HGF. PC3 cells were kept in growth medium (G) or starved in 0.1% FCS 
for 16 hours (St) and stimulated with 10 ng/ml HGF. Cell lysates were prepared at the 
indicated time points after HGF addition. PAK4 was purified by immunoprecipitation and a 
western blot o f the resulting lysates was probed with an antibody against phosphorylated 
PAK4/5/6 followed by antibody against total PAK4. An antibody against Myc was used as 
a negative control for non-specific binding in the immunoprecipitation.
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3.5: Individual PAK isoforms can be knocked down in cancer cell lines
The phosphorylation o f PAK1 and PAK2 downstream of HGF in cancer cell lines tested 
suggests that they could play a role in HGF-induced scattering and migration. To 
investigate this but avoid the problems associated with overexpression o f dominant 
negative and active mutants, RNAi was used to knock down expression of PAK1, PAK2 
and also PAK4 in cancer cells. In order to limit off-target effects o f RNAi, oligomers 
should be used at as low a concentration as possible. To determine an appropriate 
concentration, siRNA against PAK1 was transfected into DU 145 cells at varying 
concentrations and PAK expression was observed by western blotting (Figure 3.8). The 
most efficient PAK1 knockdown was achieved at a concentration o f 1 pmole/well in 24- 
well plate format (1.7 nM) or above and the level o f knockdown was persistent up to 72 
hours post-transfection. Later time points were not tested. To be sure o f efficient 
knockdown while limiting the risk o f off-target effects, a concentration o f 2 pmoles/well or 
3.3 nM was chosen for future experiments. To validate results, sets o f four separate 
oligomers o f siRNA against PAK1 or PAK2 were tested in DU145, PC3, MCF7 and HT29 
cells (Figure 3.9A). Knockdown was achieved in each cell line although PAK1 knockdown 
in HT29 cells was inefficient. This is possibly due to increased stability o f PAK1 protein in 
this cell line as PAK2 knockdown was successful. PAK4 siRNA was also tested in each 
cell line (figure 3.9B (DU145 shown)). PAK1 oligomers appeared to knock down PAK2 in 
one experiment but this was not consistent in other experiments where knockdown o f either 
PAK1 or PAK2 did not affect the expression o f the other isoform showing that the siRNA 
is specific among the homologous proteins.
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Figure 3.8: T itration of PAK1 siRNA in DU145 cells. DU145 cells were untranfected (G) 
or transfected with Control siRNA (siC) or siRNA against PAK1 (oligomer e) at 
concentrations from 0 to 100 pmoles/well in a 24-well plate. Lysates were prepared after 
24, 48 or 72 hours and western blots were performed and probed with antibodies against 
PAK1 and P-actin.
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Figure 3.9: Knockdown of individual isoforms of PAK in cancer cells (A) Control 
siRNA (Quiagen) (siC) or one o f four separate siRNAs against PAK1 or PAK2 were 
transfected into DU 145, PC3, MCF7 or HT29 cells. Cell lysates were prepared after 48 
hours and western blots were performed. Membranes were probed with antibodies against 
PAK1, PAK2 and p-actin. (B) Control siRNA (Qiagen) or one of four different siRNAs 
against PAK4 were transfected into DU 145 cells. Lysates were prepared after 48 hours, 
western blots were performed and probed with antibodies against PAK4 and p-actin.
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3.6: Effect of PAK knockdown on phosphorylation of PAK1 and PAK2 at T423
In vitro  kinase assays using degenerate substrates have suggested that PAK1 and PAK2 
may have almost identical substrate specificity (Rennefahrt et al., 2007) but it is unclear 
whether this is the case in vivo. To investigate whether there could be interplay between 
PAK1 and PAK2, the effect o f PAK1 or PAK2 knockdown on phosphorylation o f PAK1 
and PAK2 at T423 was observed by western blotting (Figures 3.10 and 3.11). Two different 
oligomers were chosen for each PAK isoform based on knockdown efficiency and 
consistent phenotype (Figure 3.9 and Chapter 4). Focusing on the T423 phosphorylation 
site, preliminary data showed that knockdown o f PAK2 decreased phosphorylation o f a 
band in DU145 cells, and to a lesser extent, PC3 cells (Figure 3.11, asterisks). More 
experiments are required to confirm this. Knockdown o f PAK 1 had no consistent effect on 
the intensity o f bands detected by the antibody (Figure 3.10). These results do not prove 
that the band decreased by PAK2 knockdown corresponds to PAK2 itself so no conclusion 
can be drawn from them. In future experiments, PAK1 or PAK2 could be 
immunoprecipitated from lysates prior to SDS-PAGE and western blotting in an attempt to 
eliminate non-specific bands.
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Figure 3.10: Effect of PAK1 knockdown on bands detected by the pT423 antibody 
(Abeam). PC3 or DU 145 cells were treated with control siRNA or one of two separate 
single oligomers of siRNA against PAK1 prior to stimulation with 10 ng/ml HGF for 0 - 6 0  
minutes. Lysates were prepared, western blots were performed and probed with an antibody 
against pT423 (Abeam), then reprobed with antibodies against PAK1 and PAK2. 
m=molecular weight markers (kDa). Some control blots are the same between Figures 3.10, 
5.2, 5.17, 5.23 and 5.21. Data are from one experiment for pT423.
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Figure 3.11: Effect of PAK2 knockdown on bands detected by the pT423 antibody 
(Abeam). PC3 or DU 145 cells were treated with control siRNA or one o f two separate 
single oligomers of siRNA against PAK2 prior to stimulation with 10 ng/ml HGF for 0 - 6 0  
minutes. Lysates were prepared, western blots were performed and probed with antibodies 
against pT423 (Abeam), and PAK2 or PAKl, PAK2 and p-actin as knockdown controls. 
m=molecular weight markers (kDa). Straight left brackets indicate reprobes of the same 
membrane. Some control bands are the same between Figures 3.11 3.13, 5.9, 5.18, 5.22 and 
5.24. Data are from one experiment for pT423.
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3.7: Knockdown of PAK2 leads to upregulation of PAKl phosphorylation
PAKl phosphorylation was not detected by the phospho-T423 antibody but the phospho- 
S199/S204 antibody did detect a band at the molecular weight o f PAKl as well as PAK2 
(Figure 3.6). This antibody was cleaner than the T423 antibodies so it was possible to say 
with certainty which band corresponds to PAKl and which to PAK2. The effect o f PAK 
knockdown on phosphorylation o f the S I99/204 phosphorylation site was observed by 
western blotting using lysates from DU 145 and PC3 cells. Knockdown of PAKl led to a 
decrease in intensity o f the upper band as expected due to decreased PAKl protein levels 
(Figure 3.12). PAK2 knockdown decreased intensity o f the lower band corresponding to 
decreased PAK2 protein expression but also increased PAKl phosphorylation at S I99/204 
(Figure 3.13 asterisks). Quantification showed that in DU145 cells the upregulation o f 
phosphorylation at S I99/204 was significant for oligomer PAK2b (Figure 3.14). 
Upregulation o f PAKl phosphorylation was also observed in PC3 cells but was not 
statistically significant from these two experiments (Figure 3.14). The upregulation o f 
PAKl phosphorylation could be due to compensation for loss o f PAK2 by PAKl or by 
down-regulation o f a negative feedback mechanism from PAK2 to PA K l. Because the 
primary means o f PAKl activation is through active Rho GTPases, the possibility that a 
Rho GTPase is responsible for increased PAK activation was investigated in Racl and 
Cdc42 activity assays but results were inconclusive (data not shown).
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Figure 3.12: PAKl knockdown does not affect PAK2 phosphorylation at S199/204.
Western blots were performed using lysates prepared for Figure 3.10 and probed with 
antibodies against pS199/204 and p-actin or PAKl, PAK2 and p-actin (DU145) or PAKl 
and p actin (PC3). Straight left brackets indicate reprobes of the same membrane. Some 
control blots are the same between Figures 3 .12, 5 .17 and 5.23. Blots are representative of 
two independent experiments
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Figure 3.13: PAK2 knockdown leads to increased PA K l phosphorylation at S I99/204.
Western blots were performed using lysates prepared for Figure 3.11, and probed with 
antibodies against pS 199/204 and p-actin, or PAKl, PAKl, PAK2 and P-actin as 
knockdown controls. Note the knockdown control blots are the same as in Figure 3.11. 
Asterisks indicate the band corresponding to pPAKl (S I99/204). Straight left brackets 
indicate reprobes o f the same membrane. Some control bands are the same between Figures 
3.11 3.13, 5.9, 5.18, 5.22 and 5.24. Blots are representative o f two independent 
experiments.
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Figure 3.14: Quantification of the effect of PAK2 knockdown on PAKl 
phosphorylation at S I99/204. Blots were quantified using ImageJ software. PAKl and 
pPAKl (S I99) bands were first normalised to actin loading controls, then pPAKl was 
normalised to PAKl level. Data are from two independent experiments, error bars represent 
the two means from each condition Control results were pooled and represent four means 
from two independent experiments. * = p < 0.05, two tailed student’s T-test.
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3.8: Cdc42 and R acl knockdown im pair phosphorylation of S199/204 or S192/194 in 
PAKl and PAK2.
PAKl binds and is activated by multiple Rho GTPases and has been shown to be activated 
by Racl and Cdc42. PAK 1/2 phosphorylation at the S I99/204 site in DU 145 cells is only 
slightly elevated by HGF stimulation meaning that either phosphorylation is not strongly 
regulated by HGF signalling or that the basal level of PAK phosphorylation at S I99/204 in 
DU145 cells is high. To investigate which Rho GTPases are responsible for PAK activation 
in DU145 cells, an siRNA library against Rho GTPases previously shown to bind PAKl 
was used. Rho A, which does not bind to PAKs, was knocked down as a negative control. 
The basal level of PAK 1/2 phosphorylated at S I99/204 in Rho-GTPase depleted DU 145 
cells was observed by western blotting (Figure 3.15). Single oligomers of Racl, Cdc42 and 
RhoA were used as they had been previously extensively tested in the laboratory. For all 
other GTPases, pools o f three or four oligomers were used as they are more likely to give a 
reliable knockdown if single oligomers have not been tested. It is also more likely that these 
pools of oligomers cause more ofF-target knockdown than single oligomers, as single 
oligomers were used at the same concentrations for the pool so the total siRNA 
concentration was higher. Positive results therefore need further testing. Of the Rho 
GTPases tested preliminary results showed that knockdown of Racl, Rac2 and Cdc42 
decreased the basal level of PAKl and PAK2 phosphorylation at S I99/204 but further 
experiments were inconclusive and should be repeated. The total level of each Rho GTPase 
in knockdown cells should also be determined in future experiments. Based on this 
preliminary evidence, Racl and Cdc42 were chosen for further study.
G siC lc  2b 2c Rac 1 Rac2 Rac3 Cdc42 RhoA RhoQ RhoJ RhoU RhoV
pPA K l
pPAK2
p-actin
Figure 3.15: Cdc42 and R acl affect activity of PAKl and PAK2: DU145 cells were 
treated with control siRNA, single oligomers of PAKl (lc), PAK2 (2b and 2c), Racl, 
Cdc42 or RhoA, or pools o f three or four oligomers of RhoJ, RhoQ, RhoU or RhoV siRNA. 
After 48 hours lysates were prepared, western blots were performed and probed with 
antibodies against PAK1/PAK2 phosphorylated at S I99/204 and actin.
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3.9: Cdc42 and Racl impair PAK phosphorylation downstream of HGF
In order to determine the importance o f Rho GTPases in activating PAKl and PAK2 
downstream of HGF, siRNA was used to knock down Racl or Cdc42 in DU 145 or PC3 
cells, and PAKl or PAK2 phosphorylation was observed following HGF stimulation by 
western blotting. Firstly, phosphorylation was observed using the phospho-T423 antibody. 
In DU 145 cells, preliminary results were inconclusive; knockdown of Racl (Figure 3.16) or 
Cdc42 (Figure 3.17) slightly decreased the intensity o f the band close to the molecular 
weight o f PAK2 but further evidence is required to show whether this corresponds to 
PAK2. In PC3 cells, the effect o f Racl or Cdc42 was unclear due to low intensity o f the 
relevant band. Further experiments could be performed to provide evidence for the effect o f 
Racl or Cdc42-depletion on PAK1/2 phosphorylation at T423. For example, as previously 
mentioned, PAKl or PAK2 could be immunoprecipitated from lysates prior to SDS-PAGE 
and western blotting to limit non-specific binding o f the antibody. A slight reduction in the 
total level o f PAK2 was also seen in Cdc42-depleted DU 145 cells but this was not observed 
in other experiments using the same oligomers.
It should also be noted that Racl and Cdc42 ran as doublets on SDS-PAGE gels under 
these conditions. The reason for this was not clear and has not been previously investigated. 
It could depend on the lysis buffer or sample buffer composition.
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Figure 3.16: Effect of Racl knockdown on bands detected by the T423 antibody 
(Abeam). DU 145 or PC3 cells were transfected with control siRNA or one o f two siRNA 
oligomers against Racl. After 48 hours, cells were treated with 10 ng/ml HGF for 0 - 6 0  
minutes and lysates were prepared. Western blots were performed and probed with 
antibodies against pT423, PAKl, Racl (PC3) or pT423, PAKl, PAK2 and Racl (DU 145). 
Data are from one experiment.
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Figure 3.17: Effect of Cdc42 knockdown on bands detected by the T423 antibody 
(Abeam). DU 145 or PC3 cells were treated with control siRNA or one of two different 
oligomers o f siRNA against Cdc42. After 48 hours, cells were treated with 10 ng/ml HGF 
for 0 - 6 0  minutes and lysates were prepared. Western blots were performed and probed 
with antibodies against pT423, PAK1, PAK2 and Racl (DU145), or pT423, Cdc42 and P- 
actin, or PAK2 and P-actin (PC3). Asterisks mark the position of the minor band affected 
by Racl or Cdc42 knockdown. Straight left brackets indicate reprobes o f the same 
membrane. Data are from one experiment
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Phosphorylation o f PAK1 and PAK2 at the S I99/204 site in Racl and Cdc42-depleted cells 
was also observed by western blotting (Figure 3.18 and 3.21). In DU 145 cells, knockdown 
o f Racl or Cdc42 impaired phosphorylation o f both PAK1 and PAK2 but oligomer 
Racl 07 had a weaker effect. (Figure 3.19 and 3.22). In PC3 cells, the low intensity o f the 
band coresponding to pPAKl made data highly variable and inconclusive for Racl 
knockdown (data not shown) while PAK2 phosphorylation was impaired by oligomer 
Racl 07 but not Racl 05. In fact Racl 05 appeared to have the opposite effect at 10 
minutes after HGF stimulation (Figure 3.20). Further experimental repeats are required as 
siRacl_05 appeared to slightly impair PAK2 phosphorylation in images o f blots (Figure 
3.18). Knockdown o f Cdc42 in PC3 cells impaired PAK1 and PAK2 phosphorylation at 
S I99 following HGF stimulation (Figure 3.23).
Taken together, although these results require further repeats they suggest that PAK1 and 
PAK2 phosphorylation at S I99/204, are impaired by knockdown o f either Racl or Cdc42 
in DU 145 cells and PC3 cells.
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Figure 3.18: Knockdown of Racl reduces phosphorylation of PAK1 and PAK2 at 
S I99/204 downstream of HGF. Western blots were performed using lysates prepared for 
Figure 3.16 and probed with antibodies against pS 199/204, Racl, and P-actin, or PAK1, 
PAK2 and p-actin, or PAK1 and P-actin (PC3, siRac 1 07). Blots are representative o f two 
independent experiments. Straight left brackets indicate reprobes o f the same membrane.
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Figure 3.19: Quantification of the effect of Racl knockdown on PAK1 or PAK2 
phosphorylation at S199/204 following HGF stimulation in DU145 cells. Blots were 
quantified using ImageJ software. PAK1 and pPAKl, or PAK2 and pPAK2 (S I99) bands 
were first normalised to actin loading controls, then pPAKl was normalised to the PAK1 
and pPAK2 was normalised to PAK2. Data are from two independent experiments, error 
bars represent the two means from each condition. Control results were pooled and 
represent four means from two independent experiments. T-tests did not reveal statistical 
significance
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Figure 3.20: Quantification of the effect of R acl knockdown on PAK2
phosphorylation at S199/204 following HGF stimulation in PC3 cells. Blots were 
quantified using ImageJ software. PAK2 and pPAK2 (S I99) bands were first normalised to 
actin loading controls, then pPAK2 was normalised to PAK2. Data are from two 
independent experiments, error bars represent the two means from each condition. Control 
results were pooled and represent four means from two independent experiments. * = p < 
0.05, two tailed student's T test.
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Figure 3.21: Knockdown of Cdc42 im pairs phosphorylation of PAK1 and PAK2 at 
S I99/204 downstream  of HGF. Western blots were performed using lysates prepared for 
Figure 3.17 and probed with antibodies against pS 199/204, Cdc42, p-actin PAK1 or PAK2. 
Straight left brackets indicate blots from the same membrane. Blots are representative of 
two independent experiments.
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Figure 3.22: Quantification of the effect of Cdc42 knockdown on PAK1 or PAK2 
phosphorylation at S199/204 following HGF stimulation in DU145 cells. Blots were 
quantified using ImageJ software. PAK1 and pPAKl, or PAK2 and pPAK2 (S I99) bands 
were first normalised to actin loading controls, then pPAKl was normalised to the PAK1 
and pPAK2 was normalised to PAK2. Data are from two independent experiments, error 
bars represent the two means from each condition. Control results were pooled and 
represent four means from two independent experiments. T-tests did not reveal statistical 
significance
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Figure 3.23: Quantification of the effect of Cdc42 knockdown on PAK1 or PAK2 
phosphorylation at S199/204 following HGF stimulation in PC3 cells. Blots were 
quantified using ImageJ software. PAK1 and pPAKl, or PAK2 and pPAK2 (S I99) bands 
were first normalised to actin loading controls, then pPAKl was normalised to the PAK1 
and pPAK2 was normalised to PAK2. Data are from two independent experiments, error 
bars represent the two means from each condition. Control results were pooled and 
represent four means from two independent experiments. T-tests did not reveal statistical 
significance
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3.10: Discussion
PAKs are often up regulated in cancer, for example DU 145 cells have elevated PAK4 and 
PAK6 mRNA, and PC3 cells have elevated PAK4 mRNA compared to normal prostate 
tissue; HT29 cells have elevated PAK4 mRNA compared to normal colon tissue; and 
MCF7 breast cancer cells express PAK4 mRNA -  but normal breast tissue was not tested 
for PAK4 expression (Callow et al., 2002). This up regulation could be significant to cancer 
progression; Wang et al. previously showed that overexpression o f active PAK1 led to the 
development o f malignant mammary tumours in mouse models and PAK1 expression 
increased with progression from ductal hyperplasia to adenocarcinoma (Wang et ah, 2006). 
However this may not always be the case as PC3 cells are more invasive than DU 145 cells 
but express less PAK1. To test PAK expression in a panel o f cancer cell lines PAK1, PAK2 
and PAK4 protein expression was investigated by western blotting. It was shown that 
DU145, PC3, MCF7 and HT29 cells each express PAK1, PAK2 and PAK4 protein.
The phosphorylation o f PAK1 and PAK2 downstream of HGF, and previously described 
effects of constitutively active and dominant negative PAK mutants on cell migration, 
suggest that PAKs could play a role in HGF-induced cancer cell responses. In order to 
investigate the roles o f PAK isoforms in HGF-induced cancer cell migration and signalling 
and avoid the problems associated with expression of dominant negative mutants, a 
protocol was established to use RNAi to knock down expression o f individual isoforms o f 
PAK in cancer cell lines. PAK1, PAK2 and PAK4 could be reproducibly knocked down in 
DU145, PC3, MCF7 and HT29 cells without affecting expression o f other PAK isoforms. 
A concentration o f short interfering RNA (siRNA) equal to 3.3 nM was used to minimise 
off-target effects while achieving a similar level of knockdown to 167 nM, which was the 
maximum concentration tested. This is considerably lower than the concentrations often 
used in previous studies (50-100 nM) and should limit off-target effects.
In MDCK cells, HGF stimulates scattering and activates overexpressed PAK1 and PAK4 
(Royal et al., 2000; Wells et al., 2002). DU 145 cells have also been shown to scatter in 
response to HGF but PAK activity has not been studied so far (Miura, 2001). Thus PAKs 
could be potential therapeutic targets if  they also control HGF-induced invasion in vivo. 
Activation o f group I PAKs begins with dissociation o f the autoinhibited dimer followed by 
phosphorylation at multiple sites which increase kinase activity, lock the kinase in an active
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state or modulate adapter binding (See chapter 1, Figure 1.9). Phosphorylation o f the 
activation loop o f group I PAKs is required for full activation (Threonine 423 in PAK1) 
(Zenke et al., 1999). Two different antibodies described to recognise PAK1, PAK2 and 
PAK3 phosphorylated at T423 were tested (CST and Abeam) and each detected multiple 
bands over a wide range o f molecular weights. PAKs are part o f a larger family o f Ste20- 
related kinases (STKs) and it is likely that many o f the bands detected using pT423 
antibodies are other Ste20 kinases. The antibody from CST has been described to cross- 
react with M stl (STK4) and Mst2 (STK3) phosphorylated at T183 or T180 respectively. 
These sites share only 46% identity with the peptide used to raise the antibody 
(EQSKRSTpMVGTPY) but using BLAST with the BLOSUM62 scoring matrix gives 85% 
positive scores showing that many o f the unmatched amino acids have similar 
characteristics (Figure 3.24A). It is likely that both pT423 antibodies will also recognise 
other STKs with homology in this region. BLAST searching using the PAK1 amino acid 
sequence as a template and looking for similarity at the T423 region reveals that there are a 
number o f possible candidates that could cross react with the antibody. Notably STK24, 
STK25 and Ste20-like kinase (SLK) have over 60% positive scores in the BLAST search. 
Unrelated proteins with homology in this region were also identified, including Myosin 
Ilia, MAP4K3 and MAP4K5 (Figure 3.24B).
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A PAK1/2/3 peptide EQ SK RSTpM V G TPY
+ K R + T p + + G T P +  
STK3/STK4 TM A K RN TpV I GT P F
B PAK 1/2/3 EQSKRSTM VGTPY
Q KR+T V G TP+ 
STK24/25 TQ IK R N TFV G T P F
PAK 1/2/3 EQSKRSTM VGTPY
+ R + + GTPY 
SLK T IQ R R D S F IG T P Y
PAK 1/2/3 EQSKRSTM VGTPY
+ + R +T V G TP+ 
Myosin Ilia TR H R R N TSV G TPF
PAK 1/2/3 EQSKRSTM VGTPY
+KR + + G T P y  
M A P 4 K 3 /5  T IA K R R S F IG T P Y
Figure 3.24: STK3/4 homology with PAK1/2/3 peptide used to generate pT423 
antibodies. A) Sequence alignment o f the PAK 1/2/3 phosphopeptide surrounding T423 
and the STK3/STK4 region surrounding T180/T183. B) Sequence alignment of the T423 
region o f PAK1 and other homologous proteins which could be recognised by the pT423 
antibody. + represents a positive score in the BLAST search using the BLOSUM62 scoring 
matrix.
Lot 3 o f the CST pT423 antibody detected phosphorylation o f a protein running close to 
PAK1 on western blots. It is possible that this corresponded to phospho-PAKl although
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this was not validated by the use o f siRNA and a different batch o f the antibody did not 
detect the band. The Abeam pT423 antibody did not detect this band either, showing that 
differences in preparation and batch lead to differences in the affinity o f the final antibody 
for the antigen. However, the Abeam pT423 antibody did detect phosphorylation o f protein 
migrating at the molecular weight o f PAK2 which decreased with PAK2 knockdown in a 
preliminary experiment. The absence o f a band corresponding to pPAK2 when using the 
CST antibody and pPAKl when using the Abeam antibody suggests that there may be a 
slight structural difference between PAK1 and PAK2 in this region even though the 
sequence is identical.
As an alternative to the pT423 antibody, an antibody described to detect PAK1 and PAK2 
phosphorylated at S I99/204 or S I92/197 respectively was used. It is thought that this is an 
autophosphorylation site but it cannot be ruled out that it is also phosphorylated by another 
kinase or another PAK isoform although this has not been shown. This antibody was 
cleaner than the pT423 antibodies and the identity o f the bands was validated using siRNA 
against PAK1 or PAK2. Western blots showed that phosphorylation of PAK1 and PAK2 at 
S I99/204 increased with HGF stimulation and decreased following knockdown o f the 
corresponding PAK isoform. Taken together, the data from both antibodies show that 
PAK1 and PAK2 are phosphorylated and probably activated downstream of HGF in the 
cell lines tested.
RNAi was used to investigate interplay between PAK1 and PAK2 in DU 145 and PC3 cells. 
Knockdown o f PAK1 had no effect on phosphorylation o f PAK2 at S I92/197 observed 
using a pS 199/204 antibody respectively. However, in both DU 145 and PC3 cells PAK2 
knockdown led to an increase in PAK1 phosphorylation at S I99/204. This suggests that 
PAK2 negatively regulates PAK1 phosphorylation at this site, which has not been 
previously described. S I99/204 are autophosphorylation sites but could also be substrates 
for other kinases. Therefore PAK2 could either negatively regulate the phosphorylation of 
PAK1 directly or the activity o f an upstream kinase or phosphatase with S I99/204 as a 
substrate (Figure 3.25). To investigate whether PAK2 knockdown could lead to activation 
o f PAK 1 through Racl or Cdc42, pull down assays to assess Cdc42 and Racl activity were 
performed but were inconclusive and should be repeated in future work. Another possibility 
for the mechanism of PAK1 regulation by PAK2 could be if  PAK2 can dimerise with
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PAK1 and block phosphorylation. Whether this is the case is unclear, studies o f PAK2 
dimerisation showed that residues in the kinase domain o f PAK2 that interact with the 
autoinhibitory domain are identical to those in the kinase domain o f PAK 1 (Pirruccello et 
al., 2006). However, the dimerisation domain in the regulatory region o f PAK 1 shares only 
30% identity with the region in PAK2 (Bokoch 2003) and PAK1 knockdown did not affect 
PAK2 phosphorylation at S I99/204. A possible future direction for experiments could be to 
directly investigate whether PAK2 and PAK1 can heterodimerise.
Racl/Cdc42 |-
PAK1 «
X
Kinase PAK2
Phosphatase *
Figure 3.25: Hypothetical pathways for the regulation of pS 199/204 on PAK1 by 
PAK2. Knockdown o f PAK2 upregulates phosphorylation o f PAK1 at S I99/204 by an 
unknown mechanism suggesting that PAK2 downregulates PAK1. This could be through 
negative feedback from PAK2 to Racl/Cdc42 leading to decreased activation and 
autophosphorylation o f PAK1; or through PAK2-mediated inhibition o f a kinase or 
activation o f a phosphatase with pS 199/204 as a substrate.
Phosphorylation o f PAK4 at S474 was not observed following HGF stimulation but PAK4 
activation was expected as it has been shown to be activated downstream o f Cdc42 in HGF- 
stimulated MDCK cells. Phosphorylation o f PAK4 at S474 could therefore be cell type 
specific, but also the physiological relevance o f Group II PAK phosphorylation at S474 is 
unclear and it may not be a readout o f kinase activity. In vitro kinase assays on 
immunoprecipitated PAKs would be the best way to study group II PAK activation 
following HGF stimulation (Wells 2002).
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To investigate upstream activators o f PAK 1/2 which could be responsible for their 
activation downstream o f HGF, siRNA was used to knock down Rho GTPases previously 
shown to bind to PAK1 or PAK2 (see Chapter 1, Table 2). O f the Rho GTPases tested in a 
preliminary experiment, R acl, Rac2 and Cdc42 decreased the basal level PAK1 and PAK2 
phosphorylated at S I99/204 in DU 145 cells while Rac3,RhoA, RhoJ (TCL), RhoQ (TC10), 
RhoU (Wrch-1) and RhoV (Chp) had no effect. In DU 145 cells, so far only R acl, Rac3, 
Rho A and Cdc42 have been shown to be expressed (Fujimoto et al., 2001 and our 
unpublished results) so the lack o f an effect o f siRNA against the other Rho GTPases could 
be due to the absence of, or low expression.
The roles o f Racl and Cdc42 in phosphorylation o f PAK1 and PAK2 following HGF 
stimulation were investigated. In DU 145 cells, both Cdc42 and Racl knockdown decreased 
PAK1 or PAK2 phosphorylation at S I99/204 following addition o f HGF. PAK1 expression 
is lower in PC3 cells than DU 145 cells and the level o f phosphorylated PAK1 detected in 
these experiments was too low to observe an effect caused by Racl knockdown but Cdc42 
knockdown slightly impaired phosphorylation o f PAK1 and PAK2 at S I99/204. In each 
condition, phosphorylation o f PAK1 or PAK2 was not completely blocked, probably 
because o f the presence o f other Rho GTPases which can activate PAK, for example Cdc42 
can still activate PAK 1/2 in Rac 1-depleted cells and may compensate for loss o f R acl. It 
would be interesting to include Rac2 in the assays and use simultaneous knockdown o f Rho 
GTPases to investigate whether this would block PAK activation more effectively. It would 
also be useful to investigate PAK1 or PAK2 activation using an in vitro kinase assay to 
determine the effect o f PAK2 knockdown on PAK1 kinase activity and observe how 
phosphorylation at S I99/204 compares to kinase activity.
In summary, PAK1 and PAK2 are phosphorylated downstream of HGF in DU145, PC3, 
MCF7 and HT29 cells, and knockdown o f Cdc42 or Racl impairs this phosphorylation in 
DU 145 and PC3 cells. PAK1 phosphorylation at S I99/204 was up-regulated in PAK2- 
deficient cells suggesting a negative regulation o f PAK1 by PAK2 via an as yet unknown 
mechanism.
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Chapter 4: Role of PAK in HGF-induced mieration and invasion 
4.1: Introduction
The hepatocyte growth factor (HGF) receptor c-Met is often overexpressed or mutated in 
cancer, and HGF signalling is involved in many cell processes associated with cancer 
progression and poor prognosis such as cell migration, invasion, proliferation and 
angiogenesis (reviewed in Maulik et al., 2002). Growing evidence implicates c-Met and 
associated signalling pathways as potential therapeutic targets for anti-cancer drugs. For 
example, HGF stimulates in vitro invasion through Matrigel (Khoury et al., 2005) and 
silencing o f c-Met expression in GTL16 gastric carcinoma cells leads to decreased invasion 
in vitro, as well as decreased tumour growth and fewer experimental metastases in vivo 
(Corso et al., 2008). Metastasis o f cancer, where single cells escape from the primary 
tumour and migrate to distal sites, is associated with poor prognosis. In vitro, HGF can be 
used to stimulate cell motility and junctional breakdown mimicking an early stage of 
metastasis. HGF stimulates scattering o f MDCK cells as well as some cancer cell lines 
including DU145 cells (Miura et al.. 2001; Stoker and Perryman, 1985). Scattering is 
accompanied by internalisation o f E-cadherin and a slight decrease in E-cadherin protein 
levels although it remains expressed.
In keratinocytes, active Racl induces junctional breakdown and loss o f E-cadherin in a 
process rescued by knockdown o f PAK1 (Lozano et al., 2008). If PAK1 proves to be 
important for junctional breakdown following HGF stimulation, it would provide further 
evidence for the pathological significance o f PAK1 upregulation in cancer. PAK1 is 
activated downstream of HGF in MDCK cells and expression o f the N-terminal regulatory 
domain o f PAK2 as a dominant negative blocks HGF-induced peripheral actin remodelling 
and lamellipodium extension (Royal et al., 2000). PAK4 is also activated downstream of 
HGF in MDCK cells (Wells et al., 2002), and the finding that PAK1 and PAK2 are 
phosphorylated downstream of HGF in several cancer cell lines (Chapter 3) suggests that 
PAKs could play a role in the response o f cancer cells to HGF.
As well as single cell migration, cells move collectively in groups. This is important during 
organism development and tissue repair, and it is also the means used by many tumours to 
invade surrounding tissue (reviewed in (Friedl et al., 2004)). During collective cell 
migration, the leading cells become polarised with membrane protrusions at the front while
114
Chapter 4 Role o f  PAK in HGF-induced migration and invasion
following cells maintain cell junctions and remain attached to the leading cells. Collective 
cell migration in cancer, also called cohort migration, is stimulated by HGF in several 
cancer cell lines including HT29 colon cancer cells (Nabeshima et al., 1998) indicating that 
it could be another mechanism by which up-regulated c-Met signalling leads to poor 
prognosis. Experimentally, a frequently used method o f measuring collective cell migration 
on a two dimensional substrate is the in vitro wound healing assay. This involves scratching 
a confluent monolayer o f cells with a pipette tip and measuring change in wound area over 
time (Rosello et al., 2004; Valster et al., 2005). In MDCK cells, expression o f neither 
kinase-dead nor constitutively active PAK1 affected the speed o f wound healing, but both 
constructs caused scattering o f unstimulated cells and increased migration towards HGF in 
Boyden chambers (Zegers et al., 2003). This could be due to the ability o f both mutants to 
sequester binding proteins although it is surprising that an increase in migration was 
observed, as the opposite was true in HMEC-1 mammary epithelial cells (Kiosses et al., 
1999).
As well as cell migration, cancer metastasis involves invasion through the extracellular 
matrix (ECM). PAK1 activity has been shown to correlate with increased invasiveness of 
breast cancer (Vadlamudi et al., 2000) and expression o f kinase dead PAK1 inhibited 
invasiveness o f MDA-MB435 breast cancer cells (Adam et al., 2000). PAK1 knockdown 
also decreased the invasion o f melanocytes through Matrigel, although only one siRNA 
oligomer was tested (Pavey et al., 2006). HGF regulates cancer cell invasion and has been 
shown to increase invasion o f DU 145 cells through Matrigel (Nishimura et al., 1998). 
There is therefore a case for investigating the roles o f PAK isoforms in this process.
The aim o f this chapter is to investigate the effect o f PAK1, PAK2 or PAK4 depletion on 
the response o f cancer cells to HGF.
4.2: The response of cancer cells to HGF
DU 145 cells scatter in response to HGF (Miura et al., 2001) and groups o f HT29 cells 
become more spread (Nabeshima et al., 1998). In chapter 3, PAK1 and PAK2 were shown 
to become phosphorylated following HGF stimulation in DU 145, PC3, MCF7 and HT29 
cells. In order to set up an assay to investigate the functional significance o f PAK1, PAK2 
and PAK4 downstream o f HGF in these cancer cell lines, the response o f sub-confluent
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cells to HGF was observed. DU 145, MCF7 and HT29 cells grow in groups with epithelial 
morphology so movies were made to test for scattering or increased spreading (Figure 4.1). 
PC3 cells grow as single cells and so do not scatter so their response was assayed 
separately. The previously described scattering response o f DU 145 cells in serum-starved 
conditions was reproduced, whereas MCF7 cells did not scatter and exhibited only a weak 
response to HGF by increased ruffling at early time points, and no significant response 
could be observed in HT29 cells.
Because DU 145 cells responded more strongly to HGF than MCF7 and HT29 cells, they 
were chosen as a model to investigate the role o f PAK knockdown on HGF-induced 
scattering. The DU 145 cell scattering assay was optimised by testing varying 
concentrations o f HGF in 10% or 0.1% FCS (Figure 4.2). There was no difference in 
scattering between 10 ng/ml or 20 ng/ml HGF and cells scattered in 10% or 0.1% FCS 
although at later time points, cell death was observed in 0.1% FCS (24 hour time point not 
shown). The conditions used for further assays were 10 ng/ml HGF in 10% FCS.
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Figure 4.1: The response of DU145, M CF7 and HT29 cells to HGF. Cells were seeded 
and allowed to grow for 48 hours prior to serum starvation in 0.1% FCS for 6 hours. Cells 
were then stimulated with 10 ng/ml HGF or kept in starved conditions and movies were 
made for 16 hours taking one frame every 10 minutes. T=0 corresponds to the start o f the 
movie 30 minutes after HGF addition. Data are representative of at least 2 experiments.
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Figure 4.2: O ptim ization of the DU145 cell scattering assay. DU 145 cells were seeded 
and allowed to grow for 48 hours. Cells were either kept in growth medium or serum 
starved in 0.1% FCS for 6 hours prior to stimulation with 0, 10 or 20 ng/ml HGF. Movies 
were made for 24 hours taking one frame every 10 minutes ( 0 - 1 6  hours shown). T=0 
corresponds to the start o f the movie 30 minutes after HGF addition.
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4.3: Effect of PAK knockdown on DU145 cell scattering
The role o f PAKs in the HGF response o f cancer cell lines is as yet unclear. To address this, 
the effect o f PAK 1, PAK2 or PAK4 depletion by RNAi on DU 145 cell scattering following 
HGF stimulation was observed. Movies were made for 24 hours taking one frame every 5 
minutes (supplementary movies 1-14), or every 10 minutes in subsequent experiments. 
Four separate oligomers were tested for each isoform to control for non-specific effects of 
individual siRNAs. A control oligomer with no known target was used and no difference 
was observed between this and untransfected cells.
In the case o f PAK1, the oligomer siPA K la had no detectable effect and cells scattered in 
the same way as control cells. However, the other three o f four oligomers used against 
PAK1 caused fewer cells to dissociate from groups and become rounded following HGF 
stimulation compared to control cells (Figure 4.3 and Supplementary movies 1-6). The 
results did not not match exactly with the efficiency o f knockdown observed for each 
oligomer. Previous western blotting showed that each PAK1 oligomer knocked down 
protein expression but oligomer PAK lb  was least efficient (Figure 3.9). siPA K lc and 
siPA K ld were chosen for future experiments due to their similar knockdown efficiency and 
phenotype. Their effect on cell rounding in response to HGF was quantified and found to be 
significant for oligomer PAK Id (Figure 4.12). The localisation o f actin filaments and E- 
cadherin in DU 145 cells before and after 18 hours o f HGF stimulation was observed 
(Figures 4.4 and 4.5). HGF stimulation led to loss o f E-cadherin from junctions as expected 
in control cells but this was retained in the junctions o f PAK 1-depleted DU145 cells. Actin 
filament distribution appeared similar in PAK 1-depleted cells. However, more rounded, 
detached cells were observed when control siRNA was used as in time lapse movies.
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Figure 4.3: PAK1 knockdown im pairs scattering of DU145 cells. DU 145 cells were 
seeded and allowed to grow for 16 hours before transfection with control siRNA or one o f 
four different siRNA oligomers against PAK1. 48 hours after transfection cells were 
stimulated with 10 ng/ml HGF and movies were made for 24 hours taking one frame every 
5 minutes. T=0 corresponds to the start o f the movie approximately 30 minutes after HGF 
stimulation. Movies are representative o f at least four repeat experiments for untransfected, 
siControl, siPAKlc and siPAKld, and one experiment for siPAKla and siPAKlb.
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Figure 4.4: Actin filam ent and E-cadherin localisation in unstim ulated DU145 cells.
DU 145 cells were treated with control siRNA or one o f two oligomers of siRNA against 
PAK1. After 66 hours cells were fixed in 4% PFA and stained for actin filaments with 
fluorescent phalloidin (F-actin) or E-cadherin with an anti E-cadherin antibody.
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Figure 4.5: E-cadherin persists in junctions in PA K l-depleted DU 145 cells following 
HGF treatm ent. DU145 cells were treated with control siRNA or one of two oligomers o f 
siRNA against PAK1. After 48 hours cells were stimulated with 10 ng/ml HGF for 18 
hours, then fixed in 4% PFA and stained for actin filaments with fluorescent phalloidin (F- 
actin) or E-cadherin with an anti-E-caherin antibody.
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When PAK2 was knocked down, each oligomer depleted protein level equally (Figure 3.9) 
but there was again some variation in the phenotype observed. Oligomer siPAK2a did not 
detectably affect scattering (Figure 4.6 and supplementary movie 7) and oligomer siPAK2d 
caused some cells to bleb (Figure 4.6B and supplementary movie 10). The remaining two 
oligomers were chosen for future experiments because they gave the most similar 
phenotype although there was still a difference. Oligomer siPAK2b gave the strongest 
phenotype where cells rounded up less although it was not statistically significant (Figure 
4.12). Cells treated with oligomer siPAK2b also had larger lamellipodia (Figure 4.9, 4.10 
and supplementary movie 8). When oligomer siPAK2c was used cells scattered and a 
similar proportion rounded compared to control conditions but a subset o f cells appeared to 
have larger lamellipodia similar to siPAK2b (Figure 4.7, 4.10 and supplementary movie 9). 
These experiments should be repeated to determine whether the difference in size of 
lamellipodia is statistically significant. Confocal microscopy and staining for F-actin 
showed that knockdown o f PAK2 led to broader lamellipodia in a proportion o f cells 
following HGF stimulation (Figure 4.9). Prior to HGF stimulation, some groups o f PAK2- 
depleted cells appeared less stable than control cells. Gaps between junctions were visible 
and some cells extended away from colonies (Figure 4.8 arrows).
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Figure 4.6: PAK2-depleted DU 145 cells remain more spread following HGF 
stim ulation. A) DU145 cells were seeded and allowed to grow for 16 hours before 
transfection with control siRNA or one o f four different siRNA oligomers against PAK2. 
48 hours after transfection cells were stimulated with 10 ng/ml HGF and movies were made 
for 24 hours taking one frame every 5 minutes. T=0 corresponds to the start o f the movie 30 
minutes after HGF stimulation. Movies are representative o f at least four repeat 
experiments for siControl, siPAK2b and siPAK2c, only one experiment was performed for 
siPAK2a and siPAK2d. B) 4X magnification o f boxed region in siPAK2d 24 hour 
timepoint showing blebbing (arrow).
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Figure 4.7: PAK2 knockdown in DU145 cells affects lamellipodia. Details from 24 hour 
timepoints from figure 4 were magnified digitally to 4X magnification.
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Figure 4.8: Effect of PAK2 knockdown on morphology of DU145 cell colonies. DU145 
cells were treated with control siRNA or one o f two oligomers o f siRNA against PAK2. 
After 66 hours cells were fixed in 4%  PFA and stained for actin filaments with fluorescent 
phalloidin (F-actin) or E-cadherin with an anti-E-caherin antibody. Note that control images 
are the same as in figure 4.4 as they are from the same experiment. Arrows show where 
there are gaps in colonies (siPAK2c) or where cells appear to be pulling away from groups 
(siPAK2b).
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Figure 4.9: Actin staining in lamellipodia is different in PAK2 deficient DU145 cells 
following HGF stim ulation. DU 145 cells were treated with control siRNA or one o f two 
oligomers o f siRNA against PAK2. After 48 hours cells were stimulated with 10 ng/ml 
HGF for 18 hours, then fixed in 4%  PFA and stained for actin filaments with fluorescent 
phalloidin (F-actin) or E-cadherin with an anti-E-cadherin antibody. Note that control 
images are the same as in figure 4.5 as they are from the same experiment.
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Figure 4.10: PAK2 knockdown leads to larger lamellipodia in DU145 cells following 
HGF stim ulation. The length of lamellipodia in control or PAK2-depleted cells following 
HGF stimulation for 24 hours was measured. Cells which were not in contact with more 
than one other cell and also had visible lamellipodia were selected and the length o f the 
leading edge of lamellipodia was measured. Data are expressed as average lamellipodium 
length (top) or as a box and whisker diagram representing at least 40 cells for each siRNA 
condition over three independent experiments. T-tests did not reveal statistical significance.
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In the case o f PAK4 knockdown in DU 145 cells, again each oligomer gave a slightly 
different phenotype (Figure 4.11 and supplementary movies 11-14) Oligomer siPAK4a did 
not knock down protein level as efficiently as the others (Figure 3.9) and cells remained 
motile (Figure 4.11 and supplementary movie 11). Oligomer siPAK4b cause cells to bleb in 
a similar way to oligomer siPAK2d (Figure 4.1 IB and supplementary movie 12). Oligomer 
siPAK4c led to a significant decrease in cell rounding following HGF addition (Figure 4.11 
and 4.12) but this was not observed when oligomer siPAK4d was used.
None o f the oligomers used against any o f the PAK isoforms tested significantly reduced 
proliferation o f DU145 cells over a period o f 24 hours o f HGF stimulation (Figure 4.13).
Variation between oligomers is thought to arise due to off-target knockdown o f genes with 
similar sequences or matching between the 5’ seed region o f the siRNA oligomer and the 3’ 
untranslated region o f an off-target mRNA. This will be discussed further later.
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F ig u re  4.11: Knockdown of PAK4 in DU145 cells. DU145 cells were seeded and allowed 
to  grow  for 16 hours before transfection with control siRNA or one o f four different siRNA 
oligom ers against PAK4. 48 hours after transfection cells were stimulated with 10 ng/ml 
H G F and movies were made for 24 hours taking one frame every 5 minutes. T=0 
corresponds to the start o f the movie approximately 30 minutes after HGF stimulation. 
M ovies are representative o f at least four repeat experiments for siControl, siPAK4c and 
siPA K 4d, only one experiment was performed for siPAK4a and siPAK4b. B) 4X 
m agnification o f boxed region in siPAK2d, 24 hour timepoint, showing blebbing (arrow).
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Figure 4.12: PAK1 knockdown decreases cell rounding in response to HGF. DU145 
cells were left untransfected or transfected with control siRNA or siRNA against PAK1, 
PAK2 or PAK4 and allowed to grow for 48 hours. Cells were stimulated with 10 ng/ml 
HGF and movies were made for 24 hours. The first and last frames were taken and rounded 
cells were counted automatically using Metamorph software as described in Chapter 2. 
Round cells were expressed as a percent o f the total cell number. Graphs include data from 
3 separate experiments. Error bars represent S.E.M., * = p < 0.05, two tailed t test.
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Figure 4.13: PAK knockdown does not significantly affect proliferation of DU145 
cells. DU 145 cells were left untransfected or transfected with control siRNA or siRNA 
against PAK1, PAK2 or PAK4 and allowed to grow for 48 hours. Cells were stimulated 
with 10 ng/ml HGF and movies were made for 24 hours. The total number o f cells in the 
last frame o f each movie was divided by the total number o f cells in the first frame to give 
an approximate number o f cell divisions. The mean number of cell divisions over three 
independent experiments is shown. Error bars represent S.E.M. T-tests did not reveal 
statistical significance.
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4.4: Effect of Rho GTPase knockdown on DU145 cell scattering
PAK activity and localisation can be controlled by binding o f active Rho GTPases. Racl 
and Cdc42 in particular have been linked to activation of PAK1 and PAK2. In chapter 3 it 
was shown that Racl or Cdc42 knockdown decreased PAK1 and PAK2 phosphorylation in 
DU 145 cells. To observe whether Racl or Cdc42 knockdown leads to a similar phenotype 
to knockdown o f a specific PAK isoform, hence suggesting an upstream role, movies were 
made o f DU 145 cell scattering following Racl or Cdc42 knockdown (Figure 4.14). Two 
oligomers previously characterised in the laboratory and shown to knockdown protein 
(Figure 3.15 and 3.16) were used for each GTPase. In a preliminary experiment, Cdc42 
knockdown induced blebbing in response to HGF but cells could still scatter and blebbing 
cells did not undergo apoptosis. Increased blebbing was not observed prior to HGF 
stimulation. In comparison to the PAK knockdown phenotypes, Racl-depleted DU 145 cells 
had a similar morphology to PAK1-depleted cells and preliminary quantification suggested 
that Racl knockdown may block cell rounding following HGF stimulation (Figure 4.14B). 
Cdc42 knockdown was not similar to knockdown o f PAK 1, PAK2 or PAK4 except for two 
o f the oligomers; PAK2d and PAK4b. It was thought that these oligomers may have had an 
off-target because they caused phenotypes that did not match with the other three out of 
four oligomers. These experiments need to be repeated to confirm the observed results.
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Figure 4.14: R acl o r Cdc42 knockdown give distinct phenotypes. A) DU145 cells were
seeded and allowed to grow overnight before transfection with control siRNA or one o f two 
different siRNA oligomers against Racl or Cdc42. 48 hours after transfection, cells were 
stimulated with 10 ng/ml HGF and movies were made for 24 hours taking one frame every 
10 minutes (0 and 24 hour timepoints shown). T=0 corresponds to the start of the movie 
approximately 30 minutes after HGF stimulation. B) Percent round cells was quantified 
before and after 24 hours o f HGF stimulation according to the protocol in chapter 2 using 
frames from the movies shown in A. Data are from one experiment.
4.5: Phenotypes of cells following combined knockdow n of PAK1 and PAK2
In Chapter 3 it was shown that knockdown o f PAK2 causes increased phosphorylation of 
PAK1 at S I99/204. To determine whether the upregulation of PAK 1 could be responsible 
for the phenotypes observed when PAK2 was knocked down, both PAK1 and PAK2 were 
knocked down simultaneously using two different combinations o f oligomers (Figure 4.15). 
Simultaneous knockdown o f PAK1 and PAK2 had been previously tested by western 
blotting using lysate from DU 145 cells and found to be as effective as knocking down 
single isoforms (result not shown). When siPAK2b was cotransfected with siPAKld, cells 
appeared flatter than with siPAK2b alone. However when siPAK2c and siPAKlc were 
cotransfected, lamellipodia appeared the same as with PAK2c alone. These preliminary 
results were therefore inconclusive, probably due to a number o f factors which could affect 
the phenotype seen in cells. Firstly, siRNA knockdown of protein is not complete and the 
phenotype observed may depend on the relative amounts of protein remaining following
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knockdown. Secondly, although single oligomers were chosen that gave a similar 
phenotype, there is still some variation between those phenotypes that could lead to 
inconsistent results when different pairs o f oligomers were used. Thirdly, PAK2 
knockdown is more effective than PAK1 knockdown (Figure 3.9) and it is unknown 
wherether there is a temporal difference between knockdown of the two proteins which 
could affect the final phenotype.
In future experiments, simultaneous knockdown o f more than one PAK isoform could be 
investigated in more detail to produce more conclusive results. For example, a single 
oligomer could be designed against a homologous region o f PAK1 and PAK2 to knock 
both isoforms down.
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Figure 4.15: PAK1 and PAK2 knockdown simultaneously in DU145 cells. DU145 cells 
were seeded and allowed to grow overnight before transfection with control siRNA (not 
shown), one o f two different siRNA oligomers against PAK2 or the combinations o f PAK 1 
and PAK2 oligomers indicated. 48 hours after transfection, cells were stimulated with 10 
ng/ml HGF and movies were made for 24 hours taking one frame every 10 minutes (24 
hour timepoint shown). Boxed areas are magnified fourfold to show detail o f cell 
morphology and lamellipodia. Data are from one experiment
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4.6: PAK1 or PAK2 knockdown impairs migration of PC3 cells
PC3 cells were not included in scattering assays because they grow as single cells. They 
express c-Met and respond to HGF and so they provide a model system to assess the role o f 
PAK isoforms in the migration o f single cells. This is relevant to the pathological process 
by which single cells which have escaped from a tumour mass migrate to distal sites. The 
effect o f knockdown o f PAK1, PAK2 or PAK4 on PC3 migration and morphology was 
assessed in movies for 16 hours taking one frame every 10 minutes (Figures 4.16 -  4.18 
and supplementary movies 15-28). Analysis was performed on the first 12 hours o f movies 
due to cell proliferation at later timepoints. Control cells responded to HGF with increased 
motility (Figure 4.20) and became more elongated (Figure 4.16). PAK1 or PAK4 
knockdown did not significantly affect the morphology o f PC3 cells before or after HGF 
treatment although one o f the PAK4 oligomers (PAK4b) caused cells to become more 
elongated than control cells following HGF stimulation (Figure 4.18). Depletion o f PAK2 
caused more cells to be localised in groups before and after HGF stimulation (Figure 4.17).
To investigate the effect o f PAK knockdown on PC3 migration in the presence o f HGF, 
cells were tracked over a period o f 12 hours. Knockdown o f PAK2 led to cell migration 
tracks which appeared shorter and less persistent (Figure 4.19). The difference between 
tracks from control cells and tracks from PAK1 or PAK4-depleted cells was less clear 
although it appeared that PAK4-depleted cell migration may be more persistent. Persistence 
should be measured in future to quantify these results. The mean speed o f PC3-cell 
migration in movies was measured (Figure 4.20). Knockdown o f PAK1 or PAK2 slowed 
the average speed o f PC3 migration whereas knockdown o f PAK4 had no effect on the 
migration speed compared to control siRNA, although more experiments are required.
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Figure 4.16: PAK1 knockdown does not affect PC3 morphology. PC3 cells were seeded 
and allowed to grow for 18 hours before transfection with control siRNA or one o f four 
different oligomers against PAK1. Forty-eight hours after transfection, cells were 
stimulated with 10 ng/ml HGF and movies were made for 16 hours taking one frame every 
10 minutes (0 and 12 hour timepoints shown). Movies are representative of two repeat 
experiments.
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Figure 4.17: PAK2 depleted PC3 cells localise in groups. PC3 cells were seeded and 
allowed to grow for 18 hours before transfection with control siRNA or one o f four 
different oligomers against PAK2. Forty-eight hours after transfection, cells were 
stimulated with 10 ng/ml HGF and movies were made for 16 hours taking one frame every 
10 minutes (0 and 12 hour timepoints shown). Movies are representative o f two repeat 
experiments.
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Figure 4.18: PAK4 knockdown does not detectably affect PC3 morphology. PC3 cells 
were seeded and allowed to grow for 18 hours before transfection with control siRNA or 
one of four different oligomers against PAK4. Forty-eight hours after transfection, cells 
were stimulated with 10 ng/ml HGF and movies were made for 16 hours taking one frame 
every 10 minutes (0 and 12 hour timepoints shown). Movies are representative o f two 
repeat experiments.
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Figure 4.19: PAK2 affects persistence of PC3 cell migration.
PC3 cells were treated with control siRNA or siRNA against PAK1, PAK2 or PAK4. 48 
hours after transfection movies were made for 12 hours taking one frame every 10 minutes. 
Cells which did not divide, leave the field o f view or become obscured by other cells were 
tracked. Tracks from one movie are shown, dots denote the finishing position of cells at 12 
hours after HGF stimulation.
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Figure 4.20: Knockdown of PAK1 or PAK2 but not PAK4 slows m igration speed of 
PC3 cells. PC3 cells were treated with control siRNA or siRNA against PAK1, PAK2 or 
PAK4. Forty-eight hours after transfection movies were made for 12 hours taking one 
frame every 10 minutes. Cells which did not divide, leave the field of view or become 
obscured by other cells were tracked and their mean speed at each time point was 
calculated. Data was taken from two independent experiments. Error bars for siControl and 
siPAKIc are shown and represent the means of two experiments. Data are from at least 120 
cells over two experiments for PAK1 and PAK2 knockdown. Data for PAK4 knockdown is 
from one experiment only tracking at least 140 cells.
4.7: HGF increases m igration of DU145 in wound healing assays
Wound healing assays have previously been used to assess collective cell migration and a 
high throughput, automated assay o f wound healing has been described (Yarrow et al., 
2005). To investigate whether a high-throughput assay could be used to generate multiple 
experimental repeats o f wound healing, and so be used to screen for the effects o f PAK 
knockdown, a similar approach to Yarrow et al. was used. Confluent monolayers o f 
DU 145 cells were scratched manually and allowed to heal for 16 hours before automatic 
imaging and calculation o f scratch area. Due to variation in the size o f the scratches at the 
start o f the experiment, this assay was not sensitive enough to measure small changes 
which might be present between conditions. However, the size o f the scratches after 16 
hours was smaller in the presence o f 10 ng/ml HGF showing that HGF increases the speed
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o f wound healing in DU145 cells (Figure 4.20). To improve this experiment, the area of 
each scratch at the start of the experiment should be taken into account and knockdown 
should be confirmed by western blotting for each individual experiment.
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Figure 4.21: HGF increases speed of wound healing in DU145 cells. DU145 cells were 
seeded in 96-well plates and allowed to grow for 18 hours prior to transfection with control 
siRNA or single oligomers of PAK siRNA. PAK oligomers used were PAKla, PAK2b and 
PAK4b. The control oligomer was from Qiagen. Forty-eight hours after transfection when 
cells had reached confluence, the cells were starved in 0.1% FCS for 8 hours then scratched 
with a 20 pi pipette tip. Medium was changed for fresh starvation medium or starvation 
medium supplemented with 10 ng/ml HGF and scratches were allowed to heal for 16 hours. 
The cells were then fixed in 3.8% formaldehyde, stained with rhodamine-phalloidin and 
Hoescht, and imaged automatically using a Cellomics ArrayScan imaging system taking an 
image of the centre o f each well. The area of the scratch in the resulting images was 
measured using the Definiens program. Data from wells where the scratch was not in the 
centre o f the well were not included in the analysis leaving 11 > n > 4. The graphs include 
data from one experiment and as such, significance can not be measured. Error bars 
represent standard deviation from the mean of results from individual wells.
144
Chapter 4 Role o f  PAK in HGF-induced migration and invasion
4.8: PAK knockdown does not slow DU145 cell wound healing
The semi-automated wound healing assay (Figure 4.21) could not reliably measure small 
changes in wound healing that might be caused by PAK knockdown. To overcome this, a 
manual approach was taken in which movies were made of wound healing so that variation 
o f the initial scratch area could be taken into account. The effect of knocking down PAK1, 
PAK2 or PAK4 using siRNA on DU 145 cell wound healing was investigated. To validate 
results, four individual siRNA oligomers for each PAK isoform were used. To confirm that 
PAK knockdown was effective under these conditions, PAK expression was assessed by 
western blotting using lysates prepared from cells after carrying out a scratch assay. None 
o f  the oligomers against PAK1 caused a significant change in speed o f wound healing 
(Figure 4.22). In the case o f PAK2 and PAK4, siPAK2d and siPAK4b slowed wound 
healing although only one point was statistically significant. The other three oligomers for 
each isoform did not slow healing, although they all decreased expression o f the relevant 
protein (Figure 4.22). Interestingly siPAK2d and siPAK4b were the oligomers which 
induced blebbing following HGF stimulation and were thought to potentially have an off- 
target phenotype (Figures 4.6 and 4.11). The consensus phenotype was therefore that the 
speed o f wound healing was not affected by depletion of PAK 1, PAK2 or PAK4.
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Figure 4.22: PAK knockdown does not affect the speed of DU145 cell wound healing.
Graphs showing wound area during wound healing in the presence of HGF. Movies o f 
wound healing assays were made using DU 145 cells treated with siRNA against PAK1, 
PAK2 or PAK4 and the area o f the scratch was measured at 4 hourly intervals after the 
start. In each movie, results were normalised to the largest starting scratch in the dataset. 
Error bars represent standard error of the mean. Each experiment was carried out in 
quadruplicate and graphs incorporate data from three (PAK1) or two (PAK2 and PAK4) 
repeat experiments. Error bars represent standard error or the mean. * = p < 0.05 two tailed 
T test. Western blots were performed using lysate taken from DU 145 cells after performing 
a scratch assay. Blots were probed with antibodies against PAK1, PAK2 or PAK4 as 
indicated. siRNA treatment is indicated, siC = control siRNA (Dharmacon), - = 
untransfected control.
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Effect of PAK2 knockdown on DU145 wound healing
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Effect of PAK4 knockdown on DU145 cell wound healing
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4.9: PAK1 knockdown does not inhibit DU145 cell invasion through Matrigel
D U  145 cells invade through Matrigel-coated transwells and HGF increases this migration 
(N ishim ura et al., 1998). To investigate the role o f PAK isoforms in this process and in 
m igration through transwells, invasion assays were performed using Matrigel -  coated 
transw ells. The invasion o f DU145 cells treated with siRNA against PAK1 or PAK2 was 
assessed. Pairs o f oligomers which previously gave similar phenotypes were used and 
invasion and migration were quantified after 24 hours by automated measuring o f the area 
o f  cells on the underside o f the transwell membrane. Results were normalised to the mean 
siC ontro l measurement for each experiment and expressed as a mean o f data from three 
independent experiments (Figure 4.23). In the case o f PAK1, knockdown did not 
significantly  affect migration or invasion through transwells. In the case o f PAK2 
knockdow n, one oligomer o f two tested significantly affected invasion through Matrigel 
com pared to the control oligomer but the second oligomer did not. The result for PAK2 
knockdow n was therefore inconclusive. These results could be checked by directly 
counting  the number o f cells which had transmigrated rather than quantifying area. In time 
lapse movies PAK1 knockdown affected rounding, and so cell area, but visual observation 
o f  im ages o f the transwells suggested that this was not the case in the conditions o f this 
assay  (Figure 4.23A). The experiment could be carried out using different PAK2 oligomers 
to  determ ine the phenotype.
148
Chapter 4 Role o f  PAK in HGF-induced migration and invasion
A
siControl siPAKIc
B
■ invasion
■  Migration
siControl siPA K Ic siPA K Id siPAK2b siPAK2c
Figure 4.23: Knockdown of PAK1 in DU145 cells does not affect invasion through 
M atrigel or m igration through transwells. DU145 cells were transfected with control 
siRNA or one o f two different oligomers against PAK1 or PAK2. After 48 hours, 105 of the 
pre-treated cells were seeded in Matrigel-coated transwells and 2xl04 were seeded in 
uncoated transwells, each with 40 ng/ml HGF in the lower chamber as a chemoattractant. 
After a further 24 hours, cells on the bottom of the transwells were fixed and stained with 
crystal violet and images o f five different fields of view were acquired using a Nikon TL 
microscope (A). The amount o f migration or invasion was quantified by measuring the 
mean stained area over the five fields o f view (B). Graphs represent data from three repeat 
experiments for siControl, siPAKIc, siPAKId and siPAK2b, and two experimental repeats 
for siPAK2c. Error bars represent standard error o f the mean. * = p < 0.05, two tailed 
student’s t test.
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4.10: Discussion
Recently, DU 145 cancer cells have been shown to scatter in response to HGF providing a 
model for the study o f junctional breakdown and migration of cancer cells (Miura et al., 
2001). HT29 colon cancer cells have also been shown to respond to HGF by increased cell 
spreading, but not scattering (Fazekas et al., 2000; Nabeshima et al., 1998) and this could 
also be used as a different readout for the response of cancer cells to HGF. In the present 
study DU 145 and HT29 cells were tested as well as MCF7 and PC3 cells to set up assays 
for the investigation o f the role o f PAKs in cancer cell migration and scattering. O f the 
three cell lines tested, only DU 145 cells scattered significantly whereas MCF7 only showed 
a slight increase in ruffling at early time points. No clear response to HGF was observed in 
HT29 cells. A possible explanation for the lack o f response in HT29 cells is the substrate 
used for the assay; previous experiments where HGF induced spreading o f HT29 cells were 
carried out on glass (Nabeshima et al., 1998) but the present study was carried out on tissue 
culture-treated plastic. This suggests that engagement o f different integrins dependent on 
substrate could play a role in the spreading response. HGF at a concentration o f 40 ng/ml 
was tested on HT29 cells in 0.1% FCS and scattering was still not observed (result not 
shown). In MCF7 cells, c-Met associates with E-cadherin (Hiscox and Jiang, 1999) so it 
might be expected that HGF stimulation would trigger junctional breakdown. This was not 
the case however so MCF7 cells may require other stimuli to scatter. It has been shown that 
overexpression o f the cell adhesion molecule LI disrupts junctions in MCF7 cells, and 
knockdown o f endogenous LI leads to more compact colonies (Shtutman et al., 2006). 
Thus, MCF7 scattering may depend on regulation o f LI.
The effect o f PAK1, PAK2 or PAK4 knockdown on random migration of PC3 cells and 
DU 145 cell scattering or wound healing in response to HGF was investigated. For each 
isoform, variation in phenotype was observed between different oligomers. This variation is 
likely to occur as a result o f off-target effects o f the siRNA sequences. It has been shown 
using microarrays that transfection o f siRNA into cells causes off-target knockdown of 
many unrelated mRNA transcripts (Chi et al., 2003). It was observed that many o f these 
off-target mRNAs had sequence similarity between the mRNA and the 5’ end o f the 
antisense strand (the seed region) implying that the knockdown could work in the same way 
as the 5’ end o f microRNAs targeting the 3’ untranslated region (UTR) o f an mRNA 
(Jackson 2003). Indeed base substitution in the seed region was found to rescue off-target
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knockdown o f many mRNAs (Jackson et al., 2006). Further to this Birmingham et al. 
developed a web-based tool for the prediction of possible off-target genes (Birmingham et 
al., 2006). When the sequences for the PAK siRNAs used in this study were input into this 
tool, lists o f between 60 and 2391 potential off-target genes with multiple seed-region 
matches were generated highlighting the need to control for possible off-target effects by 
using more than one siRNA oligomer in experiments. These predictions are not always 
correct, but they provide a possible means to suggest how an off-target effect could occur. 
For example, the seed region o f siPA K la has multiple matches to the mRNA for p-PIX 
(accession number NM_145735), a known PAK interactor, which plays a role in focal 
adhesion turnover. Interestingly, this oligomer did not give an identifiable phenotype with 
cells scattering following HGF stimulation in the same way as control cells. It would be 
interesting to know if this was due to off-target knockdown which recued the effect o f 
PAK 1-depletion. Potential off-target effects could be investigated further by western 
blotting. Recently, modification o f the 5’ end o f the antisense strand o f siRNA has been 
shown to reduce off-target knockdown (Snove and Rossi, 2006). 4On target’ oligomers with 
this modification are available (Dharmacon) and could be used in future studies
Because o f the presence o f off-target effects it would have been desirable to carry out more 
extensive controls such as re-expression o f the target protein following siRNA knockdown. 
This was attempted in DU 145 cells but lipid-mediated transfection o f DNA plasmids 
encoding PAK isoforms into cells had a very low efficincy and adversely affected the cells 
causing changes in morphology and behaviour (result not shown). Therefore it was not 
possible to carry out this control experiment and the consensus response to two or three o f 
the four oligomers was taken to be the most likely phenotype o f knockdown. However, it 
should be kept in mind that a consensus response between oligomers could still be 
influenced or caused by off-target effects.
In DU 145 cell scattering assays, depletion o f PAK1 led to a phenotype where fewer cells 
detached completely from colonies and cells remained more spread than control cells. 
Confocal microscopy and actin staining showed that more cells retained their E-cadherin- 
based junctions than control cells. The observed phenotype agrees with previous research in 
keratinocytes showing that Racl induces junctional breakdown through PAK1 (Lozano et 
al., 2008) and suggests that this could be the case in HGF-induced scattering. Preliminary
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Racl knockdown experiments showed that the phenotype they induce in DU 145 cells is 
similar to that observed with PAK1 knockdown. The relationship between Racl and PAK1 
in DU 145 cells should be investigated further in future work to elucidate their roles in 
junctional breakdown downstream of HGF. The decreased cell rounding of PAK 1-deficient 
DU 145 cells compared to control cells following HGF stimulation could be due to an 
increase in adhesion through focal contacts. Overexpression o f GIT1 and PAK-interacting 
exchange factor (PIX) lead to disassembly o f focal adhesions and interact in complex with 
PAK (Zhao et al., 2000) It would be interesting to investigate whether PAK1 depletion 
affects focal adhesion breakdown through GIT1, or whether knockdown o f GIT1 in DU 145 
cells would have a similar effect to PAK1 knockdown on spreading. However, it has 
previously been shown that knockdown o f GIT1 in HeLa cells inhibits EGF-induced cell 
spreading (Yin et al., 2005). Increased adhesion could also contribute to the decrease in 
migration seen in PAK 1-depleted PC3 cells. However, the migration of DU 145 cells in 
wound healing assays was unaffected.
Another mechanism that could lead to increased spreading is a reduction in contractility. 
This could be through the ability o f PAK1 and PAK2 to phosphorylate regulatory myosin 
light chain (R-MLC) at serine 19 leading to increased contraction (Kiosses et al., 1999; 
Zeng et al., 2000). This is backed up by evidence showing that active PAK1 increases 
permeability o f vascular endothelial cells, and this corresponds to phosphorylation o f MLC 
(Stockton et al., 2004). However, PAK1 and PAK2 can also lead to decreased contractility 
by phosphorylation and inactivation o f myosin light chain kinase (Goeckeler et al., 2000; 
Sanders et al., 1999). The dual role o f PAK1 and PAK2 in regulation o f R-MLC 
contractility suggests that their activity towards either R-MLC or MLCK depends on the 
cell context and the activity o f other signalling pathways.
DU 145 cells depleted in PAK2 were able to scatter but cells had broader lamellipodia, 
particularly when using oligomer siPAK2b, although results need to be repeated to 
determine their significance. This was further observed in confocal images o f DU 145 cells 
stained for actin filaments. Constitutively active Racl has been shown to induce the 
formation o f broader lamellipodia in PtKl cells and this effect is blocked by expression o f 
dominant negative LIMK1 or the PAK1 AID (Delorme et al., 2007). In chapter 1 it was 
found that PAK2 knockdown leads to an up-regulation o f phosphorylation o f PAK1 at
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S I 99/204. Phosphorylation o f this site reduces (3-PIX binding (Mott et al., 2005) and so 
could lead to a redistribution o f PAK from focal contacts to the cytoplasm. To investigate 
w hether PAK1 phosphorylation plays a role in the PAK2 knockdown phenotype, PAK1 
and PAK2 were knocked down simultaneously. The combination o f PAK2b and PAK Id 
oligom ers did alter the lamellipodia making them flatter and more like the PA K lb 
phenotype. Yet use o f PA K lc and PAK2c together did not alter the lamellipodia compared 
to PAK2c alone. Therefore, in these conditions, PAK1 knockdown did not rescue the 
PAK2-knockdown phenotype but knockdown o f two proteins simultaneously using two 
different pairs o f oligomers does not give identical results even when each o f the pairs o f 
oligom ers alone give a similar phenotype. This could be due to the combination o f two 
oligom ers leading to a combination o f off target knockdown which gives a different cell 
phenotype highlighting the importance o f validating results with more than one separate 
siRN A  oligomer.
It has also been shown that PAK1, PAK2 and PAK4 can activate LIMK leading to cofilin 
phosphorylation and inactivation (Misra et al., 2005) and dephosphorylated cofilin is 
required for lamellipodia extension (Kiuchi et al., 2007). This suggests that PAK 
knockdow n could lead to an increase in active cofilin which could be responsible for the 
m orphology o f the lamellipodia observed in PAK2-deficient cells. This appears contrary to 
the finding that dominant negative LIMK1 blocks the Racl-induced formation o f broad 
lam ellipodia (Delorme et al., 2007), but lamellipodium extension also depends on a free 
pool o f  actin monomers and free barbed ends in the leading edge, both supplied by cofilin.
PAK1 or PAK2 knockdown slowed the speed o f PC3 migration in the presence o f HGF. As 
w ell as a possible role for adhesion in impaired PC3 migration speed, cell polarity may 
have an effect. PAK is thought to play multiple roles in cell polarisation and maintenance 
o f  polarity. PAK1 can phosphorylate Opl8/Stathmin so promoting microtubule stability 
(W ittm ann et al., 2004). Active PAK1 is localized at the leading edge o f cells and is 
required for restricting Rac-dependent actin polymerisation to that location (Cau and Hall, 
2005). In this way, PAK1 would promote leading edge protrusion and loss of PAK1 could 
lead to a defect in cell polarisation.
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In the case o f knockdown o f PAK4 each o f the oligomers gave a slightly different 
phenotype so it was unclear which was the most likely phenotype o f PAK4 knockdown. In 
a recent study, PAK4 knockdown in PC3 cells led to cell rounding following HGF 
stimulation (Ahmed et al., 2008). This was not observed in the present study with any o f 
the oligomers, possibly due to the conditions used as the cells were starved in the Ahm ed 
study, but it could also be due to oligomer-specific effects. In this study, siPAK4b led to a 
phenotype where DU 145 cells blebbed more following HGF stimulation. This is similar to 
the phenotype seen with Cdc42 knockdown in DU 145 cells and Cdc42 has been shown to 
activate PAK4 in response to HGF in MDCK cells (Wells et al., 2002). However, as only 
one oligomer gave this phenotype it is more likely to be an off-target effect. Oligomer 
siPAK4b also gave an anomalous effect in PC3 cells where cells became more elongated 
than control cells following HGF stimulation and in DU 145 cells where wound healing was 
inhibited. The oligomers siPAK4c and siPAK4d had no significant effect on PC3 
morphology or speed o f migration suggesting that PAK4 is not important for PC3 
migration. They also had no significant effect on the speed o f DU 145 wound healing. 
Taken together, these results are not conclusive and show that further work is required to 
uncover the roles o f PAK4 in DU 145 and PC3 responses to HGF. A possible approach 
would be to use ‘on-target’ siRNA oligomers with a 5’ modification to decrease off-target 
effects.
The effect o f PAK knockdown on invasion o f DU 145 cells through Matrigel and migration 
through transwells was also investigated. PAK1 knockdown did not affect invasion or 
migration in this assay. This is contrary to previous work in melanocytes where knockdown 
o f PAK1 blocked invasion through Matrigel, although only one oligomer was used so an 
off-target effect cannot be ruled out (Pavey et al., 2006). In the case o f PAK2 knockdown, 
only one oligomer o f two tested significantly inhibited invasion so this result was 
inconclusive.
Taken together, these results show that PAK1, PAK2 and PAK4 play distinct roles in the 
scattering o f DU 145 cells and migration o f PC3 cells in response to HGF. The key 
phenotypes observed in PAK-depleted cells are summarised (table 4.1). PAK1 knockdown 
impaired PC3 migration and led to more spread DU 145 cells. PAK2 knockdown also 
impaired PC3 migration and led to larger lamellipodia with different actin staining in
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DU 145 cells. The likely role o f PAK4 in DU 145 and PC3 cells was unclear as the four 
oligomers gave different phenotypes in DU 145 cell scattering. Moreover, the two PAK4 
oligomers tested in PC3 cells had no effect on cell migration speed.
PAK isoform DU 145 cell 
wound healing
DU 145 scattering PC3 cell 
migration
DU 145 cell 
invasion
PAK1
knockdown
Unaffected Scattering decreased Migration speed 
decreased
Unaffected
PAK2
knockdown
Unaffected Scattering not 
inhibited, broad 
lamellipodia
Migration speed 
decreased
No consensus 
phenotype
PAK4
knockdown
Unaffected No consensus 
phenotype
Unaffected Not tested
Table 4.1: Observed effects o f PAK isoform knockdown in DU 145 and PC3 cells.
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C hapter 5: The role of PAK in HGF-induced cell signalling 
5.1: Introduction
In Chapter 4 it was shown that PAK1 and PAK2 play distinct roles in cancer cell responses 
to HGF. PAK1 knockdown led to a decrease in HGF-induced scattering and cell rounding 
in DU 145 cells, and slower migration o f PC3 cells. PAK2 knockdown led to broader 
lam ellipodia in DU 145 cells and slower migration in PC3 cells.
M any binding partners and substrates o f PAKs have been described, and it is thought that 
these are responsible for most o f the phenotypes observed upon expression o f constitutively 
active and dominant negative PAK. PAK-dependent control o f lamellipodia formation is 
thought to be mediated by activation o f LIM kinase 1 (LIMK1) (Edwards et al., 1999), 
w hich phosphorylates and inactivates cofilin, blocking its actin severing and 
depolymerisation functions (Arber et al., 1998; Yang et al., 1998). PAK1, PAK2 and PAK4 
have each been shown to activate LIMK1 (Dan et al., 2001a; Edwards et al., 1999; Misra et 
al., 2005) providing a pathway through which PAK could increase actin filament stability 
and block actin depolymerisation. As well as LIMK1, regulation o f LIMK2 by PAK1, 
PAK2 and PAK4 in vitro has been suggested but results have not yet been published 
(Bokoch, 2003). It is thought that PAK can also regulate actin polymerisation and 
membrane ruffle formation through filamin A; an actin binding protein that induces cross- 
linking o f F-actin into bundles (Vadlamudi et al., 2002).
PAK1 and PAK2 also regulate cell contractility. Both PAK1 and PAK2 have been shown 
to phosphorylate regulatory myosin light chain (R-MLC) directly leading to an increase in 
contractility (Chew et al., 1998; Ramos et al., 1997), but on the other hand can 
phosphorylate and inactivate myosin light chain kinase (MLCK) leading to a decrease in 
phospho-R-M LC (Goeckeler et al., 2000; Sanders et al., 1999).
The role o f PAK in adhesion is believed to be mediated through its localisation to focal 
adhesions in complex with p-PIX and GIT. PAK1 binds directly to p-PIX and both proteins 
are localised to focal adhesions in complex with GIT1 via paxillin binding, it is thought that 
the localisation o f these proteins is involved in focal adhesion turnover and lamellipodia 
formation (See Chapter 1, section 1.7) (Brown et al., 2002; Zhao et al., 2000).
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PAKs can play a role in cell polarity through microtubule stability. In motile cells, 
microtubules extend towards the leading edge and it is thought that they play an important 
role in cell polarity (reviewed in Wittmann and Waterman-Storer, 2001). Microtubules are 
regulated through Opl8/Stathmin which binds tubulin and decreases microtubule stability 
(Howell et al., 1999; Marklund et al., 1996). O pl8  can be phosphorylated and inhibited by 
PAK1 which promotes microtubule stability (Wittmann et al., 2004). In this way PAK1 
activation at the leading edge o f cells could facilitate the maintenence of cell polarity and 
persistence o f migration.
PAKs also activate MAPK signalling downstream o f some growth factors. This was 
originally indicated by the yeast PAK homologue Ste20, which is part o f the yeast mating 
factor MAPK cascade (reviewed in Dan et al., 2001b). It has been suggested that 
mammalian Group 1 PAKs can influence signalling throught the Raf/MEK/ERK pathway 
or the p38-MAPK pathway (Bagrodia et al., 1995; Eblen et al., 2002; Slack-Davis et al., 
2003; Zhang et al., 1995). However, MAPK activation downstream of PAK appears to be 
cell type and stimulus dependent, as there are multiple pathways that can feed into MAPK 
signalling.
It is unclear what the isoform-specific pathways leading to a functional difference between 
PAK1 and PAK2 could be. RNAi provides an effective way to investigate this.
The aim of this chapter is to investigate the effect o f the knockdown of PAK1 or PAK2 on 
protein signalling following HGF stimulation o f cancer cells.
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Results
5.2: PAK1 knockdown does not affect E-cadherin expression in DU145 cells following 
H G F stimulation
HGF stimulation of DU 145 cells leads to cell scattering with a loss of E-cadherin from 
junctions and a decrease in the total level of E-cadherin (Miura et al., 2001). In 
keratinocytes, PAK1 is required for loss o f E-cadherin from junctions downstream of active 
R acl (Lozano et al., 2008). Knockdown o f PAK1 in DU145 cells caused cells to remain 
m ore spread and maintain more cell junctions after HGF treatment than control cells 
(Chapter 4, Section 4.3). To investigate whether knockdown of PAK1 in DU 145 cells 
caused a defect in the down-regulation o f E-cadherin, the total level o f E-cadherin was 
determined in PAK 1-depleted cells before and after HGF stimulation for 24 hours (Figure 
5.1). In this preliminary experiment, down regulation o f E-cadherin following HGF 
stimulation was observed in control cells as expected and knockdown o f PAK 1 appeared to 
increase the total level o f E-cadherin but further experiments are required to confirm this. 
E-cadherin down-regulation following HGF stimulation was still observed in PAK1- 
depleted cells.
Untransfected
+
siControl
+
siPAKlc siPAKld
+  -  +  HGF (24 hours)
E-cadherin
PAK1
Actin
F igu re  5.1: E-cadherin expression following HGF stimulation of control and PAK1- 
depleted  DU145 cells. DU 145 cells were seeded in growth medium for 18 hours prior to 
transfection with control siRNA or one o f two oligomers o f siRNA against PAK1. Cells 
were left untransfected as a further control. Forty-eight hours after transfection, cells were 
stimulated with lOng/ml HGF in growth medium for 24 hours, or kept unstimulated in 
growth medium prior to lysis. Western blots were performed and probed with antibodies 
against E-cadherin, PAK1 or p-actin. Only one experiment was performed.
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5.3 PAK1 or PAK2 knockdown does not affect phosphorylation of FAK downstream  
o f HGF
In DU 145 cells, PAK 1-depleted cells remained more spread than control cells following 
HGF stimulation while PAK2-depleted cells had altered lamellipodia. In PC3 cells, 
knockdown o f either PAK1 or PAK2 impaired cell motility (Chapter 4). These phenotypes 
could be partly due to increased adhesion. Focal adhesion kinase (FAK) is recruited 
transiently to lamellipodia at the leading edge o f migrating cells where it is incorporated 
into new focal adhesions (Schlaepfer et al., 2004). FAK is known to be responsible for 
focal adhesion turnover and it has been shown that expression o f dominant negative PAK1 
blocks LPA-induced FAK phosphorylation in A2058 melanoma cells (Jung et al., 2004), 
This result suggests that in some situations, PAK1 could influence FAK tyrosine 
phosphorylation and activation. Phosphorylation o f FAK at Y576/577 is required for full 
kinase activity (Ruest et al., 2000) so phosphorylation o f these sites was investigated in 
PAK1 or PAK2-depleted cells (Figure 5.2 and 5.3). HGF stimulated the phosphorylation o f 
FAK in DU145 and PC3 cells and knockdown of neither PAK1 or PAK2 knockdown 
affected this phosphorylation of FAK. This is probably because FAK is phosphorylated by 
active Src directly downstream of c-Met (Pongchairerk et al., 2005). These data do not rule 
out a role for PAK1 or PAK2 in cell adhesion downstream or independent of FAK.
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Figure 5.2: PA K l knockdown does not affect phosphorylation of FAK following HGF 
stim ulation in DU 145 or PC3 cells. DU 145 or PC3 cells were transfected with control 
siRNA or one o f two siRNA oligomers against PAKl. Forty-eight hours after transfection, 
cells were stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. 
Western blots were performed and probed with antibodies against phospho-FAK 
(Y576/577), PAKl and PAK2. Some control blots are the same between Figures 3.10, 5.2, 
5.17, 5.23 and 5.21. Blots are representative o f two independent experiments.
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Figure 5.3: PAK2 knockdown does not affect phosphorylation of FAK following HGF 
stimulation in DU 145 or PC3 cells. DU 145 or PC3 cells were transtected with control 
siRNA or one o f two siRNA oligomers against PAK2. Forty-eight hours after transfection, 
cells were stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. 
Western blots were performed and probed with antibodies against phospho-FAK 
(Y576/577) and P-actin or PAKl, PAK2 and P-actin. Straight left brackets indicate images 
from the same membrane. Some control blots are from the same membrane as in Figure 
5.26 and 5.9. Blots are representative o f two independent experiments.
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5.4: Broad lamellipodia in PAK2-deficient DU145 cells have enriched ERK1 and 
GIT1/2
Although FAK phosphorylation was unaffected by PAKl or PAK2 knockdown, 
localisation o f proteins involved in focal adhesion dynamics could still be affected. PAKl 
associates with P-PIX in complex with GIT1 and localises to focal adhesions (Brown et al., 
2002; Zhao et al., 2000) and ERK1/2 localises to focal complexes following HGF 
stimulation o f  HeLa cells (Kermorgant et al., 2004). The effect o f PAKl or PAK2 
knockdown on the localisation o f ERK and GIT1/2 in growing and HGF-stimulated DU 145 
cells was observed by immunofluorescence and confocal microscopy. (Figures 5.4 -  5.7). 
In control cells prior to HGF stimulation, GIT 1/2 localisation was punctate in the cytoplasm 
and colocalised w ith ERK1/2 in lamellipodia (Figure 5.4, arrows). ERK1/2 was also diffuse 
in the cytoplasm. Microtubules were oriented towards the outside o f colonies. Following 
HGF stimulation for 18 hours, GIT 1/2 and ERK 1/2 localisation remained in the cytoplasm 
with some colocalisation at lamellipodia. Microtubules generally oriented towards 
lamellipodia (Figure 5.5 arrow). Knockdown o f PAKl with oligomer PA K lc did not have a 
strong effect on microtubules or the localisation of GIT 1/2 or ERK 1/2 before or after HGF 
stimulation in com parison to control cells. Oligomer PAK Id seemed to decrease the 
localisation o f  GIT1/2 and ERK1/2 in the cell periphery (Figure 5.5) but more experiments 
should be perform ed to confirm this. PAK2-depleted cells formed disorganised colonies 
prior to HGF stim ulation and microtubule orientation towards the edges o f colonies 
appeared disrupted (Figure 5.6). Following HGF stimulation for 18 hours, GIT1/2 and 
ERK1/2 localisation in lamellipodia was enhanced (Figure 5.7 arrows). ERK1/2 
localisation in focal adhesion-type structures following HGF stimulation was not observed 
suggesting that this could depend on the cell type, however co-staining with a focal 
adhesion marker such as paxillin is required to show this.
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Figure 5.4: Effect of PAKl knockdown on tubulin, GIT1/2 and ERK1/2 localisation in growing cells. DU145 cells 
were transfected with control siRNA or one of two siRNA oligomers against PA K l. 66 hours after transfection, cells 
were fixed in methanol and stained with antibodies against GIT 1/2 and ERK 1/2 followed by fluorescent secondary 
antibodies and a FITC-conjugated tubulin antibody. Arrows indicate colocalisation of ERK1/2 and GIT1/2.
Tubulin__________ GIT1/2_____________ERK 1/2________________Merge
siControl
m
1 9 1
I L  Pv, T
siPAK lc
S s i  I
siPAK Id
p • " " ®
Figure 5.5: Effect of PAKl knockdown on tubulin, GIT1/2 and ERK1/2 localisation after eighteen hours of HGF 
stimulation. DU145 cells were transfected with control siRNA or one of two siRNA oligomers against PAKl. 48 hours 
after transfection, cells were stimulated with lOng/ml HGF for 18 hours, cells were fixed in methanol and stained with 
antibodies against GIT1/2 and ERK1/2 followed by fluorescent secondary antibodies and a FITC-conjugated tubulin 
antibody. Arrows indicate microtubules oriented towards the edges of lamellipodia.
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Figure 5.6: Effect of PAK2 knockdown on tubulin, GIT1/2 and ERK1/2 localisation in growing cells. DU 145 cells 
were transfected with control siRNA or one of two siRNA oligomers against PAK2. 66 hours after transfection, cells 
were fixed in methanol and stained with antibodies against GIT 1/2 and ERK 1/2 followed by fluorescent secondary 
antibodies and a FITC-conjugated tubulin antibody. Note that control images are the same as in Figure 5.4 as they are 
from the same experiment.
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Figure 5.7: Effect of PAK2 knockdown on tubulin, GIT1/2 and ERK1/2 localisation eighteen hours of HGF stimulation.
DU145 cells were transfected with control siRNA or one of two siRNA oligomers against PAK2. 48 hours after transfection, cells 
were stimulated with lOng/ml HGF for 18 hours, fixed in methanol and stained with antibodies against GIT 1/2 and ERK 1/2 
followed by fluorescent secondary antibodies and a FITC-conjugated tubulin antibody. Control images are the same as in Figure 
5.5 as they are from the same experiment. Arrows indicate enhanced localisation of ERK1/2 and GIT1/2 to the edges of 
lamellipodia.
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5.5: Knockdown of PAK2 impairs phosphorylation of O pl8 at Serine 16 in PC3 cells 
but not in DU145 cells
Knockdown o f PAKl or PAK2 impaired the migration of PC3 cells causing them to move 
slower on average than control cells (Chapter 4). This could be caused by a defect in the 
establishment or persistence o f cell polarity. Microtubule organisation also appeared to be 
affected by PAK2 knockdown in DU 145 cells (Figure 5.6). Microtubules contribute to cell 
polarity and PAK activation in the leading edge o f cells is thought to affect this by 
phosphorylation and inhibition o f Opl8/stathmin, a microtubule-destabilising protein 
(Howell et al., 1999; Marklund et al., 1996). To investigate whether the migration defect in 
PAKl or PAK2 deficient PC3 cells could be due to impaired cell polarity, the effect o f 
PAKl or PAK2 knockdown on phosphorylation o f Op 18 was observed by western blotting 
(Figures 5.8 and 5.9). O pl8  was phosphorylated in response to HGF in both DU145 and 
PC3 cells and knockdown of PAKl did not affect this in either cell line. PAK2 knockdown 
did not affect Op 18 phosphorylation in DU 145 cells but in PAK2-depleted PC3 cells the 
phosphorylation o f O pl8 was decreased (Figure 5.9 and 5.10). It would be interesting to 
test later time points to investigate whether there is an effect in DU 145 cells later after HGF 
stimulation.
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Figure 5.8: PAKl knockdown does not affect the phosphorylation of O pl8  after HGF 
stimulation. DU 145 or PC3 cells were transfected with control siRNA or one o f two 
siRNA oligomers against PAKl.  Forty-eight hours after transfection, cells were stimulated 
with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. Western blots were 
performed and probed with antibodies against phospho-Opl8 (pS 16) and P-actin, or Op 18, 
PAKl and p-actin. Control blots are the same as in Figure 5.25. Straight left brackets 
indicate images from the same membrane. Blots are representative of two independent 
experiments.
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Figure 5.9: PAK2 knockdown im pairs the phosphorylation of O pl8  after HGF 
stimulation in PC3 cells but not DU145 cells. DU 145 or PC3 cells were transfected with 
control siRNA or one of two siRNA oligomers against PAK2. Forty-eight hours after 
transfection, cells were stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates 
were prepared. Western blots were performed and probed with antibodies against phospho- 
O pl8 (S I6) and P-actin or Op 18, PAK2 and actin (DU 145) or Op 18, PAKl, PAK2 and P- 
actin (PC3). Straight left brackets indicate images from the same membrane. Some control 
bands are the same between Figures 3.11 3.13, 5.3, 5.9, 5.18, 5.22, 5.24 and 5.26. Blots are 
representative o f two independent experiments.
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Figure 5.10: Quantification of O pl8  phosphorylation in PAK2-depIeted PC3 cells.
phospho-Opl8 or total Op 18 blots from figure 5.9 were quantified using ImageJ software. 
First, each was normalised against P-actin loading controls and then phospho-Opl8 was 
normalised against total Op 18. The level of phospho-Opl8 is expressed as % of the control 
value at time = 0. Data are taken from two independent experiments and error bars 
represent the two values, except for control experiments which were pooled and represent 
four values from two independent experiments for each graph.
5.6: Knockdown of Racl or Cdc42 decreases O pl8  phosphory lation following HGF 
stimulation
To investigate whether Racl or Cdc42 could be responsible for PAKl or PAK2-dependent 
Op 18 inhibition, the phosphorylation of Op 18 at Ser 16 following HGF stimulation of 
Racl-depleted (Figure 5.11) or Cdc42-depleted (5.13) DU145 or PC3 cells was observed 
by western blotting. Knockdown of either Racl or Cdc42 decreased Op 18 phosphorylation 
following HGF stimulation although the effect was weak for oligomer Racl_05. More 
experimental repeats are required to determine the significance of this (Figure 5.12). The 
effect was strongest in Cdc42-depleted PC3 cells where both oligomers gave a significant 
decrease in Opl8 phosphorylation in two separate experiments (Figure 5.14).
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Figure 5.11: Racl knockdown impairs the phosphorylation of Opl8  after HGF 
stimulation in PC3 and DU 145 cells. DU 145 or PC3 cells were transfected with control 
siRNA or one o f two siRNA oligomers against Racl. Forty-eight hours after transfection, 
cells were stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. 
Western blots were performed and probed with antibodies against phospho-Opl8 (S I6) and 
p-actin, or Op 18 and P-actin, or Racl and p-actin (DU 145), or Op 18, Racl and p-actin 
(PC3). Blots are representative of three independent experiments. Straight left brackets 
indicate images from the same membrane.
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Figure 5.12: Op l 8  phosphorylation is impaired in Racl-depletion in DU145 and PC3 
cells. phospho-Opl8 or total Op 18 blots from figure 5.11 were quantified using ImageJ 
software. First, each was normalised against p-actin loading control and then phospho- 
Opl8 was normalised against total Opl8. The level of phospho-Opl8 is expressed as % of 
the control value at time = 0. Data are taken from two independent experiments and error 
bars represent the two means, except for control experiments which were pooled and 
represent four means from two independent experiments for each graph.
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Figure 5.13: Cdc42 knockdown im pairs the phosphorylation of Op l 8  after HGF 
stim ulation in PC3 and DU 145 cells. DU 145 or PC3 cells were transfected with control 
siRNA or one o f two siRNA oligomers against Cdc42. Forty-eight hours after transfection, 
cells were stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. 
Western blots were performed and probed with antibodies against phospho-Opl8 (S I6) and 
p-actin, or PAKl,  PAK2 and Op 18, or Cdc42 and p-actin (top panel), or Op 18, Cdc42 and 
p-actin. Blots are representative of three independent experiments. Straight left brackets 
indicate images from the same membrane.
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Figure 5.14: Quantification of O p l8  phosphorylation Cdc42-depleted DU145 and PC3 
cells. phospho-Opl8 or total Opl8 blots from figure 5.13 were quantified using ImageJ 
software. First, each was normalised against p-actin loading controls and then phospho- 
O pl8 was normalised against total Op 18. The level of phospho-Opl8 is expressed as % o f 
the control value at time = 0. Data are taken from two independent experiments and error 
bars represent the two means except for control experiments which were pooled and 
represent four means from two independent experiments for each graph.. * = p < 0.05, *** 
= p < 0.001, two tailed student’s t-test.
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5.7: The effect of PAK2 knockdown on micro tubules in PC3 cells
To investigate whether the impaired O pl8 phosphorylation in PAK2-depleted PC3 cells 
could lead to a difference in microtubule organisation, fixed cells were stained with a 
FITC-conjugated tubulin antibody and observed by confocal microscopy (Figure 5.15 and 
5.16). These results require quantitative investigation o f a greater number o f cells to draw a 
conclusion. A method for earring out analysis could be to count the proportion o f cells with 
an unpolarised microtubule network such as those observed in preliminary images (Figure 
5.15 and 5.16, arrows). The cell periphery o f PAK2-depleted cells also appeared to have 
increased F-actin compared to control cells. Both o f these phenotypes could be quantified 
in future with more experimental repeats.
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Figure 5.15: Effect of PAK2 knockdown on PC3 microtubule organisation in 
unstim ulated cells. PC3 cells were transfected with control siRNA or siRNA against one 
o f two PAK2 oligomers using Lipofectamine 2000. 66 hours after transfection cells were 
fixed in 4% paraformaldehyde and stained with Alexa 546-linked phalloidin and a FITC- 
conjugated anti-tubulin antibody. Confocal images were captured using a 40X oil- 
immersion objective. Arrows indicate examples of cells without apparent microtubule 
network polarisation. Data are from one experiment.
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Figure 5.16: Effect of PAK2 knockdown on PC3 microtubule organisation in 
unstim ulated cells: PC3 cells were transfected with control siRNA or siRNA against one 
o f two PAK2 oligomers using Lipofectamine 2000. 48 hours after transfection cells were 
stimulated with 10 ng/ml HGF for 18 hours, then fixed in 4% paraformaldehyde and 
stained with Alexa 546-linked phalloidin and a FITC-conjugated anti-tubulin antibody. 
Confocal images were captured using a 40X oil-immersion objective. Arrows indicate 
examples o f cells without apparent microtubule network polarisation. Data are from one 
experiment.
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5.8: The effect of knockdown of PAK1 or PAK2 on MLC phosphorylation
PAK1 knockdown led to an inhibition o f cell rounding following HGF stimulation in 
DU 145 cells (Chapter 4, Section 4.3). This could be due to a decrease in myosin 
contractility. Myosin contraction is controlled by phosphorylation o f R-MLC at Thrl8 and 
S eri9. These sites can be phosphorylated by MLCK (both T18 and S I9), ROCK (S I9) 
(Amano et al., 1996) and PAK (S I9) (Chew et al., 1998; Ramos et al., 1997). PAK can 
also phosphorylate and inactivate MLCK (Goeckeler et al., 2000). The effect o f PAK1 or 
PAK2 knockdown on the level of diphosphorylated R-MLC following HGF stimulation 
was observed by western blotting (Figures 5.17 and 5.18). Preliminary results using lysates 
from PC3 and DU 145 cells suggested that HGF stimulation did not affect the level o f R- 
MLC phosphorylated at both T18 and S 19 up to 1 hour after HGF addition, and the level 
also remained the same following knockdown of PAK1 or PAK2. However, there was 
some variability between western blots so the results are not conclusive and should be 
repeated. No consistent change in R-MLC phosphorylation following HGF stimulation was 
observed in this assay, it is possible that there could be a difference at later time points after 
HGF stimulation as cell rounding was most apparent after 16 hours or more. It is also 
possible that the level o f monophosphorylated R-MLC could change but would probably 
not be detected by this antibody.
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Figure 5.17: PAK1 knockdown does not affect the phosphorylation of MLC 
dow nstream  of HGF. DU 145 or PC3 cells were transfected with control siRNA or one of 
two siRNA oligomers against PAK1. Forty-eight hours after transfection, cells were 
stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. Western 
blots were performed and probed with antibodies against phospho-MLC (T 18/S 19) and P- 
actin or PAK1, PAK2 and P-actin (DU145) or PAK1 and PAK2 (PC3). Straight left 
brackets indicate images from the same membrane. Some control blots are the same 
between Figures 3.10, 3.12, 5.2, 5.17, 5.23 and 5.21. Blots are from one experiment for 
pMLC.
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Figure 5.18: PAK2 knockdown does not affect the phosphorylation of MLC 
downstream of HGF. DU 145 or PC3 cells were transfected with control siRNA or one of 
two siRNA oligomers against PAK2. Forty-eight hours after transfection, cells were 
stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. Western 
blots were performed and probed with antibodies against phospho-MLC (T 18/S 19) and P- 
actin or PAK2 and P-actin. Straight left brackets indicate images from the same membrane. 
Some control bands are the same between Figures 3.11 3.13, 5.9, 5.18, 5.22 and 5.24. Blots 
represent one experiment for pMLC.
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5.9: Knockdown of PAK1 or PAK2 does not affect phosphorylation o f Raf, MEK1, 
ERK or p38 MAPK following HGF stimulation
Group I PAKs have been shown to play roles in multiple MAPK signalling pathways 
depending on the cell type and stimulus (See Chapter 1, Section 1.7.4). To investigate the 
role o f PAK1 and PAK2 in MAPK signalling downstream of HGF, the phosphorylation o f 
Raf, MEK1, ERK and p38 MAPK were observed in PAK1 or PAK2-depleted DU 145 and 
PC3 cells by western blotting (Figures 5.19-5.22). Each of the MAP kinases tested was 
phosphorylated rapidly following HGF stimulation except for MEK which seemed to have 
a high basal level o f phosphorylation. None o f the phosphorylation events were affected by 
knockdown o f PAK1 or PAK2, probably because o f the diversity o f MAPK signalling.
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Figure 5.19: The effect of PAK1 knockdown on MAPK signalling. DU145 or PC3 cells 
were transfected with control siRNA or one of two siRNA oligomers against PAK1. Forty- 
eight hours after transfection, cells were stimulated with 10 ng/ml HGF for 0 - 6 0  minutes 
before lysates were prepared. Western blots were performed and probed with antibodies 
against phospho-Raf, phospho-ERK (T202/Y204), phospho-p38 MAPK (T180/Y182), 
PAK1 and PAK2. Some control blots are the same between Figures 3.10, 5.2, 5.17, 5.23 
and 5.21. Data are representative o f two experiments for pERKl/2 and p-p38, and one 
experiment for pRaf.
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Figure 5.20: The effect of PAK2 knockdown on MAPK signalling. DU 145 or PC3 cells 
were transfected with control siRNA or one of two siRNA oligomers against PAK2. Forty- 
eight hours after transfection, cells were stimulated with 10 ng/ml HGF for 0 - 6 0  minutes 
before lysates were prepared. Western blots were performed and probed with antibodies 
against phospho-Raf, phospho-ERKl/2 (T202/Y204), phospho-p38 MAPK (T180/Y182) 
and PAK2. Some control bands are the same between Figures 3.11 3.13, 5.9, 5.18, 5.22 and 
5.24. Data are representative of two experiments for pERKl/2 and one experiment for 
pRaf.
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Figure 5.21: The effect of PAKl knockdown on the phosphorylation of MEK1 
downstream of HGF. DU 145 or PC3 cells were transfected with control siRNA or one o f 
two siRNA oligomers against PAKl. Forty-eight hours after transfection, cells were 
stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. Western 
blots were performed and probed with antibodies against phospho-MEK and P-actin or 
PAKl, PAK2 and p-actin (DU 145), or PAKl and PAK2 (PC3). Control blots are the same 
as for Figure 5.2 (PC3) and 5.17 (PC3 and DU145). Straight left brackets indicate images 
from the same membrane. Some control blots are the same between Figures 3.10, 3.12, 5.2, 
5.17, 5.23 and 5.21. Data are from one experiment for pMEK.
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Figure 5.22: The effect of PAK2 knockdown on the phosphorylation of MEK1 
downstream of HGF. DU 145 or PC3 cells were transfected with control siRNA or one of 
two siRNA oligomers against PAK2. Forty-eight hours after transfection, cells were 
stimulated with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. Western 
blots were performed and probed with antibodies against phospho-MEK and P-actin or 
PAK2 and p-actin. Straight left brackets indicate images from the same membrane. Some 
control bands are the same between Figures 3.11 3.13, 5.9, 5.18, 5.22 and 5.24. Data are 
from one experiment for pMEK.
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5.10: Knockdown of PAKl or PAK2 does not affect Akt phosphorylation in DU145 or 
PC3 cells
PAKl is thought to play a role in cell signalling through Akt/PKB and roles both upstream 
and downstream have been described. Akt is activated by phosphorylation at Ser 473 and 
Thr308 (Alessi et al., 1996; Alessi et al., 1997). PAKl has been shown to phosphorylate 
Akt at S473 in vitro while Akt phosphorylation at S473 was impaired in neonatal rat 
ventricular cardiomyocytes treated with PAKl shRNA or siRNA, and cardiac Akt 
phosphorylation was reduced in PAKl-null mice (Mao et al., 2008). To investigate whether 
PAKl or PAK2 could be responsible for Akt activation following HGF stimulation, Akt 
phosphorylation at Ser 473 in PAKl or PAK2-depleted DU 145 and PC3 cells was observed 
by western blotting (Figures 5.23 and 5.24). Akt became phosphorylated rapidly following 
HGF stimulation in each cell line and this was not affected by knockdown o f PAKl or 
PAK2.
186
Chapter 5________________________________The role o f  PAK in HGF-induced cell signalling
DU145
f  [ siControl ][ siPAK lc  ]
.  0 5 10 30 60 0 5 10 30 60 min. HGF
p-actin
•  PAKl 
v  P-actin
T siControl ] [ siPAK 1 d ]
-  0 5 10 30 60 0 5 10 30 60 min. HGF
mm mm mm mm mm mm mm w p-actin
^  P-actin
-siControl ] [------- siPAK 1 c -
5 10 30 60 0 5 10 30 60
pAkt
P-actin
PC3
V
B ^ B ^ m m m  P_act*n
[ siControl ][ siPAKld -1
_ 0 5 10 30 60 0 5 10 30 60 min. HGF
mm mm mm mm mm mm mm mm mm mm P-actin
m  m  m  mm m  p a k i
m mm mm mm P-actin
Figure 5.23: PA K l knockdown does not affect Akt phosphorylation following H GF 
stimulation. DU 145 or PC3 cells were transfected with control siRNA or one o f two 
siRNA oligomers against PAKl. Forty-eight hours after transfection, cells were stimulated 
with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. Western blots were 
performed and probed with antibodies against phospho-Akt (S473) and P-actin or PAKl 
and P-actin. Straight left brackets indicate images from the same membrane. Control blots 
are the same as in Figure 5.8. Data are representative of two experiments.
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Figure 5.24: PAK2 knockdown does not affect Akt phosphorylation following HGF 
stimulation. DU 145 or PC3 cells were transfected with control siRNA or one o f two 
siRNA oligomers against PAK2. Forty-eight hours after transfection, cells were stimulated 
with 10 ng/ml HGF for 0 - 6 0  minutes before lysates were prepared. Western blots were 
performed and probed with antibodies against phospho-Akt (S473) and P-actin or PAK2 
and p-actin. Straight left brackets indicate images from the same membrane. Some control 
blots are from the same membrane as in Figure 5.3 and 5.9. Data are representative o f two 
experiments.
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5.11: Discussion
Knockdown o f PAKl in DU 145 cells led to a decrease in scattering following HGF 
stimulation combined with a retention o f E-cadherin-based cell junctions (Chapter 4). 
Junctional breakdown following HGF stimulation can be characterised by the 
internalisation o f E-cadherin followed by a slight decrease in E-cadherin protein levels 
(Miura et al., 2001). Preliminary results showed that PAKl knockdown had no effect on the 
slight decrease in E-cadherin protein level following HGF stimulation but the total level o f 
E-cadherin appeared slightly higher and should be investigated further in future 
experiments. The mechanism underlying breakdown of adherens junctions and subsequent 
internalisation o f E-cadherin is poorly understood, p i20 catenin (pl20ctn) binding to E- 
cadherin is required for stability o f the E-cadherin complex (Ireton et al., 2002) and 
knockdown o f p i20 leads to the targeting of E-cadherin and VE-cadherin for degradation 
(Davis et al., 2003; Xiao et al., 2003). pl20ctn contains multiple phosphorylation sites, the 
majority o f which are in the N-terminal portion o f the protein and expression o f an N- 
terminal deleted mutant pl20ctn blocks HGF-induced junctional breakdown in MDCK 
cells (Cozzolino et al., 2003). This suggests that regulation o f phosphorylation o f the N- 
terminal region might be involved in pl20ctn-induced junctional breakdown, however it is 
not clear which phosphorylation sites could be involved or whether phosphorylation or 
dephosphorylation is important. The functional significance o f individual pl20ctn  
phosphorylation sites is currently the subject of intense study and the generation o f 
phospho-specific p i20 antibodies is currently underway (Vaughan et al., 2007). On first 
inspection, none o f the serine or threonine phosphorylation sites in pl20ctn appear to be 
potential PAKl substrates comparing to the proposed PAKl substrate consensus sequence 
(Rennefahrt et al., 2007). However, this does not rule out a role for PAKl in direct or 
indirect control of pl20ctn phosphorylation and junctional breakdown.
The role of PAKl and PAK2 in celkmatrix adhesion signalling was investigated. FAK 
phosphorylation following HGF stimulation was not affected by PAKl or PAK2 
knockdown but confocal imaging revealed that PAK2 knockdown in DU 145 cells led to an 
altered localisation o f GIT 1/2 and ERK 1/2 in lamellipodia. ERK 1/2 has been shown to 
localise to focal complexes following HGF stimulation in HeLa cells (Kermorgant et al.,
2004) but this was not observed in DU 145 cells where it localised to lamellipodia showing 
possible cell-specific differences. ERK 1/2 is thought to play a role in the generation o f new
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focal adhesions by phosphorylating paxillin leading to the recruitment o f FAK (Ishibe et 
al., 2003; Liu et al., 2002). This suggests that the large lamellipodia observed in PAK2- 
deficient cells could be caused by an increase in focal adhesion formation at the leading 
edge. It has recently been suggested that knockdown o f PAK2 could lead to increased size 
o f focal adhesions in heregulin-treated breast carcinoma cells (Coniglio et al., 2008), 
although only 20 cells were counted and only one oligomer o f PAK2 siRNA was used. 
Future work should include measuring the size and number o f focal adhesions in PAK2- 
deficient DU 145 cells compared to control cells to investigate how ERK 1/2 and GIT 1/2 
localisation affects focal adhesions in these conditions.
LIMK-mediated phosphorylation and inactivation o f cofilin is thought to play a role in 
lamellipodia formation, but active, dephosphorylated cofilin is also believed to function at 
the leading edge, probably in the generation o f new barbed ends by actin filament severing 
(Delorme et al., 2007). The phosphorylation o f cofilin following HGF stimulation in PC3 
cells has recently been described and it was suggested that this could occur through 
phosphorylation o f LIMK1 by PAK4 (Ahmed et al., 2008) PAKl and PAK2 have also both 
been described to phosphorylate LIMK1 and LIMK2 (Bokoch, 2003; Edwards et al., 1999; 
Misra et al., 2005). A phospho-LIMK antibody was tested but results were not conclusive 
because o f the presence o f many non-specific bands (data not shown). A phospho-cofilin 
antibody was also tested but did not detect a change in phosphorylation downstream o f 
HGF in a preliminary experiment (data not shown). This could be because HGF stimulation 
was carried out in growth medium. If the cells were starved to decrease the background 
level o f growth factor signalling, a change in cofilin phosphorylation might be observed 
and this could be tested in future experiments.
It is thought that PAK can also regulate actin polymerisation and membrane ruffle 
formation through filaminA; an actin-binding protein that induces cross-linking o f F-actin 
into bundles (Grazi et al., 1990). FilaminA binds to PAKl via a region overlapping the 
CRIB domain and is thought to induce PAK activity in the same way as Racl/Cdc42 
binding (Vadlamudi 2002). PAK can also phosphorylate filamin A at Ser2152, the 
relevance o f which is unclear but is thought to be important for cell migration (Vadlamudi 
et al., 2002; Woo et al., 2004). In the present study the role o f filamin A was not 
investigated in DU 145 or PC3 cell migration but this could be included in future work.
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Inhibition o f HGF-induced cell rounding in PAKl-deficient DU 145 cells (Chapter 4) could 
be due to an inhibition o f cell contractility. PAKl or PAK2 knockdown had no effect on the 
level o f MLC phosphorylated at T 18/S 19 and there was also no change upon HGF 
stimulation for up to 1 hour in DU145 or PC3 cells. R-MLC is diphosphorylated at T18 and 
S I9 by MLCK (Itoh et al., 1992). PAKl and PAK2 have both been shown to phosphorylate 
MLCK in vitro (Goeckeler et al., 2000; Sanders et al., 1999) and constitutively active 
PAKl induces MLCK phosphorylation when overexpressed (Sanders et al., 1999). 
Phosphorylation inactivates MLCK and would be expected to lead to a decrease in 
diphosphorylated R-MLC. The absence of a change in diphosphorylated R-MLC after HGF 
stimulation or in PAKl or PAK2-deficient cells suggests that PAKl and PAK2 do not 
phosphorylate MLCK following activation by HGF in DU 145 and PC3 cells. However, a 
role in cell contractility in this context cannot be ruled out as monophosphorylation o f MLC 
could also be important. It has previously been shown that PAKl and PAK2 phosphorylate 
R-MLC at serine 19 in vitro (Chew et al., 1998; Ramos et al., 1997) and an increase in 
monophosphorylated R-MLC at S19 was also observed with overexpression o f PAK2 or 
constitutively active PAKl (Sells et al., 1999; Zeng et al., 2000). Future experiments should 
investigate whether R-MLC monophosphorylation at S 19 is affected by HGF stimulation or 
by PAKl or PAK2 knockdown. It would also be interesting to investigate the effect o f PAK 
knockdown on phosphorylation o f MLCK.
The role o f PAKs in affecting microtubule regulation was investigated. Op 18 became 
phosphorylated at Serine 16 following HGF stimulation in DU 145 and PC3 cells. 
Phosphorylation o f Op 18 at this site inhibits its microtubule destabilisation ability and PAK 
has previously been shown to phosphorylate serine 16 in vitro (Wittmann et al., 2004). 
Knockdown of PAKl in either cell line had no effect on O pl8  phosphorylation but 
knockdown o f PAK2 impaired Op 18 phosphorylation in PC3 cells suggesting that PAK2 
can phosphorylate Op 18 at Ser 16, which has not been previously described. It is possible 
that impaired O pl8 phosphorylation plays a role in the slower migration speed o f PAK2- 
depleted PC3 cells. Interestingly, PAK2 knockdown had no effect on Op 18 
phosphorylation in DU 145 cells. The difference could be due to a higher level o f 
expression o f PAKl in DU145 cells compared to PC3 cells (Chapter 3, Figure 3.2). 
Therefore if  both PAKl and PAK2 can phosphorylate O pl8, PAKl could compensate for 
loss o f PAK2 in DU 145 cells but not in PC3 cells. If this was the case, it would be expected
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that knocking down PAKl and PAK2 simultaneously would lead to an inhibition o f Op 18 
phosphorylation following HGF stimulation in both PC3 and DU 145 cells. The observation 
that either Racl or Cdc42 knockdown affect Op 18 phosphorylation agrees with this as they 
affect both PAKl and PAK2 activation (Chapter 3.8). However, PAK2 knockdown 
appeared to affect microtubule organisation in DU 145 cells despite the lack o f an effect on 
phosphorylation O pl8. This could be due to localised differences in O pl8 phosphorylation 
or to another signalling pathway leading from PAK2 to microtubules. In future work it 
would be interesting to investigate this in more detail by investigating whether PAK 
knockdown leads to localised differences in the level o f acetylated (more stable) or 
tyrosinated (less stable) a-tubulin (Witte et al., 2008)
Akt was rapidly phosphorylated at S473 in DU 145 and PC3 cells following HGF 
stimulation and was unaffected by knockdown of PAKl or PAK2. This suggests that the 
phosphorylation o f Akt by PAK is not important in stimulation o f cell scattering and 
migration by HGF. Instead, other kinases such as protein kinase C (PKC) or mammalian 
target o f rapamycin complex 2 (mTORC2) are likely to be involved in phosphorylation o f 
Akt at S473 (Guertin et al., 2006; Kawakami et al., 2004). PAKl could be activated by Akt 
downstream of HGF. It has previously been shown that PAKl is activated by expression o f 
active Akt but not inactive Akt in COS7 cells (Menard and Mattingly, 2004) and Akt is 
thought to activate PAKl in a Rho GTPase-independent manner (Tang et al., 2000). Akt 
activation involves targeting to the membrane via its PH-domain which binds PIP3 
generated by PI3K. Subsequent phosphorylation o f Akt at S473 and T308 leads to full 
activation (Reviewed in (Manning and Cantley, 2007)). This provides a possible 
mechanism by which Akt could lead to localised PAK activation. In the future work it 
would be intersting to study this in more detail by investigating PAKl or PAK2 
phosphorylation in Akt-deficient cells.
Investigation o f MAPK signalling following HGF stimulation showed that the 
Raf/MEK/ERK pathway and p38 MAPK phosphorylation were not affected by knockdown 
of PAKl or PAK2 in DU145 or PC3 cells. This is probably due to the many diverse 
signalling pathways that can feed into MAPK signalling. For example Ras-GTP binding to 
Raf regulates Raf activation (Avruch et al., 2001; Chong et al., 2003) and p38 MAPK can 
be activated by a diverse range o f upstream MAP kinases (reviewed in Zarubin and Han,
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2005).The observation that MEK phosphorylation did not change following HGF 
stimulation but both Rafl and ERK 1/2 became phosphorylated further highlights the 
diversity o f MAPK signalling. Another way o f investigating MAPK phosphorylation 
following HGF stimulation specifically would be to serum-starve the cells prior to HGF 
addition. The absence o f other growth factors might attenuate other signalling pathways 
which could otherwise mask the effect o f PAK knockdown.
In summary, phosphorylation of most o f the known PAKl and PAK2 substrates tested was 
not affected by PAKl or PAK2 knockdown, probably due to the presence o f other 
signalling pathways or PAK isoforms. Opl8/stathmin phosphorylation was impaired by 
PAK2 knockdown in PC3 cells but not in DU 145 cells which could be due to functional 
redundancy between PAKl and PAK2, but PAK2 did seem to affect microtubule 
organisation in unstimulated cells revealing an interesting subject for future investigation. 
The effect o f PAK2 on Opl8/stathmin could explain the slower migration speed o f PC3 
cells but the same was not observed with PAKl knockdown showing that there is probably 
a difference in signalling or localisation that was not tested in this study.
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Chapter 6: Concluding remarks
In this study it was shown that PAKl and PAK2 became phosphorylated following HGF 
simulation in DU 145, PC3, MCF7 and HT29 cancer cell lines. Phosphorylation in DU 145 
and HT29 cells was weak. This phosphorylation was partially abrogated by Racl or Cdc42 
knockdown in DU 145 and PC3 prostate cancer cells. PAKl or PAK2 knockdown were 
shown to give distinct phenotypes in DU 145 and PC3 cells but phosphorylation o f many o f 
the previously identified PAK targets was not affected. Possible negative regulation o f 
PAKl by PAK2 was observed as knockdown o f PAK2 in both PC3 and DU 145 cells led to 
an up regulation o f phosphorylation o f PAKl at S eri99/204 by an unknown mechanism. 
O pl8  was identified as a likely substrate o f PAK2 which has not been previously described.
It has formerly been shown that overexpression o f dominant negative or contitutively active 
PAKl or Rho GTPases often has a strong effect on cell motility. For example dominant 
negative PAKl or Cdc42 inhibited CXCL1-induced chemotaxis (Dharmawardhane et al., 
1999); either dominant negative or constitutively active PAKl inhibited endothelial cell 
migration (Kiosses et al., 1999); and dominant negative Racl blocked macrophage 
migration towards CSF-1 (Allen et al., 1998). The results from the present study agree with 
previous results to some extent but suggest that in some cases the phenotype associated 
with knockdown o f a protein is not as strong as that associated with overexpression o f a 
dominant negative. For example, preliminary movies o f Racl-depleted DU 145 or PC3 cells 
showed that cells could still migrate and in the future these movies should be repeated and 
cell migration tracked to confirm this. One possible reason for the difference is that siRNA 
knockdown leaves a residual level o f protein in the cell which could still function. The 
difference is also probably due to the binding and sequestering functions o f dominant 
negative mutants and it is possible that in the future, siRNA might show that certain Rho 
GTPases or PAK isoforms do not have the same functional importance as previously 
described. An example o f this can be seen in fibroblasts from Cdc42 knockout mice which 
can migrate and form filopodia and lamellipodia. Expression o f dominant negative Cdc42 
in these cells blocks migration showing that the mutant protein affects other signalling 
pathways (Czuchra et al., 2005). Furthermore, macrophages from Racl or Rac2 knockout 
mice have different morphology to those from control mice but, in contrast to previous 
studies with dominant negative R acl, their migration speed is unaffected (Allen et al.,
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1998; Wheeler et al., 2006). RNAi also makes it possible to distinguish between Rho 
GTPases where it was not previously possible. For example Rho A, RhoB and RhoC have 
been studied together by inhibition with C3 transferase but siRNA allows distinction 
between the three. It would be interesting to use combinations o f siRNA to investigate 
signalling networks and compensation or feedback pathways between proteins.
Knockdown o f PAKl or PAK2 gave distinct phenotypes for which there are several 
possible explanations: PAKl and PAK2 could have one or more unshared substrates 
leading to the activation o f different downstream pathways; their cellular localisation could 
be differentially regulated or they could have one or more unshared upstream activators 
meaning their activity could be locally regulated in different parts o f the cell. It has 
previously been suggested that the group I PAKs have almost identical substrate specificity 
in vitro although it is not known whether this is the case in vivo (Rennefahrt et al., 2007). It 
is possible that specific residues around the substrate phosphorylation site could confer 
selectivity between PAKl and PAK2. For example in the Rennefahrt study, methionine at 
position -3 to the phosphorylatable serine in the substrate peptide seemed to completely 
block phosphorylation by PAK2 but not PA K l. Therefore the possibility that different 
group I PAKs have some unshared substrates cannot be ruled out. Results from the present 
study support the idea that many PAK 1/2 substrates are shared but some are unique to one 
PAK isoform. PAK2 knockdown impaired Op 18 phosphorylation in PC3 cells, but not in 
DU 145 cells where more PAKl is expressed. This is interesting as PAKl has been shown 
to phosphorylate Op 18 in vitro but the same result was not observed in cells (W ittmann et 
al., 2004). Knockdown o f either Racl or Cdc42 which both activate PAKl and PAK2, 
impaired O pl8 phosphorylation in DU 145 cells. Taken together these results suggest that 
both PAKl and PAK2 can phosphorylate Op 18 in cells but it would be interesting to 
confirm this using cells depleted in both PAKl and PAK2. Phosphorylation o f many o f the 
known PAK substrates was unaffected by knockdown o f PAKl or PAK2. This could be 
due to functional redundancy between PAKs but it is also likely to be due to compensation 
through other pathways. For example ROCK can also lead to cofilin phosphorylation 
through LIMK (Sumi et al., 2001).
Some evidence that PAK2 could have a unique substrate comes from the observation that 
total endogenous Op 18 phosphorylation was unaffected in PAKl or PAK2-depleted DU 145
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cells, but PAK2 knockdown did appear to affect microtubule organisation whereas PAKl 
knockdown did not. This effect could either be due to localised, isoform-specific PAK 
activity or a PAK2-specific substrate or signalling pathway affecting microtubule stability 
or dynamics. Little is known about which other microtubule-stabilising or destabilising 
proteins could be downstream o f PAKs. PAKl phosphorylates tubulin cofactor B (TCoB) 
and this is thought to be important for TCoB function in microtubule polymerisation 
(Vadlamudi et al., 2005) but so far no link has previously been published between PAK2 
and microtubules. Future work could investigate whether PAK2 knockdown exerts its 
effect through localized alterations in stathmin activity or through a PAK2-specific 
substrate.
Perhaps the most striking evidence that PAKl and PAK2 could have some unshared 
substrates is the observation that PAK2 knockdown led to an increase in PA K l 
phosphorylation at S I99/204 whereas PAKl knockdown had no effect on PAK2 
phosphorylation. S I99/204 has been shown to be an autophosphorylation site (Gatti et al., 
1999; Manser et al., 1997) so if PAKl and PAK2 had identical substrate specificity they 
would be expected to /raws-phosphorylate. The hypothesis would then be that PAKl or 
PAK2 knockdown would lead to a decrease in phosphorylation o f both isoforms but this 
was not the case. In addition, if  PAKl and PAK2 could heterodimerise it might be expected 
that knockdown o f either one isoform would lead to an increase in phosphorylation o f  the 
other isoform. This was not observed, suggesting that PAKl and PAK2 do not 
heterodimerise. Alignment o f the PAKl and PAK2 amino acid sequences surrounding the 
S I99/204 phosphorylation sites shows that they are highly homologous but there are 
differences that could confer a difference in binding affinity to PAKl or PAK2, although 
the non-homologous residues share similar characteristics (Figure 6.1). As yet no direct 
comparison has been made between the activity o f PAKl or PAK2 towards known 
substrates. It would be interesting to conduct an in vitro phosphorylation assay to compare 
PAKl and PAK2-mediated phosphorylation o f peptides surrounding the PAK 1/2 
autophosphorylation sites. It is likely that the phosphorylation o f T423 in the kinase domain 
o f PAKl and PAK2 can be /raws-phosphorylated between different isoforms. The region 
surrounding T423 is 100% identical between PA K l, PAK2 and PAK3 (Chapter 3, Figure 
3.19) and it has been suggested that the crystal structure o f active PAKl reveals possible 
residues involved in dimerisation o f the kinase domain (Pirruccello et al., 2006). These
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residues are conserved between the group I PAKs but their relevance to phosphorylation at 
S I99/204 is unclear as they are outside the kinase domain.
1 9 0  2 0 0  2 1 0
PA K l: VIAPRP|HTKSV fT R § V l |p |p |/T P T
1 9 0  2 0 0
PAK2: V IA P R p |H T K H Y T R |v i |p |p |
F igure 6.1: sequence alignm ent o f PA K l and  PAK2 su rro u n d in g  the S199/204 
au tophosphory lation  sites. Phosphorylation sites are highlighted green, non-homologous 
residues are highlighted red.
It would be interesting to investigate what the PAK2-specific substrates could be. They 
could include a kinase that directly phosphorylates PAKl at S I99/204 or a phosphatase that 
dephosphorylates those sites. Very little is known about phosphatases which could regulate 
PAK dephosphorylation. So far only partner o f  PIX (POPX) 1 and 2 have been shown to 
deactivate PAKl by dephosphorylation o f T423 (Koh et al., 2002). It is not known whether 
this also corresponds to dephosphorylation o f S I99/204 but it is possible as they are both 
autophosphorylation sites (Manser et al., 1997). It would be interesting to find out w hether 
POPX can be activated by PAK2.
Preliminary investigations into whether up-regulated PAKl phosphorylation was 
responsible for the larger lamellipodia seen in PAK2-deficient DU 145 cells were carried 
out by simultaneous knockdown o f PAKl and PAK2. Results were unclear due to variation 
between the phenotypes but it appeared that PAKl knockdown did not rescue the PAK2 
phenotype. Further characterisation o f  PAK2-depleted DU145 cells showed that GIT1/2 
was enriched at the leading edges o f larger lamellipodia following HGF stimulation, 
although further work is required to quantify this. The same was not observed in the 
lamellipodia o f control or PAKl-depleted cells. Interestingly, the GIT1/2 localisation in 
HGF-stimulated, PAK2-depleted DU 145 cells was similar to that observed with expression 
o f an S273D paxillin mutant in CHO-K1 cells (Nayal et al., 2006). In the same study it was 
shown that PAKl can phosphorylate paxillin at Ser273 leading to an increase in GIT1 
binding. It has also been suggested that GIT1 phosphorylation at Ser709 by PAK leads to 
increased binding to paxillin, although further evidence is required (Webb et al., 2006).
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PAKl and PAK2 localise with GIT through mutual binding o f PIX. Phosphorylation o f 
PAK 1/2 at S I99/204 decreases binding to PIX and this is believed to lead to increased 
Racl activation (see Chapter 1, Section 1.7.3.ii). These previous observations together with 
results from the present study allow a model for the control o f lamellipodium formation by 
PAKl and PAK2 to be proposed (Figure 6.2). This model could explain the generation o f 
larger lamellipodia and localization o f GIT 1/2 in PAK2-depleted DU 145 cells. PAK2- 
depletion leads to an increase in PAKl phosphorylation at S I99/204 meaning that less 
PAKl would be bound to PIX. Knockdown o f PAK2 should also lead to a drop in the 
amount o f PIX bound to PAK2. These combined effects would mean that the level o f PIX 
unbound from PAK was higher than in control cells. This could activate Racl to stimulate 
lamellipodium formation through WAVE as previously described (see Chapter 1 section 
1.6.2.iii). PAKl being unbound from PIX could also free PAKl to signal directly to 
downstream effectors, some o f which are thought to lead directly to the generation o f 
lamellipodia. Phosphorylation o f GIT1 or paxillin by PA K l, as previously described, could 
influence the localisation o f GIT 1/PIX to forming adhesions through increased binding to 
paxillin (see Chapter 1, section 1.7.3). Interestingly this model might also explain why 
PAKl knockdown did not appear to rescue the PAK2 phenotype as the absence o f both 
PAKl and PAK2 could still lead to increased PIX-induced Racl activation and 
lamellipodium formation through an increase in PIX not bound to PAK.
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Figure 6.2: Hypothetical model for the control of lamellipodium form ation by PAK1/2 
in DU 145 cells. Downstream of a stimulus, PAKl would become phosphorylated and 
stimulate lamellipodium formation directly as previously described in the literature. PAK2 
could inhibit this phosphorylation o f PAK through an as yet unknown mechanism. PAKl 
phosphorylation would free PIX to stimulate lamellipodium formation through Racl.
Clearly further evidence is required to support this model. It would be important to 
determine the level and localisation o f Racl activity in PAKl or PAK2-depleted cells. The 
level o f Racl activation could be easily determined in pull-down assays using the PAK 
PBD. Unfortunately a preliminary attempt to do this was inconclusive but in future the 
assay could be optimised to obtain a clear result. The localisation o f Rac activity would be 
more challenging to observe; a fluorescent resonance energy transfer (FRET) probe to 
visualise Racl activity in cells has previously been developed (Itoh et al., 2002). The probe 
is composed of a YFP-tagged PAKl CRIB domain linked to a CFP-tagged Racl molecule. 
Activation o f the Racl in the probe leads to binding of the PAKl CRIB which allows 
FRET to take place between the CFP donor and YFP acceptor. However, expression of the 
probe itself would probably affect cell morphology and motility. FRET could also be used 
to investigate interactions between PAK 1/2, PIX, GIT 1/2 and proteins that could localise 
these complexes to lamellipodia such as paxillin. However, this would also involve 
overexpression of tagged proteins which could affect cell morphology. If FRET was not 
successful, colocalisation of PIX with GIT 1/2 and paxillin in PAK2-depleted cells could be 
investigated by immounofluorescence on fixed cells. It would also be helpful to know the
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localisation o f PAK1 and PAK2 in this system. The PAK1 antibody does not seem to be 
specific when used for immunofluorescence as it stains a protein in ruffles in PAK1'7' 
mouse macrophages (Smith, S., personal communication). Preliminary results from the 
PAK2 antibody localised PAK2 to membrane ruffles and also gave punctate staining 
throughout the cytoplasm (data not shown). It would be interesting to test other PAK1 
antibodies to investigate whether it is localised with GIT 1/2 in PAK2-depleted cells 
following HGF treatment. A change in the level o f phospho-paxillin or increased 
localisation to the leading edge would also provide evidence for this model.
As well as possible differences in substrate, isoform-specific localisation or activity 
probably plays a role in the different functions o f PAK1 and PAK2. Most o f the previous 
work to identify Rho GTPase binding partners for PAKs has focussed on PAK1 and as yet 
only Racl and Cdc42 have been shown to bind PAK2 but it is probable that others will be 
identified in future (See Table 1.1, Section 1.7.1.1). Comparison o f the structural 
characteristics o f PAK1 and PAK2 shows that PAK1 has three additional putative SH3- 
binding regions between the regulatory and kinase domains. Possible binding partners for 
these regions remain to be identified but their presence suggests that PAK1 might bind a 
different subset o f adapter proteins than PAK2. It is also possible that PAK1/2 differ in 
their GTPase-independent activation; PAK2 is the only isoform that has been shown to be 
activated by cleavage (Rudel and Bokoch, 1997) but whether this plays any role other than 
in apoptosis is unknown. Also, so far only PAK1 has been shown to be activated by 
Filamin-A binding (Vadlamudi et al., 2002).
The role o f PAK4 in the migration o f DU 145 and PC3 cells was not clear from this 
investigation. It has recently been shown that knockdown o f PAK4 in PC3 cells leads to 
decreased migration o f serum-starved cells in response to HGF (Ahmed et al., 2008), a 
finding not replicated by the present study using growing cells. This suggests that the role 
o f  PAK.4 in PC3 cell migration may be specific to certain growth factor pathways and the 
loss o f  PAK4 could be compensated for in growing conditions. Results in DU 145 cells 
suggested that PAK4 does play some role in cell migration or scattering but variation 
between oligomers meant that it was not possible to determine the role. In the future it 
would be interesting to test siRNA oligomers with a chemical modification to decrease off- 
target effects.
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Results from PAK4 knockdown as well as PAK1 or PAK2 knockdown experiments 
highlight the problem o f off-target effects associated with siRNA and the need for adequate 
controls. This is particularly evident in wound healing experiments in DU 145 cells where 
oligomer PAK2b slowed wound healing significantly whereas all three other PAK2 
oligomers had no effect (Figure 4.22). It also appears that oligomers that give a similar 
phenotype in one assay can give a significantly different phenotype in another. For 
example, oligomers PAK2b and PAK2c gave similar phenotypes in scattering assays but 
only oligomer PAK2c impaired migration through Matrigel. However, results from the 
observation o f protein phosphorylation following HGF stimulation were consistent between 
the pairs o f oligomers chosen suggesting that RNAi is a robust technique to study cell 
signalling. Therefore, the differences in morphological and functional phenotypes between 
siRNAs directed to a common target are likely to be due to the off-target knockdown o f 
unrelated signalling pathways.
In this study, off-target effects were observed even though an siRNA concentration o f 3.3 
nM was used which is 15-30 fold lower than the concentrations used in many publications. 
This highlights the need to validate results by the use o f multiple separate and different 
siRNA oligomers against a single target and argues against the use o f pools o f siRNA 
oligomers. Using a pool o f oligomers is likely to multiply off-target effects and increase the 
risk o f a false-positive phenotype unless each individual oligomer in the pool is titrated to 
such a low concentration that it would not decrease protein expression when used alone. 
This also has implications when knocking down two different proteins simultaneously i.e. 
the risk o f an off-target phenotype is likely to increase with the number o f different 
oligomers, used as observed in this study when PAK.1 and PAK2 were knocked down 
together. Hopefully in the future, modification o f siRNA to reduce off-target effects will 
make double-knockdown experiments more reliable.
As an alternative to using siRNA, the migration and morphology o f cells isolated from 
PAK knockout mice could be investigated. This method also has a drawback in that 
compensation can occur where the gene expression profile might be different from control 
mice to knockout mice. This could be avoided by using the cyclisation recombination 
(Ctq)/LoxP inducible knockout system where transgenic mice are generated with a Cre
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gene under the control o f an inducible promoter and LoxP  recombination sites flanking the 
gene to be knocked out. Cre expression can then be induced in isolated cells in vitro leading 
to recombination o f the LoxP  sites and knockout o f the gene o f interest. However, using a 
knockout mouse does not allow the functions o f a protein in human cancer cells to be 
investigated.
The potential roles for PAK3, PAK5 and PAK6 in cancer cell migration were not addressed 
in this study and will be an important subject for future work. PAK6 has been shown to be 
upregulated at the mRNA level in several cancer cell lines although this is not as frequent 
as PAK4 upregulation (Callow et al., 2002). PAK6 is believed to play a role in the 
inhibition o f androgen receptor (AR) signalling (Lee et al., 2002; Schrantz et al.. 2004). An 
early stage o f prostate cancer is androgen-dependent growth, and inhibition o f AR 
signalling is known to be an effective treatment at this early stage. This suggests that the 
upregulation o f PAK6 in cancer is not relevant to progression o f the disease. However, it is 
not known whether PAK6 plays another role. In the case o f PAK5, it was suggested that it 
could be functionally redundant because the PAK5-null mouse had no detected 
abnormality, but emerging evidence implies that PAK5 activates Raf-1 and targets it to 
mitochondria (Li and Minden, 2003; Wu et al., 2008). PAK5 is also the only PAK that has 
been shown to bind RhoD and RhoH suggesting it is differentially regulated to the other 
PAKs (Wu and Frost, 2006). Whether PAK5 has a role in cancer is still unclear. PAK3 is 
highly homologous to the other group I PAKs and is thought to have similar substrate 
specificity implying that it could play a role in cancer cell migration if upregulated. It 
would be interesting to compare the expression o f PAK3 in normal and cancerous tissue. If 
PAK3 overexpression occurs it would be a candidate for a role in cancer metastasis.
PAK isoforms have previously been shown to be upregulated in cancer (Callow et al., 
2002) and the findings that the knockdown o f PAK 1 or PAK2 slows the migration speed o f 
PC3 cells, and PAK1 depletion inhibits scattering o f DU 145 cells agree with the suggestion 
that they could be important in cancer metastatis. A possible direction for future work 
would be to investigate how depletion o f PAK1 or PAK2 affect the migration o f cells in 
three dimensions (3D) or in an in vivo model. The question o f how two dimensional (2D) 
migration assays relate to cancer metastasis in vivo has been a subject o f debate for years. It 
has been shown that the composition and organisation o f celLmatrix adhesions differs
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between 2D and in vivo and stress fibres have only been found in vascular endothelial cells 
in vivo (Cukierman et al., 2001; Wong et al., 1983). It has also been shown in vivo that cells 
can migrate and invade in a 3D environment in an amoeboid manner as well as a 
mesenchymal manner (reviewed in (Friedl and Wolf, 2003)). The need to study cell 
migration and invasion in a 3D setting has led to the development o f in vitro assays in 
which cells are embedded or buried in a matrix often derived from the extracellular matrix 
o f a mouse tumour (Lee et al., 2007). Furthermore, advances in multi-photon excitation 
fluorescence microscopy have made it possible to image tumour cells moving in vivo in 
mouse models (W yckoff et al., 2006). Nevertheless, the study o f 2D cell migration and 
cancer cell scattering provides a simple system to determine proteins o f relevance to cell 
motility and to investigate cell signalling in detail.
In summary, in this project a novel regulatory pathway from PAK2 to PAK1 has been 
identified which clearly shows that PAK1 and PAK2 have independent functions. 
Differences between the effects o f siRNA knockdown o f PAK1 or PAK2 on cancer cell 
migration have been characterised which could be caused by a combination o f isoform- 
specific protein localisation and substrate specificity.
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